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ABSTRACT

Immunoglobulins (Igs) are expressed exclusively in B lymphocytes to protect
vertebrates from invading pathogens. This dissertation is designed to better understand
the mechanism by which B cells and plasma cells produce functional lg proteins. An lg
molecule consists of two identical heavy and two identical polypeptide light chains. The
genes encoding heavy and light chains are assembled from gene segments (V, D, and J)
through DNA rearrangements during B cell development. If these rearrangements do not
preserve the translational reading frame, the resulting lg gene very likely contains a
premature translational stop (a nonsense codon) and is, therefore, a nonproductive gene.
Since both lg alleles can be rearranged, a B cell might end up with a productive (i.e.,
a gene without a nonsense codon) and a nonproductive lg gene. The µ gene encodes the
heavy chain of IgM, which is the main lg isotype produced in a primary immune
response. Our laboratory has previously shown in hybridomas and pre-B cell lines that
a µ gene with a nonsense codon is transcribed at the same rate as a µ gene without a
nonsense codon. In contrast, the cytoplasmic steady-state level of µ mRNA with a
nonsense codon is 30-100 times lower than the steady level of µ mRNA without a
nonsense codon. Based on these data we proposed that µ mRNA with a nonsense codon
is degraded faster than µ mRNA without a nonsense codon in B cells.
To elucidate the mechanism of this nonsense codon-mediated reduction of lg
mRNA, I first determined in which subcellular compartment this reduction in lg mRNA
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level occurs. By using Northern blot analysis, I found that the level of matureµ mRNA
containing a nonsense codon is reduced in the nucleus by approximately seven fold when
compared to the level of µ. mRNA without a nonsense codon. In contrast, µ precursor
RNA increases in the nucleus of hybridomas that contain nonsense codons in their µ
genes by at least 2 fold, suggesting that a nonsense codon decreases the splicing
efficiency ofµ precursor RNA. I also showed that the presence of a nonsense codon
correlates with an accelerated turnover rate ofµ mRNA in the cytoplasm, suggesting that
in the cytoplasm the reduction of µ mRNA level with a nonsense codon is, at least
partially, due to the increased degradation rate. From these data, I conclude that the
reduction of cytoplasmic level ofµ mRNA with a nonsense codon results from both a
nuclear as well as a cytoplasmic event. These events may contribute to the potent
efficiency of humoral immune response by preventing the translation of nonproductive
lg mRNAs in B cells.
I have also attempted to test a possible mechanism, the translational translocation
model, which explains how a nonsense codon triggers the reduction of mRNA in the
nucleus. From the results of three different approaches, I suggest that the translational
translocation model is not the mechanism by whichµ mRNA with a nonsense codon is
reduced in the nucleus of plasma cells.

CHAPTER I
REVIEW OF RELATED LITERATURE

1.1

Nonsense Codon-Mediated RNA Degradation
A nonsense codon is a premature translational termination signal that is in-frame

with the translational initiation codon in a messenger RNA (mRNA). Nonsense codonmediated RNA degradation refers to the phenomenon by which nonsense codons can
trigger the rapid degradation of a mRNA. It is a unique phenomenon because there are
many out-of-frame stop codons in a mRNA that have no effect on RNA metabolism.
Only those stop codons that are in-frame with the translation initiation codon in a mRNA
can trigger RNA degradation (Daar and Maquat, 1988; Belgrader and Maquat, 1994;
Pulak and Anderson, 1993). In other words, a single nucleotide change may result in
RNA degradation. This is a fascinating system for cell biology because it prevents the
production of truncated proteins. Although not all truncated proteins are disruptive to a
cell, a cell is protected from those that are deleterious by eliminating all mRNAs
containing nonsense codons. Nonsense codons have been reported to be responsible for
many human diseases, such as the B-globin gene of B-thalassemia (Humphries et al. ,
1984; Takeshita et al., 1984) and the human fibrillin (FBNl) gene of Marfan syndrome
(Diatz et al., 1993). Nonsense codons in the unc-54 myosin heavy chain gene of

Caenorhabditis elegans have been reported to disrupt the body-wall muscle ultrastructure.
3

4

The affected C. elegans have reduced brood size (Pulak and Anderson, 1993).
The steady-state level of mRNA actually represents a balance between the rate of
nuclear RNA synthesis (transcription), the rate of nuclear RNA precursor processing, the
extent of intranuclear mRNA degradation, the rate of mRNA transport from the nucleus
to the cytoplasm, the rate of cytoplasmic mRNA degradation, and the efficiency of
protein translation (Ehretsmann et al., 1992; Belasco and Brawerman, 1993). Among
them, the regulation of mRNA stability has been shown to be a major control mechanism
in gene expression in the last decade (Atwater et al., 1990; Sachs, 1993; Decker and
Parker, 1994). The decay rates of mRNAs can differ from each other by more than 50
fold in eukaryotic cells (Ross, 1989; Atwater et al., 1990; Sachs, 1993). The high degree
of stability of some mRNAs, such as the globin mRNAs, contributes to their
accumulation to high steady-state levels (Aviv et al., 1976). Highly unstable mRNAs
with half-lives of about 10-15 minutes, such as the lymphokine and protooncogene
mRNAs, are normally present at low steady-state levels (Kelly et al., 1983; Greenberg
and Ziff, 1984). Although low mRNA steady-state level could be achieved through a low
rate of transcription, the time course of changing the mRNA level in response to a
stimulus is determined solely by the turnover rate of the mRNA, which permits rapid
cessation of the production of a protein and its more rapid induction (Ross, 1989). This
is of particular importance in the case of proteins that play critical regulatory roles for
brief periods during a development process or physiological transitions. Notably, shifts
in mRNA stability (i.e., massive reorganization of the pattern of gene expression)
contribute to Xenopus oocyte and early embryo development and erythroid differentiation

5
(Richter, 1991; Krowczynska et al., 1985); the synthesis of histones, which takes place
only during the S phase of the cell cycle (Gallwitz, 1975).
A nonsense codon might potentially influence the steady-state level of a mRNA
by influencing any or all of the regulatory processes described above. Indeed, nonsense
codons have been reported to have various effects on mRNA metabolism. Among them,
the importance of translation to mRNA stability is particularly important for mRNAs with
nonsense codons (see reviews in Atwater et al., 1990; Belasco and Brawerman, 1993).
Consistent with the assumption that nonsense codons are recognized during translation
in the cytoplasm of eukaryotic cells, the lower steady-state level of most mRNAs that
contain nonsense codons is attributed to their increased turnover rates in the cytoplasm.
Some examples are the yeast URA3 mRNA (Losson and Lacroute, 1979) and HIS4
mRNA (Herrick et al., 1990), Rous sarcoma virus gag mRNA (Barker and Beemon,
1991), human and mouse {j-globin mRNA (Maquat et al., 1981; Takeshita et al., 1984;
Lim et al., 1992), and mouse histone mRNA (Graves et al., 1987). However, several
recent studies suggest that nonsense codons may decrease the steady-state level of their
mRNAs by influencing of nuclear processing, and/or transport without affecting their
cytoplasmic stability. Several examples are human {j-globin mRNA (Humphries et al.,
1984), mouse lg heavy chain µ mRNA (Connor et al., 1994), hamster dihydrofolate
reductase mRNA (Urlaub et al., 1989), human {j-globin mRNA under the control of the
simian virus 40 promoter in Syrian hamster cells (Baserga and Benz, 1992), nonstructural
protein NS2 mRNA of the minute virus of mice (MVM) (Naeger et al., 1992), human
triosephosphate isomerase (TPI) mRNA (Cheng and Maquat, 1993), the T cell receptor
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13 mRNA (Qian et al., 1993), v-src mRNA of avian sarcoma virus (Simpson and
Stoltzfus, 1994), and mouse lg K light chain mRNA (Lozano et al., 1994). In all of these
cases the exact degradation mechanism has not been elucidated; however, for
nonstructural protein NS2 of the minute virus of mice (MVM) (Naeger et al., 1992) and
mouse lg

K

light chain (Lozano et al., 1994), it has been suggested that nonsense

mutations influence the nuclear RNA processing events by inhibiting splicing. It is
puzzling, however, how nonsense codons can affect nuclear mRNA processing, since
nonsense codons are recognized in a fully spliced transcript (mRNA) in the cytoplasm
during protein synthesis. Possible mechanisms are discussed in section 1.2 in detail.
Many cis-acting elements have been reported to be involved in nonsense codonmediated mRNA degradation, such as the coding regions (Cleveland, 1988; Parker and
Jacobson, 1990; Peltz et al., 1993), introns (Cheng et al., 1994), and 3'-untranslated
regions (Jackson, 1993). Genes encoding factors that specifically degrade certain
mRNAs with nonsense codons, while having no effect on functional mRNA, have been
cloned and characterized as up frameshift (UPF) genes in yeast Saccharomyces cerevisiae
(Leeds et al., 1991; Leeds et al., 1992) and smg genes in C. elegaris (smg denotes
.s_uppressor with morphogenetic defects on genitalia) (Pulak and Anderson, 1993). The
mammalian gene encoding for the nonsense codon-specific degradation factor has not yet
been cloned.

1.2

Mechanism of Nonsense Codon-Mediated mRNA Reduction in the
Nucleus
Although little is known about the mechanism of nonsense codon-mediated
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reduction of mRNA, several models have been proposed to explain nonsense codonmediated RNA reduction in the nucleus. Since the only identified and accepted system
that can recognize a nonsense codon is the translational machinery in the cytoplasm of
eukaryotic cells, it has been reasoned that mRNA with a nonsense codon should be
recognized and degraded in the cytoplasm. Based on this assumption, Urlaub et al.
(1989) proposed an elegant model to link the cytoplasmic translation event to the nuclear
RNA processing and nucleus-to-cytoplasmic transport events. The essence of Urlaub's
model suggests that the initiation of cytoplasmic µ protein translation starts before the
completion of RNA processing in the nucleus and the nucleus-to-cytoplasm transport.
Once the 5' end of the RNA transcript has been processed with a cap structure and
spliced, the partially processed RNA begins transport to the cytoplasm via the nuclear
pore. The binding of ribosome subunits and initiation factors to the free 5' end of the
RNA transcript on the cytoplasmic side of nuclear membrane initiates µ protein
translation. The translation in the cytoplasm serves as a force to facilitate not only the
splicing of the 3' part of the RNA transcript but also the export of fully spliced nuclear
mRNA from the nucleus to the cytoplasm. This model requires that recognition of a
nonsense codon occurs after splicing in the cytoplasm, and has been best studied by
Maquat and colleagues with human TPI mRNA.
Maquat et al. showed that nonsense codons located within the first three-fourths
of the coding region of TPI mRNA reduce the level of TPI mRNA to 20 to 30 % of
normal (Cheng et al., 1990; Cheng and Maquat, 1993). This reduction is not attributable
to a decrease in the half-life of cytoplasmic TPI mRNA (Cheng et al., 1990). Maquat et
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al. further determined that this reduction of TPI mRNA is dependent on the

translatability of mRNA with nonsense codons. They showed that nonsense codonmediated reduction of TPI mRNA is at least partially inactivated by a stem-loop in the
5'-UTR (that acts in cis to inhibit translation initiation by the 40S ribosomal subunit), or
by a suppressor tRNA (that acts in trans to suppress the nonsense codon (Belgrader et
al., 1993). Maquat et al. have further shown that deletion of a 5' splice site of the TPI

gene results predominantly in the removal (by skipping) of the upstream exon (that
contains the nonsense codon) as a part of the flanking introns (Belgrader et al., 1994).
Based on these data, Maquat et al. concluded that translation is required in the nonsense
codon-mediated reduction of TPI mRNA in the nucleus, and that the recognition of a
nonsense codon occurs after splicing. Since they did not separate the cytoplasmic
compartment from the nuclear compartment in their studies, they did not distinguish
whether the recognition of nonsense codons occurs in the cytoplasm or in the nucleus.
They also did not rule out the possibility that the stem-loop in the 5'-UTR or a
suppressor tRNA abrogated the effect of nonsense codons on TPI mRNA level by
competitive binding to the translational machinery. Thus, I do not think they have tested
the translational translocation model.
A variation of the translational translocation model proposes that the recognition
of nonsense codons in the cytoplasm sends out a degradation signal to the nucleus via the
continuous cellular network or tracks with which both nuclear and cytoplasmic mRNAs
may associate (Maquat, 1991; Belgrader et al., 1993). The mRNA localization pathway
involved in processing and transport was reviewed by Wilhelm and Vale (1993); and the
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relationship between mRNA and the cytoskeletal framework was reviewed by Pachter
(1992). This model argues against the pulling effect of translation on RNA processing.
I think there are two main requirements to validate this model. First, mRNA export from
the nucleus into the cytoplasm travels in a locomotive track; and secondly, disruption of
the transport track (such as the important components) abrogates the nonsense codonmediated reduction of mRNA.
An alternative model, the nuclear scanning model, proposes that the recognition
of a nonsense codon occurs in the nucleus and not in the cytoplasm before or at the time
of RNA splicing (Urlaub et al., 1989; Nagger et al., 1992). The recognition of nonsense
codons before RNA splicing is hard to imagine since it requires that the recognition
system distinguish exons from introns and recognize the correct open reading frame in
separate exons. There is as yet no convincing biochemical or structural data showing that
the nucleus has translational machinery like that of the cytoplasm. Thus, no direct test
for this model has been carried out. The best data supporting this model are that
nonsense codons trigger exon skipping in mutated genes (Diatz et al., 1993; Belgrader
and Maquat, 1994). If these data are true, a nuclear process is clearly involved in the
nonsense codon-mediated mRNA degradation because exon skipping has to occur at the
time of splicing. Recently, Maquat et al. showed that TPI mRNA with nonsense codons
is degraded in the nucleus (Belgrader et al., 1994). This result suggests that the
recognition of a nonsense codon occurs on the mature mRNA in the nucleus. This is a
variation of the nuclear scanning model. In summary, to validate the nuclear scanning
model, one needs to show that: 1) the recognition of stop codons that are in-frame with
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the translational initiation codon on unspliced and spliced RNAs in the nucleus; and 2)
there are, at least part of, the translational-like machinery (such as ribosomal subunit or
tRNA) in the nucleus to perform the function of scanning.

1.3

lg Gene Expression during B Cell Development
Immunoglobulins (Igs) are exclusively expressed in B lymphocytes of higher

vertebrates. An lg molecule consists of two identical heavy (H) and two identical light
(L) polypeptide chains. In bone marrow stem cells, there are no complete genes for lg
chains, only gene segments. During differentiation of B cells from stem cells in the bone
marrow, these gene segments are randomly shuffled by an ordered progression of DNA
rearrangements that are capable of generating tremendous different specificities (Alt et

al., 1984; Okada and Alt, 1994). This tremendous diversity in lg structure allows a
vertebrate to respond to a vast number of potential antigens (Kuby, 1994).
For example, at the H chain locus of chromosome 12 in the mouse, there are
about 300-1,000 VH, about 12 diversity

(D~,

and 4 joining

(J~

gene segments. In the

pre-B cells, a H chain gene is formed by assembling one gene segment of each type.
Thus, there is a large combinatorial diversity for the H chains. Further diversity of lg
molecules is mainly generated by somatic mutations (Tonegawa, 1983; Honjo, 1983).
The mutation rate in pre-B cell line is reported to be 0.3-1 X 104 per cell generation
(Wabl et al., 1985). B cells also rearrange light chain genes through a similar process,
and express both heavy and light chains that are assembled into functional lg molecules.
These lg molecules are expressed on the cell surface of B cells (Wall and Kuehl, 1983;
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Tonegawa, 1983). Thus mature B cells are antigenically committed to specific epitope.
When these cells encounter their corresponding antigen they become activated and
differentiate into plasma cells that secrete more than 2,000 molecules of lg per second
(Tonegawa, 1985). This B cell differentiation process is accompanied by a 10-100 fold
increase in the cytoplasmic steady-state level oflg mRNA (Perry and Kelley, 1979; Jack

et al., 1989), which is regulated by post-transcriptional mechanisms (Gerster et al.,
1986; Kelly and Perry, 1986), mainly at the level of mRNA stability (Mason et al.,
1988; Jack et al., 1989; Cox and Emtage, 1989; Genovese and Milcarek, 1990). The
half-lives of lg mRNA increase from 2 to 5.5 hr in B cell lines to 13-34 hr in plasma cell
lines, depending on the cell lines and the methods used (Mason et al., 1988; Cox and
Emtage, 1989; Genovese and Milcarek, 1990).
µ mRNA encodes the heavy chain oflgM, which is the major lg isotype produced

during the primary response (Kuby, 1994). The µ gene consists of a leader, a VDJ, four
constant, and two membrane exons. Generation of a functionalµ gene requires first a Dto-J and then a V-to-DJ rearrangement event, which generates a VDJ exon. These
rearrangements do not always preserve the correct reading frame and the resulting lg
mRNA transcribed from that gene may encounter premature termination codons
(nonsense codons). A B cell contains two lg alleles. If one allele rearranges
nonproductively, the cell goes on to rearrange the other allele. In mouse, 40-80 % of B
cells rearrange the second allele of lg genes. Thus a B cell may contain both productive
and nonproductive lg genes (Altenburger et al., 1980; Reth and Alt, 1984; Alt et al.,
1984; Atkinson et al., 1991). If both alleles fail to rearrange productively, B cell
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differentiation will be terminated (Alt et al., 1984).

1.4

B Cells Have a Mechanism to Eliminate lg mRNA Containing Nonsense
Codons
Jack et al. have shown by nuclear run-on assays that both productive and

nonproductiveµ genes are transcribed at the same rate (Jack et al., 1989); therefore, one
would expect to find a large amount of nonproductive lg mRNAs in B cells. But by use
of RNA dot blot analysis, they found that the cytoplasmic steady-state level of
nonproductive µ mRNAs is 60-100 fold lower than the level of the productive µ mRNAs
(Baumann et al., 1985; Jack et al., 1989). A similar phenomenon was also observed in
the pre-B cell lines (Jack et al., 1989). Based on these observations, l propose that B
cells have a mechanism to eliminate immunoglobulin RNA containing nonsense codons.
This is consistent with emerging data in the field of that almost all cytoplasmic lg heavy
chain mRNAs (approximately 99 %) in peripheral B cells are productive as revealed by
sequencing µ cDNA clones obtained from the spleen cDNA libraries.
l reason that it is very important for B cells to have a mechanism to eliminate lg
mRNAs that contain nonsense codons. As discussed before, the tremendous diversity for
antigens is a phenomenon unique to lgs. It is mainly generated by assembling variable
regions from hundreds of gene segments of H and L chain genes and by somatic
mutation. Thus the probability for B cells to generate nonsense codons in lg genes is
higher than for other genes.

Ifµ

mRNA with nonsense codons could be translated at the

same rate as µ mRNA without nonsense codons, the resulting truncated µ protein may
assemble with a complete µ protein and two functional light chains to form a chimeric
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antibody. Heavy chains translated from productive and nonproductiveµ mRNAs very
likely encode different antigen-binding specificities.

The one expressed from

nonproductive allele may be self-reactive. Thus, if B cells do not reduce the amount of
µ mRNA with nonsense codons, they would express bi-specific antibodies on the surface,

which may result in autoimmunity.
It is also important for plasma cells to have a mechanism to eliminate lg mRNAs

that contain nonsense codons. Plasma cells are terminally differentiated B lymphocytes,
in which more than 2,000 molecules of Igs are produced per second (Tonegawa, 1985).
In plasma cells, lg mRNA comprises about 10% of poly (A)+ mRNAs in the cytoplasm
(Schibler et al., 1978), and accounts for 20-30% of the total protein synthesis in plasma
cells. In the case of heavy chain µ mRNA, if both µ mRNAs with or without a nonsense
codon could be translated intoµ chains,µ mRNA with a nonsense codon (nonproductive)
will compete with the µ mRNA without a nonsense codon (productive) for the
translational machinery. In addition, the truncatedµ heavy chains will compete with the
functional heavy chains for the binding with the light chains. Thus, the amount of
functional antibody molecule will be decreased. Since the amount of lg protein has been
shown to be crucial for the success of an effective humoral immune response, the
production of large amounts of truncated µ chains would interfere with an efficient
humoral immune response. That is, the production of antibodies would not be large
enough to eliminate the pathogen. The efficiency of the humoral immune response could
also be decreased because the truncated proteins would lack the carboxyl-terminal ends
that mediate important functions of Igs, such as binding to the Fe receptor, binding to
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the heavy chain binding protein Bip (a chaperone) within the endoplasmic reticulum, or
binding and activating complements (Kuby, 1994). In addition, the truncatedµ proteins
could not be secreted into the extracellular environment, presumably they would be
trapped in the endoplasmic reticulum (Li and Jack, see Chapter IV). The accumulation
of truncated µ proteins in the endoplasmic reticulum of plasma cells might destroy the
architecture of cells, as it has been shown in C. elegans (Pulak and Anderson, 1993).

1.5

The Mechanism of Nonsense Codon-Mediated Reduction ofµ mRNA in
Plasma Cells
The main observation leading to this dissertation is that the amount of cytoplasmic

µ mRNA with a nonsense codon is 60-100 fold lower than the amount of µ mRNA

without a nonsense codon, although their transcriptional rates are the same (Jack et al.,
1989). The objective of this dissertation is to understand the mechanism of nonsense
codon-mediated µ mRNA reduction in plasma cells.
The lower cytoplasmic steady-state level ofµ mRNA with a nonsense codon
might result from either a cytoplasmic or a nuclear event, or both. These events include
nuclear RNA processing (capping, splicing, or polyadenylation), nuclear RNA
degradation, nucleus-cytoplasm export of RNA, cytoplasmic RNA degradation. To
determine whether a cytoplasmic or a nuclear event is involved in the reduction of µ
mRNA with nonsense codons, I will isolate RNA from the nuclear and cytoplasmic
fractions of plasma cells, and quantify the levels of µ RNA in the two cellular
compartments by Northern blot analysis.

Ifµ

mRNA with a nonsense codon is reduced

only in the cytoplasm and there is no blocking of RNA export from the nucleus to the
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cytoplasm, I would expect to find that the nuclear RNA level is the same forµ mRNA
with or without a nonsense codon. In contrast, if µ mRNA with a nonsense codon is
reduced in the nucleus, I would expect to find that the nuclear µ RNA level with a
nonsense codon is lower than that ofµ mRNA without a nonsense codon. Additionally,
the cytoplasmic degradation could be an independent event from the nuclear degradation.
Therefore, I will further determine whether µ mRNA with a nonsense codon is also
degraded in the cytoplasm by measuring the cytoplasmic decay rates of endogenous µ
genes using two well established inhibitors of RNA synthesis, Actinomycin D and DRB.
If µ mRNA with a nonsense codon is degraded faster in the cytoplasm than µ mRNA

without a nonsense codon, I would expect to find µ mRNA without a nonsense codon has
a decreased half-life. The results of these experiments are presented in Chapter III.
Knowing thatµ mRNA with a nonsense codon is degraded in both the nucleus and
the cytoplasm of plasma cells, I modified the testable translational translocation model
(Urlaub et al., 1989) to explain the mechanism of how a nonsense codon triggers the
reduction of µ mRNA in the nucleus. The preliminary results of three different
approaches to test the model are summarized in Chapter IV.

CHAPTER II
MATERIALS AND METHODS

2.1

Chemicals and Reagents

2.1.1

General Chemicals and Reagents
All general chemicals were molecular biology grade and were purchased from

Fisher Scientific (Pittsburgh, PA), Sigma Chemical Co. (St. Louis, MO) and Boehringer
Mannheim (Indianapolis, IN). DRB and hygromycin B were purchased from CalBiochem
(San Diego/La Jolla, CA); Actinomycin Cl, ampicillin (sodium salt) and potassium
acetate from Boehringer Mannheim (Mannheim, Germany); polyacrylamide, AGR501-X8
(D) (Mix bead resin), APS, gelatine, glycerol, TEMED, BIS and Tween 20 from BioRad (Richmond, VA); antibiotic medium, tryptone, yeast extract and Bacto-agar from
Difeo (Detroit, MI); mycophenicol acid (MPA), Geneticin (G-418 Sulfate), cesium
chloride (ultra pure), DTT, LB base, Penicillin-Streptomycin (500 units/ml) and RPMI
1640 powder from Gibco BRL Life Technologies, Inc. (Gaithersburg, MD); dextran
sulfate from Pharmacia (Uppsala, Sweden); ethyl alcohol (absolute) from Aaper Co
(Shelbyville, Kentucky); FCS from HyClone (Logan, Utah); universal autoradiography
enhancer (Intensify Part A and B) from DuPont NEN (Boston, MA); iodoacetamide and
Triton X-100 (pure) from Serva (Heidelberg, Germany); Non-fat dry milk from Real
(Los Angeles, CA); sodium hydroxide from Mallinckrodt (St. Louise, MO); scintillation
16

17
liquid (Econo-Safe) from RPI (Mount Prospect, IL). All solutions were prepared in
deionized water unless otherwise indicated.

2 .1. 2

Radiochemicals
[a-32P] dCTP (PB.165/10165/10385)

Amersham, Arlington Heights, IL

Redivue [a-32P]dCTP (AA0075)

Amersham, Arlington Heights, IL

[a-35S] dATP (SJ.264/1304)

Amersham, Arlington Heights, IL

L-[35S] Methionine (SJ. 204)

Amersham, Arlington Heights, IL

[

2.1.3
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C] methylated proteins (CFA.626)

Amersham, Arlington Heights, IL

Trans 35S-label (Cat# 51006)

ICN Biomedicals, Irvine, CA

[ -y-32P] dATP (Cat# 35020)

ICN Biomedicals, Irvine, CA

Kits
Cytoplasmic RNA isolation kit

5 Prime-+3 Prime, Inc.®, West

Chester, PA
DNA 5'-end labeling kit

Boehringer Mannheim, Germany

Magic mini prep kit

Promega, Madison, WI

Nick-translation kit

Gibco BRL, Gaithersburg, MD

pGEM-T vector system I

Promega, Madison, WI

Sequenase kit (version 2.0)

United

States

Biochemical,

Cleveland, OH
Site-directed mutagenesis kit

Promega, Madison, WI
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Superscript cDNA library kit

GIBCO BRL, Gaithersburg, MD

RNAzol™ B

Tel-Test, Inc., Friendswood, TX

TRizol™ Reagent
(Total RNA Isolation Reagent)

GIBCO BRL, Gaithersburg, MD

2.1.4

Antibodies

2.1.4.1

Antibodies Used for Immunofluorescence Analysis
Goat anti-mouse µ-FITC

Fisher Biotech, Pittsburgh, PA

Goat anti-mouse K-Tex Red

Fisher Biotech, Pittsburgh, PA

2.1.4.2

Antibodies Used for Immunoprecipitations

Goat anti-mouse IgM

2.1.5

Southern Biotech, Birmingham, AL

Molecular Weight Standards
Bacteriophage c/>Xl 74 DNA markers

Gibco BRL, Gaithersburg, MD

lKb DNA Ladder

Gibco BRL, Gaithersburg, MD

A DNA/HindIII fragments

Gibco BRL, Gaithersburg, MD

0.24-9.7 Kb RNA Ladder

Gibco BRL, Gaithersburg, MD

Rainbow protein marker

Amersham,

Buckinghamshire,

England
[
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C] methylated proteins (CFA.626)

Amersham, Arlington Heights, IL
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2.2

Oligonucleotides and Linkers

2.2.1

Oligonucleotides
All oligonucleotide primers for the polymerase chain reaction (PCR) and site-

directed mutagenesis were designed with the aid of an oligonucleotide software analysis
program (OligoTll, National Bioscience, Plymouth, MN) and synthesized by National
Biosciences (Plymouth, MN).

2.2.1.1

Sequencing
V8 17.2.25.2: 17 bases; Tm=61.1°C
5' -CATAAGGACATTCCAGC-3'
SP6 primer: 19 mer;
5'-d(GATTTAGGTGACACTATAG)-3'

T7 primer: 20 mer;
5'-d(TAATACGACTCACTATAGGG)-3'
M13 primer (-40): 17 mer;
5' -d(GTTTTCCCAGTCACGAC)-3'

2.2.1.2

Site-Directed Mutagenesis

Leader mutated primer: 57 bases; Tm=92.7°C
5'GCCCCTTCCCTGTATCCTCTTCCTCCCGGGAGTAGGTACTCG
Smal

AGCTGCATTTCATTG-3'
(Italized nucleotides represent the mutated sequences.)
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3'Ck.Clal: 26 bases; Tm=77.6°C
5'-AAGATAGGATCGATCTGGGGAGCTGG-3'
Clal

2.2.1.3

Polymerase Chain Reaction (PCR)

2.2.1.3.1

Sense Oligonucleotides

VH81X.Forward: 34 mer; Tm=81.6°C;
5' -AGCGGCCGCACCATGGACTTCGGGCTCAGCTTGG-3'
NotI
5'Cµl.Forward: 27 mer; Tm=92.0°C
5' -TGGCCATGGGCTGCCTAGCCCGGGACT-3'
991µ3.Forward: 22 mer; Tm=51.6°C
5'-ACTGACTCAAACCATGGAATGG-3'
99lk3.Forward: 28 mer;
5'-TTGGTACCATCAGCATGAGGGTCCTTGC-3'
BamHI

2.2.1.3.2

Antisense Oligonucleotides

Cµ2Bam.Backward: 27 mer; Tm=65.0°C;
5'-GGGGTGTGGATCCTTTCTTCTCGATGG-3'
3'Cµ4.Backward: 28 mer; Tm=86.0°C
5'-GCCTGACTGAGTTCACACACAAGGAGGA-3'
3'UT.µl: 20 mer;

5 '-GGA'ITITI'I"I'I'ATTTCTAAT-3'
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3'UT.µ2: 20 mer;
5'-TATGCAACATCTCACTCTGAC-3'
3'UT.µ3: 21 mer;
5' -A(c)GACACCCAG(a)GGCCTGCCTGG-3'
991µ3.Backward: 24 mer;
5'-ATCGATTCATGACCTGAAATTCAG-3'
Clal
991k3.Backward: 28 mer;
5'-ATATCGATTAGGTAGACAATTATCCCTC-3'
Clal

2.2.2

Phosphorylated Linkers
Clal linker [d(pGATCGATC}] and Spel linker [d(pGACTAGTCTC}] were

purchased from New England Biolabs (Beverly, MA). Clal linker [d(pATCGAT}] was
purchased

from

National

Biosciences

(Plymouth,

MN).

EcoRI

linker

[d(pCGGAATTCCG)] was purchased from Amersham (Arlington Heights, IL). Nhel
amber stop linker with nonsense codons in all three reading frames

[5 ' -

pd(CTAGCTAGCTAG)-3'] was purchased from Pharmacia (Piscataway, NJ).

2.3

Enzymes
Restriction endonucleases were obtained from either Boehringer Mannheim

(Mannheim, Germany) or Gibco BRL Life Technologies, Inc. (Gaithersburg, MD);
AmpliTaqTll DNA polymerase from Perkin Elmer Cetus (Norwalk, CT); T4 DNA ligase
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and Klenow fragment from Pharmacia (Piscataway, NJ) or Promega (Madison, WI);
DNase I, RNasin (40u/µl), SI nuclease and Mung bean nuclease from Promega
(Madison, WI); RNAse A (bovine pancreas) and lysozyme from Sigma Chemical
Company (St. Louis, MO); DNA sequenase version 2.0 from United States Biochemical
(USB, Cleveland, OH); Proteinase K from Boehringer Mannheim (Indianapolis, IN);
Superscript reverse transcriptase from Gibco BRL (Gaithersburg, MD).

2.4

Bacterial Strains

2.4.1

Bacterial Strains
Escherichia coli (E. coli) strain HBlOl or JM109 or DH5a from Bethesda

Research Laboratories (BRL) and BMH 71-18 mut S from Promega were made
competent using a calcium chloride procedure (Sambrook et al., 1989). For some vectors
(such as pGEM-Zf series and pSELECT™-1) that contain a sequence coding for the E.
coli (j-galactosidase (lac Z) a-peptide, interrupted by a multiple cloning site, blue/white

color selection was used for insert selection. Colonies containing plasmids with no inserts
were blue, while those containing inserts were white when grown on Luria Broth agar
plates (1.5% Bacto-agar in LB medium, pH 7.0) containing 100 µg/ml ampicillin, 40
µg/ml X-Gal, and 5 mM IPTG.

2.4.2

Preparation of Competent Bacterial Cells

2.4.2.1

Solutions and Reagents
y-a plate (per liter)

20 g

Bacto-tryptone
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5g

Bacto-yeast extract

5g

MgS04

(Adjust pH to 7.6 with KOH)

y-b medium (per liter)

14 g

Bacto-agar

20 g

Bacto-tryptone

5g

Bacto-yeast extract

5g

MgS04

Adjust pH to 7.6 with KOH.

Tbfl

30mM

KAc

100 mM

KCI

lOmM

CaC12

50mM

MnC12

15 %

Glycerol

Adjust pH to 5.8 with 0.2 M acetic acid.

Tbt'2

lOmM

MOPS

75 mM

CaC12

10 mM

KCl

15 %

Glycerol

Adjust pH to 6.5 with KOH.
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* All solutions were filter-sterilized through a 45-µm filter and stored at 4 °C.

2.4.2.2

Procedure for the Preparation of Competent Bacterial Cells
Bacteria of interest were streaked from a frozen storage onto a y-a plate. (JM

stains must be streaked onto a minimal plate that contains no proline to maintain the F'
episome. HB 101 might start from a fresh LB plate.) A single colony of the bacteria was
inoculated into 5 ml of y-b media and shaken at 300 rpm overnight at 37°C (Gyrotory®
Shaker, Model GlO, New Brunswick Scientific Co., Inc., Edison, NJ). A secondary
culture was prepared by inoculating 500 µl of the overnight culture into 50 ml of prewarmed y-b media, and aerating at 300 rpm and 37°C for 2 to 4 hours until the OD550
has reached 0.48. The culture was chilled on ice for 5 min and centrifuged at 3000 rpm
for 5 min at 4 °C (Beckman tabletop centrifuge, Model GPR, Palo Alto, CA). Bacteria
pellet was resuspended in 40 ml of ice-cold Tbfl and incubated on ice for 5 min. After
pelleting, the bacteria was resuspended in 4 ml of ice-cold Tbf2 and further incubated
on ice for 15 min. The competent bacteria were pipetted in aliquot (e.g. 250 µl) into prechilled microcentrifuge tubes placed in an ethanol-dry ice bath, and stored at -70°C.
Efficiency of transformation was determined by transforming 50 µl of competent bacteria
with 20 ng of a plasmid DNA as described in section 2.6.8. Efficiency should approach
1 X 108 cfu/µg supercoiled DNA.
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2.5

Plasmids and DNA Probes

2. 5.1

Plasmids
From Dr. I. Haas (Bothwell et al., 1981)

pABµ-11
pBluescript II KS

+/-

pBR-H4

Strategene, San Diego, CA
Dr. R. Grossschedl, UCSF, San Francisco,
CA (Grossschedl and Baltimore, 1985a;
Grossschedl et al., 1985b)

pBR-VH 17.2.25

Dr. R. Grossschedl, UCSF, San Francisco,
CA (Grossschedl and Baltimore, 1985a;
Grossschedl et al. , 1985b)

pBS-myc

Dr. Jeff Ross, University of Wisconsin,
Madison

pCR™ II

Invitrogen Corp., San Diego, CA

pCEP4

Invitrogen Corp., San Diego, CA

p5.1

From Dr. I. Haas (Reth et al., 1984)

p-y2b(l 1)7

Dr. P. Tucker (Tucker et al. , 1979)

pGEM-zfs

Promega, Madison, WI

pGEM™-T Vector System

Promega, Madison, WI

pGm/j-actin

From Dr. Joel Pachter (Tokunaga et al.,
1986)

pP2-5'

Dr. Nahum Sonenberg, McGill University,
Montreal, PQ, Canada (Pelletier et al.,
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1988)
pRGAPDH

Dr. K. Marcus (Fort et al., 1985)

pUHDl0-1

Dr. H. Bujard (Deuschle et al., 1989)

pSV2gpt

Dr. J. Murnane (Mulligan et al., 1981)

pSV2neo

Dr. J. Murnane (Southern et al., 1982)

pTlgpt

Dr. Falkner (Altenburberg et al., 1980)

pu•

Dr. R. Grossschedl, UCSF, San Francisco,
CA (Grossschedl and Baltimore, 1985a;
Grossschedl et al. , 1985b)
Jack et al. , 1992
Li and Jack (unpublished,

see section

4.2.1.1 in Chapter IV)

2.5.2

DNA Probes
mouse {3-actin

1.9 kb HindIII/BamHI

fragment

from

pGm{3-actin
human c-myc

1 kb Clal/ Smal fragment from pBS-myc

mouse cDNA (Cµl-4)

1.1 kb Smal/Apal fragment from pABµ-11

enhancer probe of mouseµ gene

1.0 kb Xbal fragment from pµ•gpt

'Y 2b

1.0 kb Asp718/BamHI or 320 bp Sstl
fragment from pB"f2b

ratGAPDH

1.3

kb

BamHI!EcoRI

fragment

from
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pRGAPDH
gpt

1. 9 kb BamHIIHindlll

fragment from

pSV2gpt. 2Xhol
Histone 2b

Oncor. Inc. (Gaithersburg, MD) (Grandy et
al. 1982)

neo probe

2.4 kb BamHI/Hindlll fragment from
pSV2neo

5 '-UTR of poliovirus

0. 7 kb Hindlll/EcoRV fragment from pP2-5'

VX.l

1.0 kb Hindlll/Xbal fragment

2.6

DNA Manipulations

2.6.1

Plasmid DNA Preparation
Plasmids used for cloning and transfection were prepared by the alkaline lysis

method for small and large scale plasmid preparation as described by Sambrook
(Sambrook et al., 1989). A rapid, small-scale plasmid preparation method (Magic
minipreps kit, Promega Corporation, Madison, Wisconsin) was used for restriction
enzyme analysis of recombinant plasmids or small-scale DNA probe isolation (see section
2.6.4.2 below).

2.6.1.1

Solutions and Media
1 X M9CA media

2mM
2%

Glucose
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LB-Amp medium

Lysis buffer

0.1 mM

CaC12

0.0025%

Nicotinic Acid

0.005 %

Thiamine

100 µg/ml

Ampicillin

2.5%

LB

0.2%

maltose

5 mM

glucose

100 µg/ml

ampicillin

1%

glucose

lOmM

EDTA (pH 8.0)

25 mM

Tris (pH 8.0)

Lysozyme solution

30 mg/ml in lysis buffer

Alkali solution

1%

SDS

0.2 N

NaOH

(prepare fresh)

Potassium acetate (pH 4.8)

60 ml of 5M KAc

(per lOOml)

11.5 ml of glacial acetic acid
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Proteinase K buffer

Proteinase K stock

50mM

Tris, pH 8.0

10 mM

CaC12

10 mg/ml in proteinase K buffer

(store at -20°C)

RNase A stock

10 mM

Tris-HCI, pH 7.5

15 mM

NaCl

(store at -20°C)

Sodium acetate (3M, pH 5.2)

Dissolve 12.3 g NaAc (MW 82.03) in about
40 ml deionized water (0.1 % DEPC water
in the case of RNA solution). Adjust with
glacial acetic acid to pH 5. 2. Bring the
volume to 50 ml with water.

TE buffer

lOmM
lmM

TE-saturated phenol/chisam

Tris-HCl, pH 8.0
EDTA

Thaw phenol at RT before melting at 65°C
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for about 30 min. Add 8-Hydroxy Qunodine
to final concentration of 1 mg/ml phenol.
Extract the phenol with equal volume of 1
M Tris-HCl (pH 8.0) for 3 to 5 times until
the pH in TE reaches pH 7-8. Then mix 1
part of the lower, phenol phase with 1 part
of chisam (chloroform +isoamyl alcohol =
24+1).

2.6.1.2

Small Scale Preparation of Plasmid DNA (Miniprep)
A fresh, single colony was inoculated into 5 ml of LB medium (containing

antibiotics). The cultures were aerated at 300 rpm overnight at 37°C in a shaker
(Gyroto~

Shaker, Model GlO, New Brunswick Scientific Co., Inc., Edison, NJ). Next

morning, 1.5-3 ml of the overnight culture was centrifuged in an Eppendorf tube for 30
seconds at room temperature and the plasmids were isolated using a magic mini prep kit
from Promega (Madison, Wisconsin) according to manufacturer's instructions.

2.6.1.3

Large Scale Preparation of Plasmid DNA
2.5 ml of a fresh overnight culture was inoculated into 250 ml of M9CA medium

in a 1 liter flask. The bacteria culture was grown at 300 rpm and 37°C to an OD550 of
0.5-0.6 (about 4 hours) before adding 25 mg of Chloramphenicol (final concentration is
100 µg/ml, Sigma), and further aerated overnight. The next morning, the bacteria was
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pelleted by centrifugation in a swinging bucket rotor in a Beckman centrifuge (Model
GPR) at 3,500 rpm for 20 minutes at 3°C. The supernatant was discarded and the
bacterial pellet was resuspended in 5 ml of ice-cold lysis buffer on ice. 1 ml of freshly
prepared lysozyme solution (30 mg/ml in lysis buffer) was added to the suspension, and
incubated at room temperature for 5 min, followed by incubation on ice for 5 min. The
bacteria were completely lysed by incubating with 12 ml of freshly prepared alkali
solution on ice for 10 min. Proteins and chromosomal DNA were precipitated with 9 ml
of ice-cold potassium acetate solution for 20 minutes on ice and centrifuged in a Sorvall
SS34 rotor at 18,000 rpm and 3°C for 30 min (Sorvall® RC-SB Refrigerated Superspeed
Centrifuge, Du Pont Instruments, Wilmington, DE). Plasmid DNA was precipitated from
the supernatant with 1 volume of ice-cold isopropanol on ice for 20 minutes and then
centrifuged in a Sorvall SS34 rotor at 12,000 rpm and 3°C for 30 min. DNA pellet was
air-dried at room temperature for approximately 20 min. RNA in the sample was digested
by dissolving and incubating the pellet with 2 ml of TE buffer containing 50 µl of 10
mg/ml RNAse A at 37°C for 15 to 30 min. Proteins in the sample were digested by
denaturing with 125 µl of 10% SDS followed by incubating with 50 µl of 10 mg/ml
proteinase Kat 42°C for 1 hour. To extract plasmid DNA, the solution was extracted
once with an equal volume of TE-saturated phenol, twice with an equal volume of
phenol/chisam (1+1) and once with an equal volume of chisam at room temperature.
DNA was precipitated by adding 1/10 volume of 3 M sodium acetate (pH 5.2) and 2.5
volume of ethanol and incubating on ice for at least 20 min or at -20°C overnight.
Precipitated DNA was centrifuged at 12,000 rpm and 4 °C for 40 minutes, washed twice
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with 1 ml of70% ethanol, dried in a Speed Vac Concentrator (Savant, Farmingdale, NY)
and then dissolved in 250 µl of TE. 1 µl of midi-prep DNA was quantitated by restriction
enzyme digestion as described in section 2.6.2 and 2.6.5.

2.6.2

DNA Digestion
Plasmid DNA was digested with restriction endonucleases. Usually, 2-5 units of

an enzyme was added to per µg of DNA. Digestion reactions were carried out in buffers
provided by the manufacturer for each enzyme and under reaction conditions
recommended by the manufacturer. Reaction mixtures were run on 0.8-1.2% agarose
gels, as described in section 2.6.3, from which purified DNA fragments were extracted,
as described in section 2.6.4.

2.6.3

DNA Agarose Gel Electrophoresis
DNA fragments were separated on 0.8-1.2% (w/v) agarose gels. 1.12-1.68 g of

agarose (weighed in an Analytical Balance, Model XL-400D, Fisher Scientific,
Pittsburgh, PA) was dissolved in 140 ml of TAB buffer (1 X TE is 40 mM Tris-HCI,
pH 8.0, 20 mM sodium acetate, 2 mM EDTA) by boiling in a microwave. The agarose
solution was cooled to approximately 60°C at room temperature before 7 µl of ethidium
bromide (EtBr) (stock solution is 10 mg/ml) was added to a final concentration of 0.5
µg/ml. The mixture was stirred gently before it was poured into a horizontal gel casting
tray (15 X 10 cm gel tray, 15 or 20 well comb, 1.5 mm, Bio-RAD, Richmond, CA).
The gel was allowed to solidify at room temperature for about 20 min prior to being
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transferred

to a horizontal electrophoresis chamber (Wide Mini-SubTll DNA

Electrophoresis Cell, Bio--RAD, Richmond, CA) filled with TAB buffer. DNA samples
containing tracing dye (0.025% bromophenol blue in 2.5% ficoll and lX TAB) were
loaded into the sample wells of the gel and the electrophoresis was run under constant
voltage of 60 V (Power supply: Model FB 135, Fisher Scientific, Pittsburgh, PA) until
the dye front migrated to the bottom of the gel. Lambda DNA cleaved with HindIII
endonuclease and 1 kb DNA ladder (Gibco BRL) were run simultaneously to serve as the
molecular weight standards. DNA bands were viewed under an ultra violet light box (312
nm Variable Intensity Transilluminator, FBTIV 614, Fisher Scientific, Pittsburgh, PA)
and photographed on a Polaroid 667 film by a Polaroid Camera (Model DS34, Polaroid
Corp. Cambridge, MA).

2.6.4

DNA Band Isolation from the Agarose Gel
Digested DNA samples were size fractionated on 0. 8-1. 2 % agarose gels stained

with ethidium bromide. DNA fragments were visualized using ultraviolet light as
described in section 2.6.3. The appropriate fragments were cut out with a scalpel and
extracted from the agarose using the 6 M Nal isolation method described below.

2.6.4.1

6 M Nal Method of DNA Band Isolation
6 M Nal was prepared by dissolving 44.97 g of Nal (FW 149.9 g/mole) in 50 ml

deionized water at RT. The DNA-containing agarose was cut into small pieces with a
scalpel and transferred into a pre-weighed appropriate tube (either an Eppendorf tube or
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a 15 ml-Falcon tube). 2.5 to 3 volumes of 6 M Nal solution per µg of agarose was added
in the tube and incubated at 45-56°C for 10 to 20 minutes until the agarose had melted.
The tube was inverted several times during the incubation. 1 ml of Magic Mini Prep
Resin (Promega) per 30 µg of DNA was added to the melted agarose, and incubated at
room temperature for 5 min. The isolated DNA was eluted from the resin by the
procedures as described in Magic Mini prep DNA preparation provided by Promega.

2.6.5

Quantitation of DNA
The concentration of the isolated DNA fragment or plasmid was estimated by

DNA agarose gel electrophoresis (see section 2.6.3). At least 0.1 µg of DNA was loaded
on 0.8-1.0% agarose/TAE gel and the intensity of its EtBr staining was compared to the
intensity of a fragment of similar size in >. DNA/HindIII standards (Gibco BRL,
Gaithersburg, MD) for plasmid and DNA fragments that were larger than 1.6 kb or to
Bacteriophage c/>Xl 74 DNA markers (Gibco BRL, Gaithersburg, MD) for DNA
fragments that were smaller than 1.6 kb.

2.6.6

Dephosphorylation of DNA Fragment (CIP-treatment)
A kinase reaction is required to prevent the cloning vector from self-ligation.
Dephosphorylation mixture:
DNA digestion mixture:

20-30 µl

1Ox CIP buffer:

5 µl

Calf intestinal phosphatase (CIP): 0.01 unit/pmol DNA for 5' overhang)
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Deionized H20 to 50 µl total volume
For 5'-overhangs: the reaction mixture was incubated at 37°C for 30 min, after
which another aliquot of CIP was added and the incubation was repeated. For 3 ' overhangs or blunt ends: the reaction mixture was incubated at 37°C for 15 min then at
56°C for 15 min, after which another aliquot of CIP was added and the incubation at
both temperatures was repeated.
To inactivate the CIP enzyme, 20 µl of 500 mM EGTA (pH 8.0) was added to
the reaction mixture followed by heat inactivation at 65°C for 45 min or at 68°C for 15
min.

2.6.7

DNA Ligation

2.6.7.1

Solutions
10 X ligation buffer

10 X Kienow buffer

10 X dNTPs

250 mM

Tris-HCl, pH 7.6

100 mM

MgC12

100 mM

DTT

100 mM

ATP

100 mM

Tris-HCI, pH 7.5

500mM

NaCl

50mM

DTT (optional)

0.125 mM of each dNTPs
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2.6.7.2

Sticky End Ligation of DNA Fragment
A 5-10: 1 molar ratio of insert: vector DNA was used to obtain the optimal ligation

efficiency. Usually, 0.1 µg of vector DNA was used in the total volume of 15 µl of 1 X
ligation buffer. One Weiss unit ofT4 DNA ligase (Pharmacia) was added to each ligation
mixture. Ligation reactions were allowed to proceed at 15°C overnight (10 to 18 hours).
T4 DNA ligase was heat-inactivated at 70°C for 10 minutes before transformation.

2.6.7.3

Blunt-End Ligation of DNA Fragment with Phosphorylated Linkers

A 100-200 molar ratio ofphosphorylated linker:phosphorylated vector (see section

2.6.6) was usually used for each ligation. Ligation reactions were performed as described
in the above section except following the overnight incubation, the ligation reactions were
further incubated at room temperature for 4 hours.

2.6.7.4

Two-Step Ligation of DNA Fragments

Two-step ligation is a procedure to ligate two fragments that are compatible with
only one of their ends.
A. First round ligation mixture for enzyme 1 ends:

CIP-treated vector

0.5 µg

insert DNA

5-10: 1 molar ratio of insert:vector

10 X ligase buffer

1.5-2.0 µl

T4 DNA ligase

1 unit
to final volume 15 µl-20 µl
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Ligation reactions were allowed to proceed at 15°C overnight. T4 DNA ligase
was heat inactivated at 70°C for 10 minutes. (The vector self-ligation was stored at 20°C for use as a transformation control.)

B. Klenow enzyme filling in the remaining sticky end:
DNA ligation mixture

15-20 µl (from the above)

10 X Klenow buffer

3 µl

0.125 mM dNTPs

3 µl

100 mM DTT
Kienow
sterile H 20

1.5 µI
1 unit (diluted in 1 X Klenow buffer)
to final volume 30 µl

Incubate at RT (22°C) for 30 min.

C. Second round ligation for the blunt ends:
1) Ligation mixture

10 X ligase buffer

12 µl

40% PEG

15 µl

100 mM DTT

1.2 µl

T4 DNA ligase

1 unit
to final volume 120 µl

2) the ligation mixture was added to the 30 µl of Klenow reaction mixture;
3) the mixture was incubated at 15°C overnight;
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4) the following morning, the mixture was incubated at RT for an
additional 3 hours;
5) the ligase was heat inactivated at 68°C for 10 min.

D.

The ligation mixture was transformed into competent HB 101 cells as

described in 2.6.8.
1) for vector+insert: 50 ng or 100 ng/100 µl HB 101;
2) for vector control: 100 ng/100 µl HB 101.

2.6.8

DNA Transformation
For transformation, a 50-100 µl aliquot of competent cells (the amount depends

on the number of cells) was measured into a cold microcentrifuge tube containing 50-500
ng of plasmid DNA or ligation mixture. The cell/DNA suspension was mixed gently and
incubated on ice for 20-30 min, followed by a heat shock in a 42°C water bath for 45
seconds. The tubes were chilled on ice for 2 min and 1 ml of S.O.C. (2% Bactotryptone, 0.5 % yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgC12 , 10 mM
MgS04 , 20 mM Glucose) was added. The suspension was incubated for 1 hour at 37°C
with shaking (225 rpm) to allow expression of the antibiotic-resistant gene before plating
onto a LB plate containing ampicillin (100 µg/ml) or tetracycline (15 µg/ml).
Transformants were selected by standard methods described below.
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2.6.9

Screening for Recombinant DNA

2.6.9.1

Blue/white Color Screening
JM109, which contains an F' episome that carries a nutritional requirement for

growth (proline biosynthesis), is used for blue/white color screening of the pGEM-Z and
pGEM-Zf plasmids (Promega). To prepare plates containing IPTG and X-Gal, 50 µl of
2% X-Gal and 100 µl of 100 mM IPTG were spread on LB plates and allowed to absorb
for 30 min at 37°C prior to plating transformed JM109 cells. The plates were incubated
overnight at 37°C. Recombinant colonies were white while nonrecombinant colonies
were blue.

2.6.9.2

Colony Lift

The following protocol was modified after the procedures described in
manufacturer's instruction and Sambrook et al. (1989). LB plates with selective agent
containing single isolated colonies were cooled at 3 °C before use. Nylon membrane
(HyBond"'-N, Nylon, 0.45 µM, X82 mm, Cat# RPN.82N, Amersham, Arlington
Heights, IL) was overlaid onto the agar plate to allow uniform wetting. The nylon
membrane and agar gel were marked in several places with India ink. The nylon
membrane was then placed on a Whatman paper (Whatman 4 filter paper, 9.0 cm,
Whatman limited, England) soaked in denaturation solution (2 X SSC and 5 % SDS) for
2 minutes (the colony side should be upward). The DNA was fixed to the nylon by
microwaving the membrane at high power for 2.5 minutes (650 watts). The bacterial
debris was rubbed off with a glove after soaking the membranes in 2- X SSC.
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Prehybridization of the membrane was performed in a solution containing 0.5 M sodium
pyrophosphate, 1 % BSA, 7% SDS, 1 mM EDTA at 65°C for at least 1 hour.
Hybridization was performed overnight in the same solution as prehybridization except
2 X 106 counts of denatured
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P-labeled DNA probe was added and incubation

temperature was 65°C. The membrane was washed first in 2 X SSC at room temperature
for 2-5 minutes and then in 0.1 SSC and 0.1 % SDS at 55°C until the background was
low. The holes were labeled with a radioactive pen before autoradiography.

2.6.10

Labeling of DNA Probes

2.6.10.1

Nick Translation

Radioactive probes were prepared by nick translation using nick translation kit and
protocol supplied by BRL. One µg of probe was added to a mixture containing 100 µCi
[a-32P]-dCTP (Amersham, Arlington Heights, IL), 5 µl of a 0.2 mM solution of three

deoxyribonucleoside triphosphates (dNTPs: dATP, dGTP, dCTP), 5 µl of a solution
containing 2 units DNA polymerase I and 200 pg DNase I in a total volume of 50 µI.
The labeling reaction was incubated at 15°C for 1 hand then stopped by the addition of

5 µl of 300 mM Na2EDTA solution on ice. The labeled DNA was immediately separated
from unincorporated nucleotides by chromatography on a 0.9 X 1.5 cm G-50 Sephadex'I')(
(Fine) column using the protocol provided by Boehringer Mannheim Corporation
(Indianapolis, IN). The specific activity of the labeled probe is 5-10 X 107 cpm/µg DNA.
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2.6.10.2

Random Priming

25-50 ng template DNA was added with distilled water to bring the total volume
to 37 µl in a screw-capped microcentrifuge tube. The DNA was denatured by boiling for

5 minutes, immediately placing the tube on ice. The following mixture was added to the
DNA solution: 10 µl of 5 X c· buffer (containing 250 mM Tris-HCl, pH=8.0, 25 mM
MgC12 , 5 mM ,8-mercaptoethanol, 2 mM each of dA TP, dGTP and dTIP, 1 M HEPES
(adjusted to pH 6.6 with 4 N NaOH) and 1 mg/ml random primers (mostly hexamers,
BRL), 2 µl of 10 mg/ml BSA (BRL), 0.5 µl of [a-32P]dCTP (Amersham), and 1 unit of
the Klenow fragment of E. coli DNA polymerase I. The reaction mixture was incubated
at room temperature for at least 30 minutes. The specific activity of the labeled probe
was determined by counting 1 µl of the total reaction mixture in liquid scintillation
counter. 108-109 cpm/µg is suitable (Sambrook et al., 1989; protocols from GIBCO
BRL).

2.6.10.3

5' End Labeling

100 pmol (or 50-100 ng) oligonucleotide was phosphorylated by adding 1 µl of
T4 polynucleotide kinase (8 units/µl in the solution containing 50 mM Tris-HCl, 10 mM
MgC12 , 10 mM DTI, 1 mM spermidine, and 800 µCi ['y-32P] dATP {ICN). The reaction
was incubated at 37°C for 30-45 minutes and the kinase was inactivated by heating at
70°C for 10 minutes. The labeled oligonucleotide was immediately separated from
unincorporated nucleotides by chromatography on a 0.9 X 1.5 cm of G-25 SephadexTll
(Fine) column using the protocol provided by Boehringer Mannheim Corporation
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(Indianapolis, IN). The specific activity of the labeled probe is 4 X

HY

to 1.2 X 106

cpm/ng oligonucleotide.

2. 7

Site-Directed Mutagenesis

2. 7 .1

Solutions
10 X annealing buffer

10 X M9 solution (per liter)

M9 agar plate (per liter)

200mM

Tris-HCl, pH 7.5

100 mM

MgC12

500mM

NaCl

60 g

Na2HP04 (MW= 131. 96)

30 g

KH2P04 (MW= 136.09)

5g

NaCl

10 g

NH4 Cl

100 ml

10 X M9 solution

875 ml

distilled H 20

15 g

agar

Autoclave, cool to 55°C and add
1 ml

100 µl

MgS04
CaC12

10 ml

20% (w/v) Glucose

1 ml

10 mg/ml Thiamine

43
Pour 20 ml in each plate

Phage precipitation solution

10 X synthesis buffer

TYP broth (per liter)

20%

PEG 8000 (Sigma)

2.5 M

NaCl

100 mM

Tris-HCl, pH 7.5

5mM

dNTPs

lOmM

ATP

20mM

DTT

16 g

Bacto-tryptone

16 g

Bacto-yeast extract

5g

NaC12

2.5 g

2. 7 .2

K2HP04

Preparation of Phagemid Single-Stranded DNA
The following protocol was modified from instructions of Promega Altered Sites

kit protocol and an internal protocol. The DNA to be mutated was cloned into the
pSelect-1 vector. Recombinant DNA was transformed into competent cells of JM109 or
a similar host and selected by plating on the LB-Tet (tetracycline 15 µg/ml) and IPTG/XGal plate. (The LB-Tet plate was spread with 100 µl of 0.1 M IPTG and 50 µl of 2%
X-Gal, and these components were allowed to absorb for 30 minutes at 37°C prior to
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plating cells.) The original pSelect-1 vector was used as a positive control and the
pSelect-control phagemid (Promega) was used as a negative control. Several white
colonies on the recombinant transformation plate were picked with toothpicks to do minipreps for confirmation of the correct recombinant clones. The overnight cultures of cells
containing pSelect-1, pSelect-control, and correct recombinant DNAs were plated on M9Tet plate (15 µg/ml tetracycline) to select for the presence of F' which carries a
nutritional requirement for growth and decreases the number of false positives. The
incubation time was about 40 hrs. An overnight culture was prepared from each M-9
plate by picking individual colonies on M9-Tet plates and inoculating 5 ml of TYP broth
containing 15 µg/ml tetracycline and shaking overnight at 37°C. The next morning, 25
ml TYP broth (15 µg/ml tetracycline) was inoculated with 500-1000 µl of overnight

cultures. These were shaken vigorously at 37°C for 2-3 hrs until the A550 =0.5-1.0. This
was the plating culture and could be stored at 3°C up to 1 week. The culture was
infected with helper phage R408 (which obtains high yields when it is used in conjunction
with the JM109 strain) at a multiplicity of infection (m.o.i.) of 10.

1 O.D. at

A550 =5Xl08 cells/ml. The cultures (10-20 ml) were incubated at 37°C for 20 minutes,
and then shaken vigorously at 37°C for at least 6 hrs. After shaking, the cultures were
transferred to SS34 tubes, and the culture supernatant was harvested by pelleting the cells
at 12K rpm/4 °C/15 minutes. The supernatant was then transferred to a new SS34 tube,
and spun again as described above. 1 ml of each supernatant was saved in 3°C
refrigerator. The rest of supernatant was precipitated with 0.25 volume of phage
precipitation solution (20% PEG and 2.5 M NaCl) overnight at 3 °C. The phage pellet
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was then spun down at 12K rpm/3°C/15 min. The tubes were thoroughly drained, spun
again for 2 min, and any liquid was removed with a pipeter. The pellet was resuspended
in 0.5 ml of TE (pH=7.5-8.0), and transferred to a 1.5-ml microcentrifuge tube. The

phagemid DNA was phenol extracted once; phenol:chisam extracted twice; and then
chisam extracted once. The phagemid DNA was precipitated with 1/10 volume of 3M
NaAc and 2.5 volume of ethanol at -20°C for 30 minutes or overnight. The pellet was
spun down and dried in a Speedvac. The pellet was sometimes difficult to see, and was
resuspended in 30 µl of TE. 2 µl was quantitated on 0.8-1.0% agarose gel. The helper
phage band of R408 is 6.4 kb and pSelect-control is 5.6 kb. The single-stranded DNA
standard from the sequencing kit (USB) may also be used as the size standard for
estimation of single-stranded DNA.

2.7.3

5' Phosphorylation of Oligonucleotides
1) The following components were added to a microcentrifuge tube:
oligonucleotide

100 pmol

10 X kinase buffer

2.5 µl

10 X ATP (10 mM)

2.5 µl

T4 polynucleotide kinase

5 units
to final volume 25 µl

2) Incubated the reaction at 37°C for 30 minutes.
3) Incubated the reaction at 70°C for 30 minutes to inactivate the kinase.
4) The reaction products were stored at -20°C or added directly to the.annealing
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reaction.

2.7.4

Site-Directed Mutagenesis
A phosphorylated mutagenic oligonucleotide (1.25 pmol) and ampicillin repair

oligonucleotide (0.25 pmol, Promega) were annealed to the recombinant pSELECT-1
ssDNA (0.05 pmol)in annealing buffer by heating to 70°C for 5 min followed by slowly
cooling to room temperature. After extension with T4 DNA polymerase and ligation by
T4 DNA ligase in synthesis buffer, DNA strands were used to transform the BMH 71-18
mut S mismatch repair-deficient E. coli competent bacteria to select for ampicillin
resistant transformants. Total plasmid DNA was prepared and transformed into the JM
109 competent bacteria. Mutant colonies were first screened by the restriction enzyme
specific to the site present in the mutagenic oligonucleotide and further confirmed by
sequencing as described in section 2.9.

2.8

Reverse Transcription Polymerase Chain Reaction (RT-PCRl
RNA was prepared by using the GIT/CsCl method as described in section

2.12.1.1, and cDNA was synthesized by using the Superscriptase library kit (Gibco
BRL).

2.8.1

Synthesis of cDNA Fragment by Reverse Transcriptase (RT)

2.8.1.1

Reagents and Solutions
Amplitaq DNA Polymerase

200 U/µl
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2.8.1.2

dNTPs

0.1 M

First strand buffer (5 X)

250 mM

Tris, pH 8.3

375 mM

KCl

15 mM

MgC12

Oligo(dn 15 primer

0.5 µglµl

PCR buffer (10 X)

100 mM

Tris/HCl (pH 8.0)

500mM

KCl

25 mM

MgC12

0.1%

gelatin

sense oligonucleotide:

50 pMole/µl

antisense oligonucleotide:

50 pMole/µl

rRNasin® RNAse inhibitor

40 U/µl

Procedure

5 µg of total cellular RNA in TE was precipitated with 1/10 volume of 3M NaAc

(pH 5.2) and 2.5 volumes of EtOH overnight at -20°C. RNA was pelleted in a
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microcentrifuge at 13,000 rpm for 1 hour at 3°C, washed twice in 70% EtOH, air-dried
and resuspended in 22.5 µl of DEPC-water. The RNA was denatured in the presence of
4 µl oligo (dT) primer (0.5 µglµl, Promega) by heating at 65°C for 3 minutes, chilled
on ice for 2 minutes, spun briefly, followed by adding 10 µl 5 X RT buffer, 5 µl 5 mM
dNTPs, 5 µl 0.1 M DTT, 2 µl rRNasin (40 U/µl, Promega, optional), and 1.5 µl
Superscript Reverse Transcriptase (200 U/µl, GIBCO BRL). Incubated the samples for
10 minutes at room temperature, followed by 1-hour incubation at 42 °C. To inactivate
reverse transcriptase, the samples were heated for 3 minutes at 95°C in a heat block,
chilled on ice and pulse spun. This RNA mixture was usually good for at least 10 PCR
reactions. It was either frozen at -20°C, or immediately used for a PCR amplification
(see section 2.8.2).

2.8.2

PCR Amplification
PCR was performed with 2 µl of the cDNA product from FH (0.2 µg) or 5 µl of

the cDNA product (0.5 µg) from VXH or CH2XH in a 1.5-ml microcentrifuge tube
containing 3.5 µl of 10 X PCR buffer, 3.5 µ12 mM dNTPs, 1.0 µl forward primer (50
µM), 1.0 µl reverse primer (50 µM), 21 µl water, and 0.5 U AmpliTaq polymerase (Taq

polymerase, BRL). The mixture was overlaid with 35-50 µl of mineral oil and the cDNA
was amplified for 30 cycles under the following conditions for each segment in a DNA
Thermal Cycler (Perkin Elmer Cetus, Model 480, Emergyville, CA): denaturation, 94 °C
for 1 minute; annealing, 50°C for 1 minute; extension, 72 °c for 2 minutes. After the
amplification reaction, 30 µl of the PCR products were analyzed on a standard 1 %
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agarose TAB (or TBE) gel stained with ethidium bromide (Sambrook et al., 1989) to
confirm the sizes of synthesized DNA fragments.
PCR amplification of plasmid DNA fragment was performed as described above
except that 1 ng of DNA template was used for 25-30 cycles of amplification.

2.9

DNA

Sequencin~

For single-stranded DNA sequencing, the gene segments of interest were
subcloned into M 13 phage expression vector or pGEM vector (Pro mega Corp., Madison,
WI) and the single-stranded DNA template was prepared as described before (see sections
2.6 and 2.7.2). For double-stranded plasmid sequencing, the single-stranded template
DNA was generated by denaturing 5-10 µg of plasmid DNA in 2 N NaOH and 2 mM
EDTA solution at room temperature for 5 minutes. The mixture was neutralized by
adding 0.1 volumes of 3M NH4Ac (pH=4.5) and the DNA was precipitated in ethanol
at-70°C overnight. After washing the pelleted DNA with 70% ethanol, it was dissolved
in 7 µl of distilled water for the sequencing reaction. Appropriate primer (see section
2.2.1) and the reagents in the Sequenasen1 Version 2.0 Kit (United States Biochemical,
Cleveland, OH) were used in the sequencing reactions as instructed by the manufacturer.
The single-stranded bacteriophage M13mp18 was used as positive control for the
sequence reaction.
The samples were denatured at 80°C for 3-5 minutes prior to loading on 6% ureapolyacrylamide gel. The electrophoresis was performed at 50 watts and 55°C gel
temperature in 1 X TBE buffer. The gel was fixed in 10% methanol and 10% acetic acid
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for 15 minutes at room temperature, transferred onto a Whatman filter and dried for 30
minutes at 80°C (Hoefer Scientific, Model SE 1160, San Francisco, CA). The
Fluorography was performed by exposing the dried sequencing gel to an X-ray film at
room temperature for overnight or 1 day.

2.10

Cell Culture Techniques and DNA-Mediated Cell Transfection

2.10.1

Cell Maintenance
Mouse plasmacytomas and hybridomas were maintained in RPMI 1640 medium

supplemented with 10% (vol/vol) fetal calf serum (FCS, Hyclone Laboratories), 4 mM
L-glutamine, 50 units or µg of a penicillin-streptomycin solution per ml, 0.05 mM {3mercaptoethanol and 1 mM sodium pyruvate at 37°C in a 5 % COrhumidified incubator
(Heraeus Instrument, S. Plainfield, NJ). This media is referred to as complete RPMI
1640 media. All cell culture reagents were from GIBCO BRL unless specifically
indicated.

2.10.2

Cell Lines That Were Used in the Dissertation
Mouse pre-B cell line F (Jack et al., 1989)
Mouse hybridoma FH (LOCB 83.13.13, Jack et al., 1989)
Mouse hybridoma VXH (GAMO 12.8, Jack et al., 1989)
Mouse hybridoma CH2XH (GAMO 62.12, Jack et al., 1989)
Mouse plasmacytoma J558L (Oi et al., 1980)
Mouse plasmacytoma NYCH.µK (Bornemann et al., 1995)
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Mouse myeloma Ag8.653 (Kearney et al., 1979; Bornemann et al., 1995)

2.10.3

Cell Harvesting
Cells were harvested by centrifuging at 1, 100 rpm and 4 ° C for 5 minutes in

polypropylene tubes (Silencer® S-103 NA, Rupp & Bowman, Tustin, CA).

2.10.4

Freezing and Thawing of Cells
About 2 X 107 cell were pelleted, resuspended in 1.5 ml of RPM! freezing media

(RPMI 1640 with 30% FCS, 15% dimethyl sulfoxide, and 0.05 mM {j-ME), and
transferred into an ice-chilled cryogenic tube (Vangard CRYOS,..., Sumitomo Bakelite
Co., Ltd., Japan). The tubes were kept in a styrofoam box overnight at -70°C to allow
for slow freezing and stored in liquid nitrogen (Nitrogen tank type 5k, Taylor-Wharton,
Theodore, AL).
To thaw cells, the frozen tubes were warmed up in a 37°C water bath until most
of the cells were thawed, then completely thawed on ice. Then the cells were transferred
into a 50-ml Falcon tube, washed once with 25 ml of complete RPMI 1640 media, and
cultured in 10 ml of the complete media.

2.10.5

Cell Counting
Cells were diluted in an equal volume of trypan blue solution and counted in a

Neubauer hemacytometer chamber (Bright-Line®, 0.1 mm, American Optical Co.,
Buffalo, NY). The cell number was determined by the following equation:

·
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Cells/ml = cells per large square x 2 x 104

Subcloning

2.10.6

Hybridoma cell lines were subcloned by limiting dilution in 96-well plates (0.15
cells/100 µI/well, Costar, Cambridge, MA). 100 µI of the complete RPMI 1640 media
was added to each well after 7-10 days. The wells were screened for colony growth
under the light microscope (400 X, Labovert Inverted Microscope FS, Leitz Wetzlar,
Germany) after 12 to 15 days. Subclones were analyzed for lg expression by cytoplasmic
immunofluorescence analysis as described in section 2.13 .1, or the presence of µ gene
by PCR as described in section 2.8.2.

2.10.7

Transfection
For electroporation, 5Xl06 cells were removed and washed twice in ice-cold

protein-free RPMI 1640 medium (the complete RPMI 1640 media without FCS), and
resuspended in 500 µI of the same medium. After addition of 5-20 µg DNA (in 1 X TE,
total volume

< 20 µl), the cells were incubated on ice for 10 minutes and subjected to

1 pulse of 330 µF, 285 volts at low conductivity with a Cell Porator (BRL, Gaithersburg,
MD). The transfected cells were immediately transferred into 50 ml-flasks and grown in
10 ml of 20% FCS-RPMI 1640 media for 48 hours. To isolate stable transfectants, we
grew the transfected cells that were plated in 96-well plates (Costar, Cambridge, MA)
at the density of 5 X 1Q4 cells per ml media, 100 µl media per well in growth media
containing 2.5 µg of mycophenolic acid (MPA) and 250 µg of xanthine per ml for 7-10
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days (Jack et al., 1989). The MPA positive stable transfectants were screened by
cytoplasmic immunofluorescence forµ protein expression (see section 2.13.1).

2.11

DNA Isolation from Mammalian Cells and Analysis

2.11.1

DNA Isolation by Guanidinium Isothiocyanate (GIT)/Cesium Chloride
(CsCl) Method
High molecular weight DNA was isolated as described in Sambrook et al., 1989.

Briefly, DNA bands in cesium chloride phase (see section 2.12.1.1 below) were aspirated
into a pasteur pipette and washed twice with 10 ml of 70% ethanol in 50 ml-Falcon tube.
After air-drying briefly, the DNA was digested with 200 µg/ml proteinase K (PK) in 10
ml of PK buffer at 42°C overnight (about 16 hours). To remove the proteins, the DNA
solution was extracted once with equal volume of TE-saturated phenol, twice with
phenol/chisam (1+1) and once with chisam. The extracted DNA was then precipitated
with 2 volumes of 100% ethanol, spooled onto a pasteur pipette, washed once in 80%
ethanol, briefly dried, resuspended in TE (pH 8.0), and incubated overnight at 37°C to
facilitate the dissolving process. The concentration of DNA was determined by
photometric measurement at 260 nm as described in 2.11.2. DNA preparations were
stored at 4 °c.

2.11.2

Quantitation of DNA
The concentration of DNA was quantitated by measuring the absorption or optical

density (OD) at 260 nm (Spectrophotometer, Spectronic 20, Bausch & Lomb, Rochester,

NY).

1 OD at 260 nm

= 50 µg/ml DNA.
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The purity of DNA was determined by the ratio of the absorbance of DNA at 260
nm to its absorbance at 280 nm. Our samples were in the range of 1.8 to 2.2.

2.11.3

Southern Blot Analysis

2.11.3.1

Solutions

Alkali solution

Neutralization solution

Washing solutions

10 X SSC (pH 7.0)

2.11.3.2

0.5 N

NaOH

1.5 M

NaCl

0.5 M

Tris-HCl, pH 7.4

3M

NaCl

1) 0.4 N

NaOH

2) 0.2 M

Tris-HCl, pH 7.5

2X

SSC

0.15 M

Citric Acid

1.5 M

NaCl

Procedure

High molecular weight DNA that was prepared as described in section 2.11.1 was
digested to completion (overnight) with the appropriate restriction enzymes, and
electrophoresed on a 0.8% agarose gel. The gel was then denatured in 250 ml of alkali
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solution under shaking at room temperature for 30 minutes and neutralized with 250 ml
of neutralization solution for 30 minutes. The DNA was capillarilly transferred onto the
concave side of genescreen plus• (DuPont Biotechnology System

NE~

Research

Product, Boston, MA) in 10 X SSC at room temperature overnight. The genescreen filter
was washed first with 0.4 N NaOH for 30 seconds, and then washed with 0.2 M TrisHCl (pH 7.5) and 2 X SSC for 2 minutes. The filter was dried under an infrared lamp
or between 2 Whatman papers (3MM). The filters were prehybridized in 10% Dextran
sulfate, 1 % SDS and 1 M NaCl at 65°C for about 2 hours and hybridized with 100 µCi
of 32P-nick-translation labeled DNA probes and 200 µg/ml of salmon sperm DNA in 10%
Dextran sulfate, 1 % SDS and 1 M NaCl at 65°C overnight. The filter was washed as
described in section 2.12.5 except at 65°C.

2.12

RNA Isolation from Mammalian Cells and Analysis

2.12.1

Total RNA Isolation

2.12.1.1

GIT/CsCl Method

Total RNA was prepared from cells with guanidinium thiocyanate followed by
centrifugation in cesium chloride solutions (Sambrook et al., 1989). Briefly, 1-2 X 107
cells were removed and washed twice with ice-cold phosphate-buffered saline (PBS,
GIBCO BRL) without calcium and magnesium. Then the cells were transferred in 1 ml
of PBS into a 15 ml-Falcon tube and lysed in 2 ml of GIT homogenization buffer (4 M
GIT, 0.12 M {3-Mercaptoethanol, and 25 mM Sodium acetate, pH 5. 6-6. 0). The resulting
homogenate was then layered on a 2 ml cushion of cesium chloride (CsCl) solution (5. 7
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M CsCl, 25 mM NaAc, pH 5.2) in a clear ultracentrifuge tube (NalgeneTll UltraTubes,
thin wall/polyallomer, open-top, size 13 X 51 mm, Nalge Company, Rochester, NY).
The tubes were balanced with GIT homogenation buffer. The gradient was centrifuged
at 35 K rpm for at least 20 hours at 20°C in a Beckman SW50.1 rotor (Preparative
Ultracentrifuge, Model L8-70, Beckman, Palo Alto, CA). After centrifugation, the DNA
band was collected (if preparation of DNA was desired, see section 2.11.1), the
remaining supernatant was aspirated until the CsCl layer. The rest of CsCl layer was
poured off and briefly air-dried. The bottom of the tube was cut off with a razor blade,
the RNA pellet (may be not visible) was resuspended in 270 µ1 (3 x 90 µ1) of TE, and
transferred to an Eppendorf tube. 30 µ1 of 3 M sodium acetate (pH 5. 2) and 750 µ1 of
absolute ethanol were added to precipitate the RNA at -20°C overnight. The precipitate
was dissolved in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0).

2.12.1.2

Trizol or RNAzolTll B Method

Total RNA was rapidly isolated for the screening of hybridoma subclones by a
single-step method (Chomczynski and Sacchi, 1987; Kedzierski and Porter, 1991) using
TRizol Reagent (GIBCO BRL Cat No. 15596-026) and protocol supplied by BRL.
Briefly, 5 X 106 plasmacytoma cells were pelleted by centrifugation as described in
section 2.10.3. The cells were lysed in 1 ml of the TRizol Reagent by repetitive
pipetting, and the samples were transferred to microcentrifuge tubes. The homogenized
samples were then incubated for 5 minutes at room temperature to permit the complete
dissociation of nucleoprotein complexes. 200 µl of chloroform was added to the-samples,
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shaken vigorously by hand for 15 seconds and incubated at room temperature for 2 to
3 minutes. The samples were centrifuged at 12,000 X g for 15 minutes at 4 °C, and 500
µl of the upper aqueous phase was transferred to a fresh tube. The RNA was precipitated
by incubating samples with an equal volume of isopropanol at room temperature for 10
minutes and centrifuging at 12,000 X g for 10 minutes at 4 °C. The RNA pellet was
washed once with 1 ml 70% ethanol by centrifugation, briefly air-dried, and dissolved
in 25 µl of RNase-free water or TE by passing the solution a few times through a pipette

tip. If the RNA pellet was not completely dissolved, the tubes were incubated for 10
minutes at 55°C-60°C. The isolated RNA had an A2601280 ratio of 1.6-1.8.
The isolation of RNA using RNAzolni B solution (Tel-Test, INC., Friendswood,
TX) is based on the same principle and similar procedures as suggested by the
manufacturer.

2.12.2

Cytoplasmic RNA Isolation
Cytoplasmic RNA was isolated by the Nonidet P-40/Phenol method (modified

from Favaloro et al., 1980). Briefly, 5 X 106 cells were removed, centrifuged, washed
with PBS once in an Eppendorf tube. Cells were lysed in 200 µl of ice-cold lysis buffer
(5 Prime to 3 Prime, Inc.®, 0.14 M NaCl, 1.5 mM MgC12 , 0.5 % Nonidet-P40, 10 mM
Tris, pH 8.6, and 0.05 unit/ml rRNasin from Promega) for 10 minutes on ice. The
nuclei and unlysed cells were removed by centrifugation at 13 K rpm (12,000 X g) and
4 °C for 5 minutes. 175 µl of the supernatant was transferred to a new Eppendorf tube
and digested with 0.2 mg Proteinase K (Boehringer Mannheim) in 175 µl of preheated
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2 X proteinase K buffer (0.3 M NaCl, 2 mM EDTA, 2% SDS, 0.2 M Tris, pH 7.6) at
42°C for 1-2 hours. The RNA solution was then extracted three times with 300 µl of
phenol/chloroform (1+1) and once with 300 µl of chisam at room temperature, and
precipitated with sodium acetate and absolute ethanol as described above. The precipitate
was dissolved in 25 µl of TE buffer. The concentration of RNA was determined by
measuring the absorbance at 260 nm as described in section 2.12.4. The RNA yield was
60 µg per 5 X 106 hybridoma cells and 35-40 µg per 5 X 106 plasmacytoma cells.

2.12.3

Nuclear RNA Isolation

2.12.3.1

RNA Isolation for Crude Nuclei Fractions

To prepare nuclear RNA, the nuclear pellet from NP-40 lysis method was washed
twice with 1 ml of ice-cold PBS, then 1 ml of GIT homogenization buffer (described
previously) was added followed by vortexing for 15 sec to completely lyse the nuclei.
The nuclear lysate was diluted with GIT homogenation buffer and layered over a 2 ml
cushion of 5. 7 M cesium chloride (CsCl) solution as described above. The gradient was
centrifuged in a SW50.1 rotor at 45 K rpm for at least 20 hr at 20-24 °C (Wilkinson et

al., 1988). The rest of the procedures were as the same as those for total RNA isolation.

2.12.3.2

RNA Isolation for Purified Nuclei

2.12.3.2.1

Solutions and Reagents

PBS (GIBCO)

Dulbecco' s

Phosphate-Buffered

without CaC12 and MgC12 (GIBCO)

Saline,
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2 X Isotonic high salt lysis buffer 0.02 M

2 X 0.88 M Sucrose

Tris-HCl, pH 8.4

0.28 M

NaCl

0.003 M

MgC12

1 % (v/v)

Nonidet-P 40

0.1%

DEPC water

Dissolve 120.49 g Sucrose (MW 342.3
g/molar) in 200 ml 0.1 % DEPC water at
65°C. Vigorously shake until dissolving.

0.88 M Sucrose-Lysis buffer

Mix equal volume of 2 X lysis buffer with
2 X 0.88 M Sucrose

2 M Sucrose

Dissolve 136.92 g Sucrose in 200 ml 0.1 %
DEPC water at 65°C.

2 M Sucrose cushion

2M

sucrose

5mM

magnesium acetate

0.1 mM

EDTA

lOmM

Tris, pH 8.0

lmM

DTT
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10% Tween 20

10 % (w/w) in 0.1 % DEPC water

10 X Tween-Doc

3.3% (v/v) of 10% sodium deoxycholate
6.6% (v/v) of 10% Tween 20

DNase I buffer

0.5 M

NaCl

0.05 M

MgC12

0.01 M

Tris-HCl, pH 7.4

(Holtzman et al. , 1966)

2.12.3.2.2

Procedure

The following protocol was generated by modifying several protocols (Nevins,
1980; Birnie, 1978; and Penman, 1966). 2.5 X 107 hybridoma cells were collected by
centrifugation at 1,100 rpm and 4°C for 5 minutes. The pelleted cells were resuspended
with 10 ml of ice-cold PBS (GIBCO BRL), transferred into a 15-ml polypropylene tube
(17 X 100 mm culture tube, Gemini, Chicago, IL), and centrifuged again. The pellet of
washed cells was suspended in 5 ml of ice-cold isotonic-high salt lysis buffer by pipetting
the solution 10 times. The samples were incubated for 10 minutes on ice and vortexed
gently for 5 seconds. One drop of the lysis solution was placed on a glass slide (25 X 75
mm, 1 mm, VWR Scientific, Media, PA) overlaid with a cover slide (18 mm square,
VWR Scientific, Media, PA), and the nuclei were examined under the phase-contrast
microscope (1,000 X, Biological Microscope, OPTIPHOT, Nikon Corporation, Tokyo,
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Japan) to determine whether the cells were completely lysed and whether the cytoplasmic
components are removed from the nuclei. If the majority of cells (95 %) were lysed and
there was no obvious cytoplasmic contamination to the nuclei, the homogenized nuclei
solution was layered over 5 ml of 0.88 M sucrose-lysis buffer solution in a new 15-ml
polypropylene tube, and the nuclei were purified by centrifugation at 800 X g (2750 rpm)
(Silencet4 S-103 NA) and 4 °C for IO min. Cell debris was found at the interface
between the lysis buffer and 0.88 M sucrose solutions. The nuclei were found at the
bottom of the tube after centrifugation. The lysis and sucrose solutions were removed
phase by phase by aspiration without disturbing the nuclei. The nuclei pellet was
resuspended very well by tapping vigorously with the hand and repetitive pipetting. In
most cases, the pellet could not be dispersed very well. Thus it was digested with 50 µl
of RNase-free DNase I (40 units/µl, Promega) in 500 µl DNase I buffer for 20 to 40
minutes at room temperature. 5 ml of lysis buffer and 500 µI of Tween-Doc solution
were then added, vortexed for 5 seconds and incubated on ice for 5 minutes. This
mixture was overlaid with either 5 ml of 0.88 M sucrose-lysis buffer and centrifuged as
described above, or 5 ml of 2 M sucrose cushion in a SW41 polyallomer tube (NalgeneTM
UltraTubes, thin wall/polyallomer, open-top, size 14 X 98 mm, Nalge Company,
Rochester, NY) and centrifuged at 25 K for 1 hour at 4 °C (Preparative Ultracentrifuge,
Model L8-70, Beckman, Palo Alto, CA). After purification of nuclei by centrifugation,
a drop of the lysis solution was checked under the phase-contrast microscope to
determine whether the nuclei were still intact and free of visible cytoplasmic
contamination. The 0.88 M sucrose cushion centrifugation was repeated until no visible
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cytoplasmic tab was attached to the pure nuclei. To remove the sucrose from nuclei
preparation, the nuclei were washed twice with 1 ml of lysis buffer and the RNA isolated
from nuclei by the GIT/CsCl method as described in section 2.12.3.2.

2.12.4

Quantitation of RNA
The concentration of RNA was quantitated by measuring the absorption or optical

density (OD) at 260 nm.

1 OD at 260 nm

= 40 µg/ml RNA

The purity of RNA was determined by the ratio of the absorbance of RNA at 260
nm to its absorbance at 280 nm. My samples were in the range of 1.8 to 2.2. The typical
yields of different cell lines are summarized in Table 1.
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Table 1. Average Yield of RNA Isolation
7

Cell lines
Total

RNA (µg/10 )
Cytoplasmic

Nuclear

AgS.653

90 to 100

ND

ND

J558L

90 to 120

80 to 220

ND

FH

180 to 220

80 to 180

12 to 15

VXH

100 to 160

100 to 150

12 to 15

CH2XH

100 to 120

50 to 90

12 to 15

Values are determined from the results of several experiments
ND, not determined.
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2.12.5

Northern Blot Analysis

2.12.5.1

Solutions

10 X MOPS

0.2 M

MOPS (sodium base)

lOmM

sodium EDTA

50mM

sodium acetate

0.1%

DEPC water

Adjust pH to 7.0 with glacial acid

5 X RNA loading buffer

RNA sampling buffer

Gel overlay buffer

IX

MOPS

2.5%

Ficoll

0.025%

bromophenol blue

0.1%

DEPC water

IX

MOPS

2.2 M

formaldehyde

50%

deionized formamide (dFA)

0.1%

DEPC water

IX

MOPS

2.2M

formaldehyde

O.I%

DEPC water
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deionized formamide (dFA)

formamide

(Ultrapure,

Boehringer

Mannheim) was deionized with 5 g per 100
ml AG 501-XS(O) and Bio-Rex MSZ 501
mixed bed resins (Bio-Rad) by stirring very
slowly at room temperature for about 1
hour,

filtered

through

0.45-µm

filter

(Schleicher & Schuell) and stored at -20°C
in aliquot.

50 X Denhardt's reagent

1%

bovine serum albumin

1%

polyvinylpyrrolidone

1%

Ficoll (DL-400)

0.1 %

DEPC water

1 M sodium phosphate buffer (NaP, pH 7.0, per liter)
200 ml of 1 M NaH2P04
600-700 ml of 1 M Na2HP04
fill to 1 L with deionized water

Prehybridization solution

0.1%

SDS

50%

dFA

5X

SSC
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5X

Denhardt's reagent

50 mM

sodium phosphate buffer

0.25 mg/ml

denatured

sheared

salmon

sperm DNA (from 10 mg/ml
stock solution)

Hybridization solution

0.1%

SDS

50%

dFA

5X

SSC

IX

Denhardt's reagent

20mM

sodium phosphate buffer

10%

Dextran sulfate

0.3 mg/ml

denatured

sheared

salmon

sperm DNA

2.12.5.2

Procedure

5-10 µg RNA (with 3 µg of ethidium bromide per lane) was loaded in the sample
wells of a formaldehyde agarose electrophoresis gel (1.2 % agarose, 2.2 M formaldehyde,
1 X MOPS in 0.1 % DEPC water) submerged in overlay buffer. RNA size markers (RNA
ladder, GIBCO-BRL) were usually also run on the gels. The electrophoresis was
performed in 1 X MOPS buffer in a horizontal gel electrophoresis chamber (Model H3,
BRL) under a constant current of 10-15 mA (about 35-40 volts) for 15-20 hours until the
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bromophenol blue migrated to the bottom of the gel. After capillary transfer of RNA
onto a nitrocellulose filter (0.45 µm, Schleicher & Schuell, Inc., Keene, NH) in 20 X
SSC for overnight at room temperature, the blot was baked for 2 hours in 80°C vacuum
oven (VWR 1410, VWR Scientific, San Francisco, CA). Hybridization was performed
with an Omniblot system (ABN) according to the manufacturer's instructions. The
prehybridization was performed in a 11 cm X 15 cm milliblot plastic bag (Millipore
Corporation, Bedford, MA) at 42 °C for at least 1 hour in a 21 ml mixture of 0.1 % SDS,
50% deionized formamide, 5 X SSC, 5 X Denhardt's reagent, 50 mM sodium phosphate
buffer (NaP, pH 7.0), and 5 mg of denatured sheared salmon sperm DNA (from 10
mg/ml stock solution). The radioactive DNA probe was denatured by boiling for 5 min
and put immediately on ice. Once chilled, the probe was added to 15 ml hybridization
solution containing 0.1 % SDS, 50% dFA, 5 X SSC, 1 X Denhardt's reagent, 20 mM
NaP, 10% dextran sulfate, and 1.5 mg denatured sheared salmon sperm DNA. Then the
blot was hybridized with 1-2 X 106 cpm per ml of a denatured

32

P nick-translated µ

cDNA probe (covering the region between Cµl and part of Cµ4) for 12-18 hours at
42°C. The filter was washed consecutively with 2 X SSC and 0.1 % SDS for 10 minutes
once and with 0.1 X SSC and 0.1 % SDS for 20-30 minutes at 55-60°C several times
until the background detected by Geiger counter (Mini-Instrument, LTD., Model 900,
Essex, England, through Research Products International Corp., Mount Prospect, IL) on
the filter was low. After washing, the blot was dried briefly, and the position of RNA
standards and ribosomal RNAs was labeled with radioactive ink. The blot was then
wrapped with Saran wrap and exposed to X-ray film (Kodak X-OMAT"" AR or X-ONAR
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LS, Eastman Kodak Company, Rochester, NY) between intensifying screens (Fisher
Biotech, Pittsburgh, PA) for appropriate time at -70°C before processed by Developer
X-Ray Film Processor (Model QX-60A, Konica, Tokyo, Japan).
The amount of RNA on the blot was quantitated with a Betagen Radioanalytic
imaging system (Betascope 603 Blot Analyzer, Betagen Corp., Mountain View, CA).
The sizes of specific RNA bands were determined by measuring the distance from the
loading well to each of the bands of RNA on the autoradiograph. The log 10 of the size
of the fragments of standard RNA was plotted against the distance migrated. The
resulting curve was used to calculate the sizes of the RNA species detected by
hybridization. RNA size standard used was RNA Ladder (GIBCO-BRL) and ribosomal
rRNAs (Rogers et al., 1981).
To control for the copy number of active transcripts of plasmids in stable
transfectants, Northern blots from stable transfection with pµ

1

gpt~M

plasmids, blots were

stripped of hybridized DNA probe by washing them twice with boiled 0.1 % SDS-0.1 X
SSC, and subsequently rehybridized to a 1.055 kb of HindIII-Apal fragment or a 1.335
kb of Pvull-BamHI fragment of gpt gene from pSV2gpt.2Xhol (SF#189). The relative
amount ofµ mRNA per sample was calculated by dividing the amount ofµ mRNA by
the amount of gpt mRNA from the same blot.
To control for RNA loading on each lane, Northern blots from hybridoma cell
lines, the blots were rehybridized with a 1.3 kb BamHl-EcoRI fragment of rabbit
GAPDH or a 1.918kb HindIII-EcoRI fragment of mouse {3-actin probe.
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2.12.6

mRNA Decay Rates Measured by Actinomycin C 1 or DRB Treatment
Decay rates of individual mRNAs in different hybridoma cell lines were measured

by two transcriptional inhibitors, Actinomycin Cl and DRB as described before (Jack et

al., 1988). Briefly, cells were seeded in complete RPMI medium to a density of 5 X H>5
cells/ml, and preincubated for 1 hr at 37°C before addition of Actinomycin Cl
(Boehringer Mannheim, Mannheim, Germany) or DRB (Calbiochem, San Diego, CA).
The final concentration of Actinomycin Cl was 5 µg/ml from a stock solution of 10
mg/ml in dimethyl sulfoxide (DMSO). The final concentration ofDRB was 1.2 mM from
a stock solution of 120 mM in DMSO. At 0, 4, and 8 hr, 20 ml (about 107) or 10 ml
(about 5Xla6) of cells were removed, centrifuged, and subjected to total RNA isolation
by the GIT method and cytoplasmic RNA isolation by the NP-40/phenol method,
respectively. Total viable cell counts at each time point were determined using 5 µg/ml
fluorescein diacetate (FDA) stain and a hemocytometer under a fluorescence microscope
(630 X, Leica Photofluorescence Microscope, Leitz Wetzlar, Germany). This method is
based on the principle that only living cells cleave diacetate from FDA, which releases
the fluorescein molecule that can be visualized under the fluorescence microscope. The
amount of mRNA left at each time point after the addition of the transcriptional inhibitor
was determined by Northern blot analysis as described before. The absolute amount of
radiolabeled probe hybridized to specific bands was quantitated on a Betascope Blot
Analyzer (Betagen, Mountain View, CA) and normalized to the amount of {3-actin
mRNA. The efficiency of transcriptional inhibition was determined by rehybridizing the
blot with H2b or c-myc probe, whose mRNA has a short half-life of 15 to 120-min (Old
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and Woodlane, 1984; Dani et al., 1984a; Herrick and Ross, 1994). Thus, I should not
detect H2b or c-myc mRNA at 2 hr after the addition of the drug.

2.12.7

ORB Titration Experiment
The ORB titration experiment was performed as following: FH cells were

maintained in complete RPMI 1640 media. After counting, 2 ml of FH cells (at a density
of 5 X 1<>5 cells/ml) were distributed into wells of 24-well Costar plate and kept for 1 hr
at 37°C before addition of ORB (Calbiochem, San Diego, CA). The final concentration
of ORB is 0, 0.12 mM, 0.24 mM, 0.48 mM and 0. 96 mM, respectively, from a stock
solution of 120 mM in dimethyl sulfoxide (DMSO, Sigma). At 0 and 4 hr, 2 ml (about
H>6) of cells were removed, centrifuged, and subjected to cytoplasmic RNA isolation by
the NP-40/phenol method. Total viable cell counts at each time point and after overnight
incubation were determined using 5 µg/ml fluorescein diacetate (FDA) stain and a
hemocytometer under a fluorescence microscope (630 X, Leica Photofluorescence
Microscope, Model LABOVERT FS, Leitz Wetzlar, Germany). The amount of H2b
mRNAs left at each time points after the addition of the transcriptional inhibitor were
determined by Northern blot analysis. The absolute amount of radiolabeled probes
hybridized to specific bands was quantitated on a Betascope Blot Analyzer (Betagen,
Mountain View, CA) and normalized to the amount of GAPDH mRNA. The inhibitory
effect of DRB on transcription was also determined by rehybridizing the blot with a 32P
nick-translated 1 kb Clal-Smal human c-myc cDNA probe (Dr. Jeff Ross), whose mRNA
is transcribed from a single copy gene and has a short half-life.
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2.13

Analysis of Proteins

2.13.1

Immunofluorescence Analysis
To detect cytoplasmic proteins, 1-5 X la4 cells in 200-300 µl of RPMI 1640

media were centrifuged onto a glass slide at 1200 rpm for 3 minutes (Shandon centrifuge,
London, England). After air-drying the pellets, cells were fixed in ethanol for 5 minutes,
and rehydrated in PBSF solution (PBS - 0.1 % bovine serum albumin - 0.1 % NaN3) for
at least 1 hr. The expression of transfected mouse heavy chain genes was detected by
incubating the cells with 10 µl of 1:20 diluted FITC-conjugated goat antibodies (50
µg/ml) specific for mouse heavy chain isotypes in a wet chamber for 10 minutes at room
temperature (Burrows et al., 1981). After mounting with Cytoseal (VWR Scientific,
Media, PA), the fluorescence-labeled cells were examined under a fluorescence
microscope (Leica Photofluorescence Microscope, Model LABOVERT FS, Leitz
Wetzlar, Germany).
To detect membrane proteins, 2 X 106 cells in suspension were incubated with
fluorescein (FITC)-labeled goat anti-mouse IgM antibody for 20 minutes on ice. The cells
were centrifuged and fixed onto a glass slide in absolute ethanol and overlaid with
Cytoseal (VWR Scientific, Media, PA) as described above.

2.13.2

Metabolic Labeling and Immunoprecipitation

2.13.2.1

Solutions and Reagents

RPMI labeling medium

500

ml

(GIBCO)

Methionine-free

RPMI

1640
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50 ml Fetal calf serum (Hyclone)
10 ml 200 mM L-Glutamine(GIBCO)

0.5 ml 1 M Sodium pyruvate

5 ml 500 units/ml Penicillin-Streptomycin
(GIBCO)
2.5 ml 10 mM (1-mercaptoethanol

10 X NET

500 mM Tris base, pH 7.4
1.5 M NaCl

50 mM NaEDTA
1 % NaN3
Store at -20°C

1 X NET/Triton (100 ml)

10 ml 10 X NET
2.5 ml 20% Triton X-100 in water
Store at -20°C

0.1 M PMSF

0.1 M in ethanol, store at -20°C

10 X NET lysis buffer

500 mM

Tris base, pH 7.4

1.5 M

NaCl

50mM

NaEDTA
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1%

NaN3

0.5%

Triton X-100

0.1 M

PMSF

10% Staphylococcus aureus

S. aureus in PBS and Azide

S. aureus wash buffer

50mM

Tris, pH 8.2-8.5

5mM

EDTA

0.5 mM

NaCl

0.02%

NaN3

0.1%

SDS

0.5%

Triton X-100

0.5%

NaDOC

lmM

methionine

supplemented with 1 mg/ml ovalbumin
(albumin chicken egg, Sigma)

SDS sampling buffer

0.0625 M

Tris-HCI, pH 6.8

5%

{3-mercaptoethanol

2.5%

SDS

0.002%

bromophenol blue

10%

glycerol
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2.13.2.2

Procedure

For continuous labeling, 1-3 X 106 cells were starved for 1 hr in 1 ml methioninefree RPMI 1640 medium with 10% dialyzed FCS and then metabolically radiolabeled
with 75 µCi/ml Trans-[35S] label (1076 Ci/mmol, ICN) for 30-180 min in 5% C02 at
37°C. After washing, cells were lysed with NET lysis buffer supplemented with the
protease inhibitor phenylmethylsulfonyl fluoride (PMSF, 1 mM) by incubating on ice for
20 minutes. lg proteins were precipitated from cell culture supernatants and cell lysates
with goat anti-mouse IgM (µheavy chain specific) (Southern Biotechnology Associates,
Inc., Birmingham, AL). The incubation was carried out at 4 °C shaker for 2-3 hours
(sometimes overnight), followed by with formalin-fixed and heated-denatured 10% S.

aureus that was prepared as described by Kessler (Kessler, 1975). The S. aureus pellets
were washed in S. aureus wash buffer for 2 to 3 times and low salt washing buffer (50
mM Tris, pH=8.0) once (Burrow et al., 1981). The washed precipitates were
resuspended in equal volumes of SDS sample buffer, boiled for 3 minutes, cooled in a
water bath to room temperature, and analyzed by 10% SDS-PAGE under reducing or
nonreducing conditions as described below.

2.13.3

Protein SDS Polyacrylamide Gel Electrophoresis

2.13.3.1

Solutions

40% Acrylamide/1.07% BIS

Solve 40

g acrylamide and

1.07 g

bisacrylamide in about 90 ml water, heat
slightly up to solve and make the volume to
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100 ml. Filter sterilizes and store at 4 °C in
an aluminium foil-wrapped bottle.

3M Tris, pH 8.8

Solve 72.7 g Tris in 170 ml water, pH to
8.8 with 5 N HCl and make the volume to
200 ml. Filter sterilizes and store at 4 °c.

0.5 M Tris, pH 6.8

Solve 6.05 g Tris in 80 ml water, pH to 6.8
with 5 N HCl and make the volume to 100
ml. Filter sterilizes and store at 4 °C.

10% APS

100 mg APS in an Eppendorf tube, add 1 ml
water. Prepare fresh.

10 X Laemmli electrode buffer

2.13.3.2

0.25 M

Tris

1.92 M

Glycine

1%

SDS

Procedure

The SDS polyacrylamide gel electrophoresis was carried out according to the
method of Laemmli with modifications (Laemmli, 1970). Immunoprecipitated proteins
from about 106 cells in sample buffer was loaded in each well. The separating· gel was
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made of7.5-12.5% (w/v) acrylamide, 0.20-0.33% (w/v) N,N'-methylene bisacrylamide,
0.375 M Tris-HCl (pH 8.8), 0.1 % (w/v) SDS, 0.1 % (w/v) ammonium persulfate, 0.05%
(v/v) TEMED. The stacking gel was made of 3.8% (w/v) acrylamide, 0.09% (w/v)
bisacrylamide, 125 mM Tris-HCl (pH 6.8), 0.1 % (w/v) SDS, 0.1 % (w/v) ammonium
persulfate, 0.05% (v/v) TEMED. The electrophoresis was run in a vertical slab gel
electrophoresis unit (Hoefer Scientific, Model SE 600, San Francisco, CA) under a
constant current of 10 mA/1.5 mm gel overnight, or 40 mA/ 1.5 mm gel for
approximately 4-5 hours. The gels were fixed by shaking in 5 % glacial acetic acid and

5% methanol for 30 min to 1 hour. The gel was incubated with Intensify solutions
(EN3HANCE™ Autoradiography Enhancer, E.I. DuPont de Nemours & Co., Boston,
MA): A for 40 minutes and solution B for 40 minutes with shaking at room temperature.
The gel was then dried at 80 °C for 2 hours under vacuum in a slab gel dryer (Hoefer
Scientific, Model SE 1160, San Francisco, CA). The dried gel was exposed to X-ray
films (Kodak X-Omat OR) between 2 intensifier screens at -70 °C for appropriate time.
Selected bands were quantitated by counting the radioactivity in dried gels with a
Betascope blot analyzer.

CHAPTER III
IMMUNOGLOBULIN µ mRNA WITH A NONSENSE CODON IS DECREASED
IN BOTH THE NUCLEUS AND THE CYTOPLASM OF PLASMA CELLS

3.1

Characterization of the Cell Lines That Are Used in This Chapter
The 18-81 cell line is the Abelson-virus-transformed mouse pre-B cell line that

synthesizes only H chain (as well as some that synthesize no lg chain) (Alt et al., 1982;
Burrow et al., 1981). The majority of cells synthesize µ chain, while some cells can
switch fromµ to -y2b chain synthesis in vitro (Burrow et al., 1983). The 18-81 cell line
is diploid for the H chain loci (Burrows et al., 1881) on chromosome 12 (Meo et al.,
1980). Both alleles have correctly joined VDJ segments, containing either a J2 or a J3
gene segment (Alt et al., 1982; Burrow et al., 1983). Thus the variable region alleles are
named V2 and V3, respectively. Cells of the 18-81 line usually express only the V3
allele, because the V2 allele contains an amber nonsense codon codon in the Cµ2 exon
(Alt et al., 1982). However, a few cells continuously produce H Chain from both alleles
by reversion of the amber nonsense codon (Wahl et al., 1984; Jack and Wahl, 1987).
In order to study the expression ofµ mRNA from a single allele, variants of the
18-81 cell line that have switched from µ to -y2b chain synthesis were fused with the
myeloma P3X63-Ag8.653 (called Ag8.653 here after, which has lost its functional lg
genes) to generate hybridomas (Wahl and Burrows, 1984). This switch of heavy chain
77
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from µ to -y2b is accompanied by a loss of DNA sequences between the joining region
and -y2b constant region gene segments, including the Cµ gene segments, on the V3 allele
(Burrow et al., 1983). However, all these cells retain theµ gene without (FH) or with
(VXH or CH2XH) a nonsense codon on the V2 allele (Jack et al., 1989). Thus, these

hybridomas contain two alleles of lg genes: the V2 allele expresses µ transcript and the
V3 expresses -y2b transcript. The genomic configuration of endogenous µ gene on the V2
allele in hybridomas used in this chapter is diagrammed in Figure 1. Hybridoma FH has
a functional µ gene that directs the synthesis of full-length µ chain. Hybridoma VXH has
an amber nonsense codon (TAG) in its diversity (D) segment ofµ gene, and CH2XH has
an opal nonsense codon (TGA) in the Cµ2 exon of µ gene. The gene dosage is
approximately the same in the three hybridomas as determined by Southern blot analysis
(Jack et al., 1989). One characteristic of the 18-81 cell line is that it has spontaneous
deletions at the H chain locus at high rate (Jack and Wahl, 1987). The spontaneous
deletions in the largest J8 -Cµ intron accumulate during growth in vitro (Alt et al., 1982;
Burrow et al., 1983), and contribute to the different lengths of precursor µ transcript in
hybridomas FH, VXH and CH2XH. The sizes of these deletions were determined by
Southern blot analysis (Figure 2B), and are depicted in Figure la.
Since hybridomas are polyploid cells that often lose chromosomes and
spontaneous deletions at lg H chain locus occur at high rate, we subcloned all three
hybridomas by limiting dilution just before using them in the experiments described
below. The subclones were screened for the presence of the -y2b (that is expressed from
the V3 allele) by cytoplasmic immunofluorescence (CIF) using Texas Red-labeled goat
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anti-mouse -y2b. In the case of FH subclones, the expression ofµ chain was determined
by CIF using FITC-labeled goat anti-mouse lgM antibodies. Since the µ chain is not
expressed in hybridomas VXH and CH2XH. that contain nonsense codons in their µ genes
on the V2 allele (Figure la), the presence of the µ gene in these hybridomas was
determined by PCR using two sets of primers. Primer A and B amplified the genomic
Cµ gene segments in the µ gene, and the resulting products are revealed in Figure 2A.

One subclone from the µ-producing hybridoma FH, FH. 8, was used as a positive control.
As shown in panel b of Figure 2A, we identified seven subclones of CH2XH. and five
subclones of VXH, all of which contain the complete Cµ region of 2.0 kb (only visible
on the original gel). The presence of variable region in all subclones was also confirmed
by PCR using primers that are specific for the VH exon (Beck-Engeser, unpublished
result). These data suggest that VH exon and the constant region ofµ genes are present
in all subclones.
To determine the size of the large JH-Cµ intron in theµ gene, we isolated cellular
DNAs from various subclones, digested them with different restriction enzymes, and
analyzed the DNA fragments containing lg gene segments using Southern blotting (Figure
2B). We found thatµ gene in FH had a deletion of 1.3 kb and µgene in VXH had a
deletion of 1. 85 kb when compared to the µ gene in CH2XH.. All these deletions are in
the region of a 4.8 kb Hindlll fragment in the large JH-Cµ intron. However, the CH2XH.
itself was shown to have a deletion of 4.25 kb in this region (Wabl and Burrows, 1984).
The sizes of these deletions were determined by Southern blot analysis (Figure 2B), and
are depicted in Figure la.
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Figure 1

Schematic Representations of DNA Structures, Hybridization Probes
and p. Transcripts.

(a) DNA structures of endogenous µ genes in

hybridomas that are used in this Chapter. For the V2 allele that has a
completely assembled µ gene, open boxed and interspersed lines
designate, respectively, exons and introns of the mouse µ gene in
hybridoma FH. The numbers above indicate the size of respective exons
and introns in base pairs (not drawn to scale). Arrows above the structure
specify the sites at which spontaneous point mutations have generated
nonsense codons in the µ gene of hybridomas VXH and CH2XH. The
variations of spontaneous deletions in the large JH-Cµ intron as determined
by Southern blot analysis (Figure 2B) have also been shown with an
inverted triangle above the structure. (b) Bold lines represent the DNA
probes used in the hybridizations. (c) Expected sizes of precursor and
matureµ transcripts. Pre, precursor transcript. TAG, an amber nonsense
codon; TGA, an opal nonsense codon.
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Figure 2A

PCR Analysis to Screen for the Presence of Cµ. Gene Segments in
Hybridoma Subclones. (a) Schematic representation of the positions of
primers A and B used in the PCR and the expected size of PCR product.
(b) DNA isolated from 2.5 x 104 cells of each subclone was amplified by

PCR using 5'Cµl. Forward (Primer A) and 3'Cµ4. Backward (Primer B)
primers (For primer sequences, see section 2.2.1.2.1) for 35 cycles under
the following conditions for each cycle: denaturation at 94 °C for 20
seconds; annealing at 65°C for 1 minute; extension at 72°C for 1 minute.
The resulting products were resolved by electrophoresis in a 1 % TBE
agarose gel and visualized by ethidium bromide staining. The Cµ gene
segments (2.0 kb) were present in all sample lanes on the original gel,
including lanes 5 to 8 and lanes 13 to 16 even though the bands are not
visible in this figure. DNA isolated from F (the progenitor cell line) and

FH (a hybridoma that contains a functionalµ gene) were used as positive
controls. Asterisk (*) indicates nonspecific priming products of PCR.

:::i.

~

(.)

Ct)

:::i.

(.)

C\I
:::i.

(.)

,:::i.

(.)

Cl)

m
...
Jappe1 q)i
~

::I
aie1dwai ON
B"H::I
v"HX
O~"HX

6"HX
rHX

G~"HX

Jappe1q)I
Jappe1 dq £G

+

.0

0

~

C\I

(\J
T""

(J')

+

0

T""
T""

CX>

T""

G~"HXGH

......

£~"HXGH
~~·HXGH

T""

(\J

ct)

-.::t"

I{)

<O

O~"HXGH

6"HXGH
£"HXGH
aie1dwai o

~·HXGH

Cl)

B"H

c..

'i::

E

<C
...

c..

"i::

E

•

~

.0

0
C\I

t

.c

83

84
Figure 2B

Southern Blot Analysis to Identify the Deletion in the J11Cp. lntron of
p. Gene on the V2 Allele. (a) Restriction enzyme cleavage map of the

embryonic DNA that contains the JH and Cµ gene segments. The DNA
probes used in the hybridizations are diagrammed below. (b and c)
Southern Blot Analysis of the hybridomas. High molecular weight DNA
was isolated from the various hybridomas, digested to completion with
different restriction enzymes, electrophoresed in a 0.8% agarose gel and
transferred to nitrocellulose filters. The filters were hybridized with a µ
cDNA probe (b), stripped and rehybridized with the J34 probe (c). The
size of respective bands (in kb) was determined on a semi-logarithmic plot
of the apparent size of standard DNA fragments versus their migration
distance (indicated in kb). A copy of the autoradiogram (exposed for 2
weeks at -70°C) for Cµ hybridization was used in panel b because the
original film is lost (as suggested by Dr. H.M. Jack). The autoradiogram
for J34 hybridization was exposed for 1 week at -70°C. Ba, BamHI; H,
HindIII; E, EcoRI; Ag, Ag8.653 (the fusion partner).
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3.2

Nonsense Codons Decrease the Level ofµ mRNA but not Precursor µ
RNA in Hybridomas
To determine the level of µ RNAs expressed in the subclones, I isolated total

cellular RNA by the Trizol method, and performed a Northern blot analysis using a Cµ
cDNA probe (panel a in Figure 3A). The same blot was sequentially rehybridized to ')'2b
and 13-actin probes after stripping (panel band c, respectively). Radioactivity of bands
was determined by a betascope blot analyzer, which detects the counts per minute (cpm)
of the bands. The relative amount ofµ mRNA ([µ]) was calculated by dividing the
hybridization signal ofµ mRNA by the signal of 13-actin mRNA. Table 2A summarizes
the results of Figure 3A. I found that all subclones that contain µ gene with nonsense
codons produced less µ mRNA than the subclone that expresses productive µ gene (in
hybridoma FH.8): subclones of hybridoma VXH produce about 30 fold lessµ mRNA,
while subclones of hybridoma CH2XH produce about 125 fold less µ mRNA. These
values are the averages calculated from four different subclones in Figure 3A. The
expression ofµ mRNA also varied within subclones of the same hybridomas (e.g. lane
7 to lane 10 in Figure 3A). The progenitor cell line 18-81 of the hybridomas acquires
spontaneous deletions within the JH-Cµ intron during growth in vitro (Alt et al., 1982b;
Burrow et al., 1983). Although the enhancer element in the JH-Cµ intron is not required
for the a high level of H chain production (Wabl et al., 1984), the deletion around this
region (Figure 2B) still might be responsible for the variation ofµ mRNA expression in
subclones in Figure 3A. The levels of ')'2b mRNA ([')'2b] in Table 2A) also varied
between subclones, probably for the same reason. From these data, I confirmed that the
presence of a nonsense codon in the µ gene decreases the steady-state level ofµ mRNA
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in plasma cells.
In contrast to the decrease in the level of µ mRNA with a nonsense codon, I
found that the presence of a nonsense codon did not decrease the level of precursor µ
RNA ([preµ] in Table 2A). Since the transcriptional rates forµ gene with or without a
nonsense codon are the same in hybridomas (Jack et al., 1989), this finding may result
from theµ mRNA with a nonsense codon in the plasma cell being degraded faster than
µ

mRNA without a nonsense codon. Alternatively, the higher relative (rel) [preµ] level

may result from a nonsense codon preventing the splicing of precursor µRNA.
I also found that µ RNAs (including precursor µ RNA and µ mRNA) in
hybridomas VXH and CH2XH (lane 5' and 7', respectively in Figure 3A) had different
gel mobility thanµ RNAs in hybridoma FH (lane 6' in Figure 3A). Possible mechanisms
that account for the differences in gel mobility of µ RNAs between hybridomas will be
discussed and studied in detail in section 3. 4.
Since the results of Northern blot analysis using total cellular RNA isolated by
the Trizol method are sometimes not reproducible, I also isolated total cellular RNA by
the conventional GIT/CsCl method, and quantified the levels ofµ RNAs by Northern blot
analysis (Figure 3B). The results summarized in Table 2B are similar to those obtained
by the Trizol method (Table 2A). The slower gel mobility of the precursorµ RNA and
µ mRNA in hybridomas VXH and CH2XH than those in hybridoma FH is more obvious

in Figure 3B than Figure 3A.
In summary, the presence of nonsense codons decreases the level ofµ mRNA of
the total cellular fraction in hybridomas by about 30 fold in VXH and about 100 fold in
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CH2XH, when compared to the wild-type µ mRNA in hybridoma FH. Subclones FH. 8,
VXH.10 (34 fold lower than FH. 8, calculated from the average of two experiments from

Table 3A and 3B) and CH2XH.1 (16 fold lower than FH.8, calculated from the average
of two experiments from Table 3A and 3B) were selected for further studies. Total
cellular RNA will be only isolated by the GIT/CsCl method.
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Figure 3A

Northern Blot Analysis of Total Cellular RNA Isolated from Various
Subclones. Total RNA from various subclones was isolated by the Trizol
method. 5 µg of RNA was loaded onto each lane, electrophoresed on a gel
(1.2% agarose; 1 X MOPS; 2.2 M formaldehyde), and transferred onto
a nitrocellulose filter.

The filter was hybridized,

rehybridized sequentially with

stripped, and

32

P-labeled DNA probes. The filter was

then washed, dried and exposed at -70°C to X-ray film between two
intensifier screens. (a) Autoradiogram of the nitrocellulose blot that was
hybridized with a Cµ cDNA probe, as indicated in Figure 1. Film was
exposed for 18 hr at -70°C. The diminished exposure (film exposure was
for 18 hr at room temperature) of lanes 5, 6 and 7 is shown on the right
in Figure 3.1 as lanes 5', 6', and 7'. (b) The same blot was stripped, and
rehybridized with a /j-actin probe to control for the amount of RNA
loaded onto each lane. Film was exposed for 18 hr at room temperature.
(c) The same blot was rehybridized with a ')'2b probe. Film was exposed
for 24 hr at -70°C. (d) Ethidium bromide staining of the same gel
revealed the integrity and the positions of pre-rRNA and rRNA markers.
RNA standards used to determine the sizes of RNAs: 28S rRNA, 5.0 kb;
18S rRNA, 1.84 kb (Rogers et al., 1981). The 4.4 kb in lane 6' (panel a)
is present in several Northern blot analyses, although its identity is
unknown. The results of this figure are summarized in Table 3A.
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Table 2A

Quantitation of Northern Blot Analysis in Figure 3A

Hybridomas Method

RNA
loaded

Preµ

µ
[cpm]

'Y 2b

(3-actin

rel [pre-µ]
rel[µ]
{pre-µ/actin) (µ/actin)

% [µ]
[y 2b]
%FH.8 (y 2b/actin)

FH.8

Trizol

5µg

4

1398.2

23.6

106.2

<0.1

13.2

100%

0.2

VXH.12
VXH.9
VXH.10
VXH.4
VXH.1
average

Trizol
Trizol
Trizol
Trizol
Trizol

5µg
5µg
5µg
5µg
5µg

22.5
19.2
26.3
19.5
24.5

63.5
32.6
48.2
22.7
65.7

124.9
108.7
< 0.1
125.8
135.6

110.2
34.8*
108.4
124.8
149.6

0.2

0.6

4.4%

1.1

0.2
0.2
0.2

0.4
0.2
0.4
0.4

3.4%
1.4%
3.3%

<0.1
1.0
0.9

CH2XH.1
CH2XH.12
CH2XH.13
CH2XH.11
average

Trizol
Trizol
Trizol
Trizol

0.2
0.1
0.1
0.0
0.1

1.7%
0.7%
0.5%
0.3%
0.8%

5µg
5µg
5µg
5µg

8.2
3.7
4.1
3.1

30
6.8
5.3
2.2

16.8
15.3
2.0
4.9

132.9
74.1
89.3
63.9

0.1
<0.1
<0.1
<0.1

3.1%
0.1
0.2
<0.1
0.1

Radioactivity of respective bands (cpm) was determined by betascope scanning of Northern blot analysis.
Relative steady-state level ([x]) of respective RNA was calculated by dividing cpm of band x by cpm of (3-actin
in the same lane. Background of respective bands have been subtracted.
%[µ] is the percent of[µ] relative to that of FH.8 by setting FH.8 value equal to 100%.
* Value is not included in the calculation for average because (3-actin hybridization is visibly not accurate.
\0

.......

92

Figure 3B

Northern Blot Analysis of Total Cellular RNA Isolated from Various
Subclones.

Total RNA from various subclones was isolated by the

GIT/CsCl method. 0.4 µ.g of RNA from FH and 8 µ.g of RNA from VXH
and CH2XH were loaded onto each lane and Northern blot analysis was
performed as described in Figure 3A using a Cµ. probe (panel a, film was
exposed for 4 days at -70°C), or a /j-actin probe after stripping to control
for the amount of RNA loaded onto each lane (panel b, film was exposed
for 4.5 hr at -70°C), or a -y2b probe to detect the expression of -y2b
mRNA (panel c, film was exposed for 18 hr at -70°C). In panel d,
ethidium bromide staining of the agarose gel revealed the integrity and the
positions of pre-rRNA and rRNA markers. Lane 7: Ag8.653 that does not
express µ. mRNA was used as a negative control for µ. specific
hybridization. The results of this figure are summarized in Table 3B.
Asterisk (*) indicates an unidentified band that is hybridized to the Cµ.
cDNA probe.
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Table 28

Quantitation of Northern Blot Analysis in Figure 38

Hybridomas Method

RNA Preµ RNA
loaded

µmRNA
(cpm)

~-actin

mRNA

relative pre-µ
(pre-µ/actin)

relativeµ
(µ/actin)

relativeµ
{%)

FH.8
FH.1

GIT
GIT

0.4 µg
0.4µg

0.2
1.1

77.8
40.6

48.3
29.0

<0.1
<0.1

1.6
1.4

100.00A>
87.0%

VXH.12
VXH.10
average

GIT
GIT

8µg
8µg

4.6
3.8

25.5
27.4

425.3
717.2

<0.1
<0.1
<0.1

0.1
<0.1
<0.1

3.7%
2.5%
3.1%

CH2XH.1
CH2XH.13
average

GIT
GIT

8µg
8µg

2.7
1.5

8.0
13.6

536.3
711.0

<0.1
<0.1
<0.1

<0.1
<0.1
<0.1

0.9%
1.2%
1.1%

\0
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3.3

Nonsense Codons Reduce the Steady-state Level ofµ RNA in the Nucleus
To determine whether the lower total steady-state level of µ mRNA with a

nonsense codon results from either cytoplasmic or nuclear RNA reduction, I isolated
RNA from the nuclear and cytoplasmic fractions, and quantified the levels ofµ RNA in
the two subcellular compartments by Northern blot analysis.
The isolation of nuclear RNA is a very difficult task, mainly because of its low
abundance when compared with cytoplasmic RNA (Schilbler et al., 1978) and the
technical difficulty in separating the nuclei from the endoplasmic reticulum in the
cytoplasm. Endoplasmic reticulum binds the majority of cytoplasmic mRNA. Thus, I first
compared several published methods to isolate nuclear RNA from hybridomas FH and
CH2XH. Briefly, cell pellets from the lysate of NP-40-containing lysis buffer (the lysis

buffer for cytoplasmic RNA isolation) were purified through 2 M sucrose cushion by
either microcentrifugation or centrifugation, washed twice with PBS and taken as the
crude nuclei. The nuclear RNA was isolated by either the GIT/CsCl or Trizol method,
and quantified by Northern blot analysis (Figure 4). I found that the level of nuclearµ
mRNA was visibly lower in CH2XH (lane 11 and 12 in panel b) when compared to that
of FH (lane 4 to 7 in panel b). Since cytoplasmic RNA is about nine fold more abundant
than nuclear RNA (Schilbler et al., 1978), this lower steady-state level of nuclear µ
mRNA in CH2XH might result from either the nuclearµ mRNA level being lower, or
the nuclear RNA measured in Figure 4 reflects the steady-state level of cytoplasmic RNA
that was contaminated with nuclei during nuclear RNA isolation. Thus, I needed to
establish a reliable protocol to exclude cytoplasmic RNA contamination in the procedure
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Figure 4

Comparison of Methods to Isolate Nuclear RNA from Hybridomas FH
and CH2XH.

Nuclei from FH and CH2XH were purified by either

washing the pellets of NP-40 lysed homogenate twice with PBS (lane 5,
6, 7, and 12) or centrifugation through a 2 M sucrose cushion in a
microcentrifuge tube (lane 4 and 11). Nuclear RNA was either isolated by
the GIT/CsCl method (lane 5, 6, and 12) or the Trizol method (lane 4, 7,
and 11). Total RNA was isolated by either the Trizol method (lane 1 and
8) or the GIT/CsCl method (lane 2 and 9). Cytoplasmic RNA was isolated
by the NP-40/phenol method (lane 3 and 10). 5 µg of RNA from FH or
10 µg RNA from CH2XH was loaded onto each lane and Northern blot
analysis was performed as described in the legend to Figure 3A. (a)
Ethidium bromide staining of a representative gel shows the integrity and
the positions of pre-rRNA and rRNA markers. The identity of rRNA
precursors (45S and 35S) is suggested by the sizes of RNAs measured on
the autoradiogram correlate with the published sizes of precursor rRNAs
(Penman, 1966). (b) Autoradiogram (65 hr exposure) of the nitrocellulose
blot that was hybridized with a Cµ cDNA probe. (c) The same blot was
rehybridized with a -y2b probe. Film was exposed for 24 hr at -70°C. (d)
After stripping, the same blot was rehybridized with a (j-actin probe to
control for the amount of RNA loading onto each lane. Film was exposed
for 45 hr at -70°C. T, total cellular RNA; C, cytoplasmic RNA; and N,
nuclear RNA. Since the hybridomas FH and CH2XH used in this
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experiment were not subcloned after a long time in culture, the amounts
of ')'2b expression are different from those shown in Figure 3A.
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of nuclear RNA isolation in order to evaluate the level of nuclear RNA. Since the use
of microcentrifugation and the Trizol method did not generate reproducible results (Li
and Jack, unpublished results), I chose a 2 M sucrose cushion centrifugation method to
purify the nuclei and the GIT/CsCl method to isolate nuclear RNA in future experiments.
Since the outer membrane of nuclei is continuous with the membrane of the
endoplasmic reticulum in the cytoplasm (Amstein and Cox, 1992), an efficient way to
eliminate the cytoplasmic RNA contamination is to remove the outer nuclear membrane
in the nuclear RNA isolation procedure. Thus I used ionic and nonionic detergents to
remove the outer membrane of the nuclei (Nevins, 1980) and subsequently used 0.88 M
(Birnie, 1978) or 2 M (Nevins, 1980) sucrose cushion centrifugation to remove the
cytoplasmic RNA, polyribosomes, the outer membranes of nuclei and endoplasmic
reticulum from the nuclei. As shown in Figure 5c by ethidium bromide staining of the
agarose gel, I found that the rRNA precursors (45S and 35S) were enriched and the
ratios of 28S rRNA to 18S rRNA were visibly increased in the nuclear RNA preparation
of FH Oane 4 and 5). This suggested that the preparation was enriched in the nuclear
fraction (Penman, 1966). The removal of cytoplasmic components was determined by
phase-contrast microscopy after each step of nuclear RNA isolation. Representative
photographs are shown in Figure 6. I found that there were no obvious cytoplasmic tabs
in the examined fields after I purified the nuclei. I also attempted to examine the removal
of outer nuclear membrane by electron microscopy (Holtzman, 1966) with the help of
Dr. McNulty's laboratory. Due to the difficulty in counting enough nuclei to ensure their
purity and DNase I-mediated disruption of the chromosome structure inside the nuclei,
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I decided to use a novel approach to determine the removal of cytoplasmic components
in nuclear RNA isolation.
As discussed above, one efficient way to ensure the purity of nuclear RNA is to
eliminate all cytoplasmic components in the procedure of nuclear RNA isolation. Since
the nuclear and cytoplasmic fractions of the same cell type contain the same type of
RNAs, it is hard to distinguish the nuclear RNA from the cytoplasmic RNA. However,
hybridoma FH expresses only the heavy chain but no light chain of lg. Thus by mixing
cytoplasmic RNA isolated from plasmacytoma J558L (that expresses only a lambda (A)
light chain but no heavy chain) with the cell homogenate of hybridoma FH, I was able
to determine whether my modified nuclear RNA isolation protocol can efficiently remove
the exogenous cytoplasmic RNA. The main steps are illustrated in Figure 5A. Briefly,
I mixed the cell homogenate from 2.5 X 107 hybridoma FH (that expresses onlyµ but
no A mRNA) with post-nuclear supernatant containing cytoplasmic RNA either in
polyribosome-bound form or free mRNA form isolated from same number of cells of
plasmacytoma J558L (that expresses only A but noµ mRNA). The mixture was then
subjected to the nuclear RNA isolation procedure, and the amount of A mRNA by
Northern blot analysis was quantified by Northern blot analysis and betascope scanning.
The extent of cytoplasmic RNA contamination was determined by comparing the signal
of A mRNA in nuclear RNA isolated from FH (lane 5 in Figure 5B, panel a) to the signal
of A mRNA in cytoplasmic RNA isolated from the same number of J558L cells (lane 6
in panel a of Figure 5B and Table 3A). The amount of nuclear µ mRNA isolated from
the mixture (lane 5 in panel b) was comparable to that of FH (lane 4 in ·panel b),
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suggesting equal amounts of RNA were loaded in lane 4 and 5. These results are
summarized in Table 3A. I found that the amount of cytoplasmic >.. RNA contamination
in nuclear RNA isolated from FH was 0.001 % in the polyribosome-bound form of
cytoplasmic RNA (experiment 2) and 0.009% in the free cytoplasmic mRNA form
(experiment 1). Thus I concluded that the extent of cytoplasmic RNA contamination to
the nuclear RNA isolation can be ignored in my modified protocol.
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Figure 5B

Quantitation of the Extent of Cytoplasmic mRNA Contamination in
Purified Nuclei by Northern Blot Analysis. Cell homogenate from 2.5
X 107 hybridoma FH in 5 ml lysis buffer was mixed with either 5 ml postnuclear supernatant (for the polyribosome-bound cytoplasmic RNA) or
cytoplasmic RNA extract (for the free cytoplasmic RNA) isolated from the
same number of cells of plasmacytoma J558L, and the mixture was
subjected to the subsequent established nuclear RNA isolation procedure
as described in section 2.12.3.2. 8 µg of RNA was loaded onto each lane
and Northern blot analysis was performed as described in the legend to
Figure 3A. Table 3 summarizes the results of two independent
experiments. (a) Autoradiogram of a representative nitrocellulose blot that
was hybridized with a VAl probe. (b) The same blot was rehybridized
with a Cµ cDNA probe to control for the amount of nuclear RNA (lane
4 and 5) loaded onto each lane of the blot. (c) Ethidium bromide staining
of the gel revealed the amount of RNA loaded on the gel, and the integrity
and positions of pre-rRNA and rRNA markers.
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Table 3 Quantitation of the Amount of Cytoplasmic RNA
Contamination in the Purified Nuclei (Fig 58)
Experiment 1
Cell line
RNA Isolation

RNA loaded (µg)
Cell# (xl05) loaded
At mRNA (cpm)
µ mRNA(cpm)
(A.] (A./µ)
[A.]/105 Cells
% (A.] left

FH
Total Cytoplasmic Nuclear
8
3.6
<0.1
388.3

8
6.6
<0.1
319.6

8
55.5
0.2
30.4
<0.1
<0.1
<O.l

FH.Nuc+
JSSSL.Cyto

JS58L
Cyto

8
84.4
2.5
21.7
0.1
<0.1
<0.1

8
11.85
1368.3
7.8
175.4
14.8
100.0

FH.Nuc+
J558L.Cyto

JS58L

8
67.0
3.7
107.9
<0.1
<0.1
<O.l

8
10.0
1014.3
2.7
375.7
37.6
100.0

Experiment 2
Cell line
RNA Isolation

RNA loaded (µg)
Cell# (:1.105}
At mRNA (cpm)
µ mRNA(cpm)
[A] (A./µ)
(A]/105 Cells
% [A.] left

FH
Total Cytoplasmic Nuclear
8
3.6
<0.1
1681.7

8
10.2
<0.l
1264.6

8
57.0
<O.l
180.7
<0.1
<0.1

<0.1

c
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Figure 6

Representative Photographs of Nuclei in the Nuclei Isolation
Procedure. Intact cells of hybridoma FH (in panel a) were lysed in 5 ml
NP-40 lysis buffer, and the resulting cell homogenate was centrifuged
through a 0.88 M sucrose cushion to isolate nuclei (termed "crude
nuclei"). Only about 5% of the crude nuclei had visible cytoplasmic tabs
(in panel b). The outer membrane of crude nuclei was removed by ionic
and nonionic detergents and pure nuclei were purified by centrifugation
through either a 0.88 M or a 2 M sucrose cushion as illustrated Figure
5A. None of the nuclei examined had visible cytoplasmic tabs. A
representative picture is showed in panel c. All of the photographs were
viewed at the same magnification (more than 1OOX).

Representative Photographs of Nuclei
in the Procedure of Nuclear RNA Isolation
a

b

C

-s

lOS
By the established methods diagrammed in Figure 7, I isolated RNA from
different compartments of hybridomas and analyzed the RNA by Northern blot analysis
as revealed in Figure S. The Northern blot was first hybridized to a Cµ cDNA probe
(Figure Sb). The relative amounts ofµ mRNA in each lane (Figure Sb) were normalized
to the levels of {j-actin hybridization signal (Figure Sd). The steady-state levels ofµ RNA
in each subcellular compartment (obtained from three Northern blot analyses of two
independent RNA isolations) are summarized in Table 4 and illustrated in a bar graph
(Figure St). I found that in both mutant hybridomas (VXH and CH2XH), the nuclear
levels of nonsense codon-containing µ mRNA (lane 7 and lane 10 in Figure S,
respectively; nuclear[µ] in Table 4) were decreased by about 7 fold as compared to the
functionalµ mRNA in hybridoma FH Qane 4, p

< 0.01). This suggests that lg mRNA

with a nonsense codon starts to decrease in the nucleus. The same parameters as
discussed before, such as the presence of enriched rRNA precursors and the increased
ratio of 2SS to lSS rRNA (Figure Sa) and the lack of visible cytoplasmic tabs to the
purified nuclei as determined by phase-contrast microscopy (data not shown), were used
to determine the removal of cytoplasmic components in the nuclear RNA isolation
procedure. In addition, since mature histone mRNA is exported rapidly to the cytoplasm
(Sun et al., 1992), I should find the amount of H2b is lower in the nuclear fraction than
in the cytoplasmic fraction of RNA isolations. Thus I rehybridized the Northern blot with
a H2b probe and found the levels of H2b mRNA in nuclear fractions were low as
predicted (lane 4, 7, and 10 in Figure 8e; H2b in experiment 2 of Table 4).
The presence of precursor µ RNA in all fractions of hybridomas in Figure 8b was
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verified by rehybridizing the blot with an intron probe (1.0 kb Xbal fragment of the lgH
enhancer in the large JH-Cµ intron) as shown in Figure 8c. The presence of precursorµ
RNA in the cytoplasmic fraction may result from the cytoplasmic RNA being
contaminated with nuclear RNA during the isolation procedure. This possibility could not
be ruled out by the lack of precursor 45S and 35S rRNAs in the RNAs isolated from the

cytoplasmic fraction (lane 4, 7 and 10 in panel a of Figure 8), since the precursor rRNAs
are processed in the nucleolus which is unlikely affected by the removal of nuclear
membrane (Sommerville, 1986). However, the amount of nuclear lg RNA is only about
one ninth that of the cytoplasmic lg RNA (Schibler et al., 1978). Thus the cells loaded
in lanes of cytoplasmic RNA were far less than those of the nuclear RNA. Therefore,
the majority of precursor µ RNA in Figure 8b and 8c should not have resulted from
nuclear RNA contamination. Alternatively, the presence of precursor µ RNA is a unique
phenomenon in hybridoma cells used in this study. Usually unspliced precursor RNAs
are not exported from the nucleus, presumably by the effect of spliceosome-retention
(Legrain and Rosbash, 1989; Green, 1991). However, the transport of precursor RNA
can be facilitated by some RNA-binding proteins. The best example is the Rev protein,
which binds to a specific sequence in the precursor RNA of human immunodeficiency
virus-1 and facilitates viral precursor RNA nuclear export (Malim et al., 1989). The
mechanism for the presence of precursor µ RNA might also be mediated by a Rev like
protein.
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Figure 8

Northern Blot Analysis to Quantify the Steady-state Levels of RNAs
in Subcellular Compartments of Hybridomas. Total RNA was isolated

by the GIT/CsCl method (lane 1, 2, 5, and 8). Cytoplasmic RNA was
isolated by the NP-40/phenol method (lane 3, 6, and 9). Nuclear RNA
was isolated by established protocol as described in section 3.3.3.2 (lane
4, 7, and 10). 8 µ.g of RNA was loaded on each lane and Northern blot
analysis was performed as described in the legend to Figure 3A. Table 4
summarizes the results from three Northern blot analyses of two
independent RNA isolations. (a) Ethidium bromide staining of a
representative gel shows the amount of RNA loaded, and the integrity and
positions of pre-rRNA and rRNA markers. (b) Autoradiogram (exposure
time was 7 days at -70°C) of the nitrocellulose blot that was hybridized
with a Cµ. cDNA probe (as shown in Figure 1). The diminished exposure
(16 hr) of FH RNA (lanes 2, 3, and 4) was shown on the right as lanes
2', 3', and 4'. (c) The identity of precursor µ.transcripts was verified by
rehybridizing the blot with an intron probe in the large J8 -Cµ. intron (as
illustrated in Figure lb) after stripping. Film was exposed for 8 days. (d)
The same blot was rehybridized with a (3-actin probe after stripping to
control for the loading of RNA. Film was exposed for 6 hr. (e) The same
blot was rehybridized with a H2b probe to determine the level of H2b
mRNA in different fractions of RNA isolation. Film was exposed for 3
days. Lane 1: Ag8.653 that expresses noµ. RNA was used as a negative
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control for µ specific hybridizations. By comparing RNA to RNA size
markers (as indicated at left), I estimated the size of each RNA (as
indicated at right). The mechanism for precursor µ RNA present in the
cytoplasmic fractions of hybridomas (lane 3, 6, and 9) is unknown. (t) A
bar chart indicates the levels ofµ transcripts in subcellular compartments
relative to the wild-type µ RNAs in FH. The means and standard errors
were calculated from the results of three Northern blot analyses of two
independent RNA isolations and are listed in the summary tables in Table
4 (the levels ofµ RNAs for each experiment in FH is defined as 100%,
see [µ] and [pre µ] in Table 4). *: p

<

0.01 when compared to the

control in FH (Newman-Keuls' multiple range test).
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Table 4. Steady-State Levels of RNA Transcripts
Experiment 1
Hybridoma RNA

µ

4

ere p.

Loaded

4
(µ]2 •,4[µ]3
enh H2b Jl·actin
[cpm] 1
(µ/actin) % FH.8

a. Total Cellular RNAs
FB.8
0.4 µg 70.6 N.D.
8µg
VXH.10
27.0 13.3
CH2XB.l
10.4 5.9
8 f:l8

N.D. N.D. 19.4
1.8 N.D. 403.2
0.9 N.D. 571.0

3.6
0.1
<0.1

100.0
1.8
0.5

b. Cyto2lasmic RNAs
0.4 µg 33.6
FB.8
8 µg
VXH.10
21.4
8µg
CH2XH.1
10.3

N.D. N.D. 15.0
1.1 N.D. 292.6
0.6 N.D. 470.0

2.2
0.1
0.0

100.0
3.3
1.0

N.D.
8.4
4.4

[pre µ] 2 %[pre µ] 3
(µ/actin) %FH.8

[enh)

[Blb)

100.0
<0.1
<0.1

<0.1
<0.1

100.0
<0.1
<0.1

<0.1
<0.1

c. Nuclear RNAs
8µg
FB.8
54.0 4.8 N.D. N.D. 23.7
2.3 100.0
0.2
100.0
8µg
9.7 17.7 2.2 N.D. 34.0
VXB.10
0.3 12.5
0.5
257.0
0.1
8 µg
CH2XH.l
4.6
7.8
1.4 N.D. 30.5
0.2
6.6
0.3
126.3
<0.1
1. Radioactivity of respective bands ([cpm]) was determined by a betascope blot analyzer.
2. [µ]and (preµ) were calculated by dividing cpm ofband µor preµ by cpm of Jl-actin in the same lane.
3. %(µ)and %[preµ] are the percent of[µ] and [preµ] of respective cell line related to those ofFH.8
4. preµ, precursorµ~ enh, enhancer.
.......
.......
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Table 4. Steady-State Levels of RNA Transcripts (Continued)
A. Experiment 2 (Figure 8)
[µ)2 %[µ]3
µ ere ll4 enh4 Hlb P-actin
Hybridoma RNA
[cpm] 1

Loaded

(µ/actin) % FH.8

[pre µ) 2 %[pre µ) 3
(µ/actin)

[enh]

[Hlb]

%FH.8

a. Total Cellular RNAs
8 µg
I74
FH.8
8 µg
4.9
VXH.10
8 µg
2.5
CH2XH.1

2.6
2.4
1.6

1.9
5.1
2.4

5.0 497.9
7.4 553.2
6.0 661.6

0.3
<O.I
<0.1

100.0
2.5
I. I

<0.1
<O.I
<0.1

100.0
83.I
46.3

<0.1
<0.1
<0.1

<0.1
<0.1
<0.1

b. ~to~lasmic RNAs
8 µg
58.9
FH.8
8 µg
3.6
VXH.10
2.4
CH2XH.1 ~g

1.4
1.5
1.4

0.6
2.8
1.8

9.5 414.I
5.3 335.4
7.0 440.5

O.I
<O.I
<0.1

100.0
7.5
3.8

<O.I
<O.I
<0.1

100.0
132.3
94.0

<O.I
<0.1
<0.1

<O.I
<0.1
<O.I

c. Nuclear RNAs
1.3 34.4
<0.1
100.0
<0.1
8 µg
5.9
0.5
1.3
0.2 100.0
FH.8
<O.I 19.8
371.6
8 µg
2.2
7.7
I.I 64.8
O.I
0.1
VXH.10
3.5
1 44.3
<0.1 19.7
O.I
372.7
O.I
CH2XH.1
1.5
3.6
2.4
8 µ~
1. Radioactivity of respective bands ([cpm]) was determined by a betascope blot analyzer.
2. [µ]and [preµ] were calculated by dividing cpm of bandµ or preµ by cpm of P-actin in the same lane.
· 3. %[µ]and %[preµ] are the percent of[µ] and [preµ] of respective cell line related to those ofFH.8
4. preµ, precursorµ; enh, enhancer.

<0.1
<O.I
<0.1

,.....
,.....
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Table 4. Steady-State Levels of RNA Transcripts (Continued)
A. Experiment 3
Bybridoma RNA

µ

pre 11' enh' Blb Jl-actin
[cpm]

Loaded

1

a. Total Cellular RNAs
8µg 2186
FH.8
8 µg
60.0
VXH.10
8 µg
CHlXB.1
30.3

84.1
23.9
8.1

N.D. N.D. 656.5
N.D. N.D. 617.2
N.D. N.D. 753.5

b. Cytoplasmic RNAs
1696
FH.8
8 µg
8µg
42.7
VXH.10
8 µg
CHlXB.1
14.6

27.4
15.4
2.5

N.D. N.D. 461.5
N.D. N.D. 499.5
N.D. N.D. 185.l

[µ) 2 %(µ] 3
(µ/actin) % FH. 8

3.3
0.1

100.0
2.9

<0.1

1.2

3.7
0.1

100.0
2.3

0.1

2.1

[pre µ) 2 %[pre µ] 3
(µ/actin)

(enb]

[Blb]

% FH.8

0.1
<0.1
<0.1

100.0
30.2

0.1
<0.1
<0.1

100.0
51.9
22.7

8.4

c. Nuclear RNAs
8 µg 230.7 13.4 N.D. N.D. 58.1
100.0
4.0 100.0
0.2
FH.8
0.3
8.3
0.5
VXH.10
8mg 12.6 18.5 N.D. N.D. 38.1
210.5
0.4
0.5
234.3
10.3
CH2XB.1
8ma 10.1 13.4 N.D. N.D. 24.8
1. Radioactivity of respective bands ([cpm]) was determined by a betascope blot analyzer.
2. [µ)and [preµ) were calculated by dividing cpm of bandµ or preµ by cpm of P-actin in the same lane.
3. %[µ]and %(preµ] are the percent of[µ] and [preµ] of respective cell line related to those ofFH.8
4. pre µ, precursor µ~ enb, enhancer.

......

......
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Summary of The Relative Steady-State Levels ofµ RNA
Total Cellular µ
FH.8 VXH.10 CH2XH.1

Cytoplasmic µ
FH.8 VXH.10CH2XH.1

Nuclearµ
FH.8 VXH.10 CH2XH.1

Exp 1
Exp2
Exp3

100.0
100.0
100.0

1.8
2.5
2.9

0.5
1.1
1.2

100.0
100.0
100.0

3.3
7.5
2.3

1.0
3.8
2.1

100.0
100.0
100.0

12.5
19.8
8.3

6.6
19.7
10.3

Mean
SE

100.0

2.4
0.3

0.9
0.2

100.0

4.4
2.8

2.3
1.4

100.0

13.5
5.8

12.2
6.8

,....
,....
-.....l
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Quantitation of 1..1 Transcripts
in Subcellular Compartments
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3.4

Cytoplasmic Decay Rates ofµ. mRNA With or Without a Nonsense Codon
Since cytoplasmic degradation could be an independent event from nuclear

degradation, I further determined whetherµ. mRNA with a nonsense codon is degraded
in the cytoplasm of plasma cells in addition to the reduction observed in the nucleus. The
cytoplasmic decay rates ofµ. mRNA were measured using two transcriptional inhibitors
(Actinomycin Cl, Figure 9A and DRB, Figure 9B).
Actinomycin Cl is a transcriptional inhibitor that blocks all DNA-dependent RNA
polymerases by binding to guanine-rich region of duplex DNA (Perry and Kelly, 1970).
Although various effects of Actinomycin Cl on mRNA stability have been reported in
the literature (Belasco and Brawerman, 1993), 5 µ.g/ml of Actinomycin Cl was shown
to almost completely inhibit the transcription in FH cell lines within an hour as measured
by the [3H] uridine incorporation into RNA (Jack, 1988). Cytoplasmic RNA was isolated
from the cells at 0, 4, and 8 hrs after addition of Actinomycin Cl to the culture. The
levels ofµ. mRNA left in the cells were determined by Northern blot analysis using a Cµ.
cDNA probe (Figure 9Aa). The amount ofµ. mRNA was quantitated by a betascope blot
analyzer. The size of GAPDH mRNA is smaller thanµ. mRNA. Although the amount
of GAPDH expressed in three different hybridomas is different, it remains the same
within the same hybridomas. Thus GAPDH was used instead of /3-actin as the control for
RNA loading at different time points of the same hybridoma (panel bin Figure 9A). The
results from three independent experiments are summarized in Table 5A. I found that the
relative level ofµ. mRNA ([µ.]) with a nonsense codon decreased by about 1.5 fold in
both VXH and CH2XH during the 8-hour drug treatment. In contrast, the relative level
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of µ mRNA without a nonsense codon was increased in the FH cell line during the 8hour drug treatment. This increase probably occurs because GAPDH mRNA, which has
a half-life of 8 hr (Dani et al., 1984b), is less stable than functionalµ mRNA (that has
a half-life of 13-34 hr) (Mason et al., 1988; Cox and Emtage, 1989; Genovese and
Milcarek, 1990). The almost undetectable amount of GAPDH at 8 hr after addition of
Actinomycin Cl probably accounts for the two-phase decay rate of µ mRNA in
hybridoma VXH. Alternatively, VXH might be more sensitive to Actinomycin Cl
treatment. At 4 hr and 8 hr after addition of the drug, rRNAs were degraded in
hybridoma VXH as evidenced in lane 6 and 7 of panel e in Figure 9A. Thus it would be
wise to isolate cytoplasmic RNA between time points 0 to 4 hr while the RNA in
hybridoma VXH are not degraded.
DRB, an adenosine analogue, is a protein kinase inhibitor, which only blocks the
initiation of RNA polymerase II-mediated transcription (Zandomeni et al., 1983;
Chodosh et al., 1989; Dubois et al., 1994). It does not influence the transcription of
tRNA and rRNA (Zandomeni et al., 1983). I used this drug as an alternative to measure
the decay rate ofµ mRNA without or with a nonsense codon. Unlike Actinomycin Cl,
0.12 mM of DRB was shown to inhibit only the transcription of mRNA but not rRNA
in the FH cell line within an hour as measured by the [3H] uridine incorporation (Jack,
1988). As shown in Figure 9B and summarized in Table 5B, the half-life ofµ mRNA
with a nonsense codon was decreased from being relatively stable in FH to 3-4 hours in
hybridomas VXH and CH2XH during 8 hour-treatment.
As time went by, µ mRNA in hybridomas VXH and CH2XH migrated faster
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through the gel (panel a in Figure 9A and 9B). The degradation of mRNA in eukaryotic
cells is initiated by endonucleolytic cleavage, by shortening of the poly A tail, or by
decapping. Among them, control of poly A tail length has an important effect on RNA
degradation. For some mRNAs, decapping requires prior deadenylation (Jackson, 1993).
Thus the progressive shortening ofµ mRNA as a result of ribonuclease digestion most
likely results from µ mRNA deadenylation. However, premature translational termination
in yeast can trigger deadenylation-independent mRNA decapping (Muhlrad and Parker,
1994). Thus it is also possible that µ mRNA with a nonsense codon is degraded by
deadenylation-independent decapping mechanism.
The inhibitory effect of Actinomycin Cl or DRB on transcription in each
experiment was evaluated by rehybridizing the same blot with probes that detected the
mRNAs with short half-lives of 15 to 30 minutes, including Histone 2b (Old and
Woodland, 1984) or c-myc (Dani et al., 1984a; Herrick and Ross, 1994) (panel c and
d, respectively, in Figure 9A and Figure 9B). I found that the levels of c-myc mRNA
were visibly decreased with time in panel d of both Figure 9A and 9B, suggesting that
the transcriptional inhibitors (Actinomycin Cl and DRB) efficiently blocked the
transcription of mRNAs in each experiment. The differences in the size of c-myc mRNA
in different cell lines are probably attributable to differential DNA rearrangements at the
myc oncogene locus (Shen-Ong et al., 1982). The amount of H2b mRNA decreased
significantly after 4 hours of treatment with Actinomycin Cl, which is consistent with
the reported half-life of H2b mRNA as discussed above. Surprisingly, the amount of H2b
mRNA was exceptionally stable after 8 hours of treatment with DRB.
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Figure 9A

Northern Blot Analysis of Cytoplasmic Decay Rates of p. RNA in
Hybridomas by Using the Actinomycin Cl Method. Cytoplasmic RNA
was isolated from 5 X H>6 cells at 0, 4, and 8 hours after the addition of
Actinomycin Cl (5 µg/ml) to the culture, and analyzed by Northern blot
analysis as described in the legend to Figure 3A. Table 5A summarizes
the results from three independent RNA isolations. As time went by, the
mRNAs migrated faster through the gel because they became
progressively shorter as a result of ribonuclease digestion. Only the
darkest band ofµ mRNA in each lane was quantified. (a) Autoradiogram
(exposure time was 7 days at -70°C) of a representative nitrocellulose blot
that was hybridized with a Cµ cDNA probe. (b) The same blot was
rehybridized with a GAPDH probe to control for RNA loading onto each
lane of the blot. Film was exposed for 10 days. The inhibitory effect of
Act C 1 on transcription in each experiment was determined by
sequentially rehybridizing the blot with a H2b probe (panel c, exposure
time was 15 hr) or a 1 kb ClaI-SmaI human c-myc cDNA probe (panel d,
exposure time was 7 days). The virtual disappearance of H2b, c-myc
mRNAs at 4 hr in lanes 2, 6 and 9 shows that they were degraded faster
thanµ mRNA in FH. (e) Ethidium bromide staining of the gel revealed
the integrity and positions of pre-rRNA and rRNA markers. Lane 4:
Ag8.653 was used as a negative control forµ specific hybridization.
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Cytoplasmic Decay Rates
of RNAs (the Act C1 Method)
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Table SA. Cytoplasmic Decay Rates of RNAs (the Actinomycin C1 Method)
Hybridoma Time
RNA
µ
H2b c-myc GAPDH [µ]
%[µ] [H2b] %[H2b]
(hr)

Loaded

(cpm]

%t=O

%t=O

FH.8

t=O Exp 1 4 µg
Exp 2 8 µg
Exp 3 8 µg

262.4 12.1 0.9
297.6 83.4 N.D.
1041 161 N.D.

5.0
31.2
59.5

52.5
9.5
17.5

100.0 2.4
100.0 2.7
100.0 2.7

100.0
100.0
100.0

FH.8

t=4 Exp 1 4 µg
Exp 2 8 µg
Exp 3 8 µg
mean

289.1 1.2 0.2
239.6 0.4 N.D.
924.2 35.2 N.D.

4.5
20.8
60.1

64.2
11.5
15.4

FH.8

t=8

158.6 <0.1 0.1
131.1 <0.1 N.D.
443.5 17.6 N.D.

1.7
12.2
27.5

93.3
10.7
16.1

VXH.10

t=O Exp 1 8 µg
Exp2 8µg
Exp3 8µg

14.5 26.8 3.0
9.7 168 N.D.
6.4 155 N.D.

7.1
39.9
15.2

2.0
0.2
0.4

122.4
120.8
87.9
110.3
8.7
177.8
112.7
92.1
127.5
19.3
100.0
100.0
100.0

11.0
0. 7
21.7
11.1
4.1
<0.1
<0.1
23.7
7.9
6.1
100.0
100.0
100.0

VXH.10

t=4 Exp 1 8 µg
Exp2 8 µg
Exp3 8 µg
mean

7.0
2.9
3.7

2.2 1.4
21.8 N.D.
39.3 N.D.

4.7
19.6
18.8

1.5
0.1
0.2

VXH.10

t=8

1.7
1.5
2.3

<0.1 0.7
13.8 N.D.
24.0 N.D.

0.6
7.6
9.3

2.8
0.2
0.2

CH2XH.1

t=O Exp 1 8 µg
Exp2 8µg
Exp3 8 µg

4.9
7.7
6.8

23.3 2.3
149 N.D.
95.1 N.D.

3.3
22.6
17.2

1.5
0.3
0.4

CH2XH.1

t=4 Exp 1 8 µg
Exp2 8 µg
Exp3 8µg
mean

2.7
2.4
2.7

3.0 0.6
14.7 N.D.
47.7 N.D.

2.6
7.9
15.7

1.0
0.3
0.2

CH2XH.1

t=8

1.4
0.8
1.5

<0.1 0.3
13.6 N.D.
45.2 N.D.

1.2
4.2
8.0

1.2
0.2
0.2

SE
Exp 1 4 µg
Exp2 8µg
Exp 3 8 µg
mean

SE

SE
Exp 1 8 µg
Exp2 8µg
Exp3 8µg
mean

SE

SE
Exp 1 8 µg
Exp2 8µg
Exp3 8 µg
mean

SE

72.9
60.9
46.7
60.2
5.2
138.7
81.2
58.7
92.9
17.6
100.0
100.0
100.0

0.3
<0.1
0.6

<0.1
<0.1
0.6

3.8
4.2
10.2
0.5
1.1
2.1

7.1
6.6
5.5

12.4
26.4
20.6
19.8
2.8
<0.1
43.1
25.4
22.8
8.8
100.0
100.0
100.0

69.9 1.2
89.2 1.9
43.5 3.0
67.5
9.3
78.6 <0.1
55.9 3.2
47.4 5.7
60.6
6.9

16.3
28.1
54.9
33.1
8.4
<0.1
49.0
102.2
. 50.4
19.9

<0.1
1.8
2.6
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Figure 9B

Northern Blot Analysis of Cytoplasmic Decay Rates of p. RNA in
Hybridomas Using the DRB Method. Cytoplasmic RNA was isolated
from 5 X 106 cells at 0, 4, and 8 hours after the addition of DRB (0.12
mM) to the culture. 4 µg of RNA from FH and 8 µg of RNA from VXH
and CH2XH were loaded onto each lane and Northern blot analysis was
performed as described in the legend to Figure 9A. Table 5B summarizes
the results from three independent RNA isolations. As time went by, the
mRNAs migrated faster through the gel because they became
progressively

shorter as a result of ribonuclease digestion. Only the

darkest band ofµ mRNA in each lane was quantified. (a) Autoradiogram
(exposure time was 7 days) of a representative nitrocellulose blot that was
hybridized with a Cµ cDNA probe. (b) The same blot was rehybridized
with a GAPDH probe to control for the amount of RNA loaded onto each
lane of the blot. Film was exposed for 8 days. The inhibitory effect of
DRB on transcription in each experiment was determined by sequentially
rehybridizing the blot with an H2b probe (panel c, exposure time was 15
hr) or a c-myc probe (panel d, exposure time was 8 days). The virtual
disappearance of H2b, c-myc mRNAs at 4 hr in lane 2 shows that they
were degraded faster thanµ mRNA in FH. (e) Ethidium bromide staining
of the gel revealed the integrity and positions of pre-rRNA and rRNA
markers. Lane 4: Ag8.653 was used as a negative control forµ specific
hybridization.
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Cytoplasmic Decay Rates
of RNAs (the ORB Method)
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Table 58. Cytoplasmic Decay Rates of RNAs (the ORB Method, Figure 98)
Hybridomffime
(hr)

RNA µ
Loaded

H2b c-myc GAPDH
[cpm]

[µ]

%[µ]
o/ot=O
100.0
100.0
100.0

1.9
1.7
1.9

100.0
100.0
100.0

181.8
143.9
107 .5
144.4
14.4
38.7 122.3
76.6 141.1
33.6 100.6
121.3
8.0
2.0 100.0
0.9 100.0
0.4 100.0

2.7
2.0
1.1

146.3
117.9
58.4
107.5
18.9
89.0
136.4
53.7
93.0
16.7
100.0
100.0
100.0

FH.8

t=O Exp 1 4 µg
Exp 2 8 µg
Exp 3 8 µg

304.2
977.6
541.4

17.9
30.8
31.1

3.6
N.D.
N.D.

9.6
18.0
16.2

31.7
54.3
33.4

FH.8

t=4

316.8
921.9
2260

15.0
23.8
70.5

1.0
N.D.
N.D.

5.5
11.8
62.9

57.6
78.1
35.9

FH.8

t=8

182.1
942.3
1926

7.8
28. 7
59.1

0.9
N.D.
N.D.

4.7
12.3
57.3

VXH.10

t=O

Exp 1 8 µg
Exp 2 8 µg
Exp 3 8 µg

14.1
26.8
16.0

35.6
76.7
62.5

7.4
N.D.
N.D.

7.2
29.8
38.7

VXH.10

t=4

Exp 1 8 µg
Exp2 8µg

3.7
3.4
12.5

23.1
25.0
124

3.9
N.D.
N.D.

5
9.2
87.4

0.7
0.4
0.1

1.8
5.9
3.1

13.3
30. 7
30.4

2.1
N.D.
N.D.

3.7
14.5
19.2

0.5
0.4
0.2

Exp 1 4 µg
Exp 2 8 µg
Exp 3 8 µg
mean

SE
Exp 1 4 µg
Exp 2 8 µg
Exp 3 8 µg
mean

SE

Exp3 8 µg
mean

SE
Exp 1 8 µg
Exp 2 8 µg
Exp 3 8 µg
mean

VXH.10

t=8

CH2XH.1

t=O

Exp 1 8 µg
Exp 2 8 µg
Exp3 8 µg

8.5
22.9
11.7

57.6
86.9
74.6

5.2
N.D.
N.D.

8.1
27.2
42.2

1.0
0.8
0.3

CH2XH.1

t=4

Exp 1 8 µg
Exp2 8 µg

2.3
7.1
6.3

42.5
55.2
64.3

2.1
N.D.
N.D.

5.1
20.0
53.2

0.5
0.4
0.1

1.8
5.2
2.4

31.2
57.2
33.5

1
N.D.
N.D.

4.7
15.8
28.4

0.4
0.3
0.1

SE

Exp3 8µg
mean

SE
CH2XH.1

t=8

Exp 1 8 µg
Exp 2 8 µg
Exp 3 8 µg
mean

SE
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37.8
41.1
34.6
37.8
1.3
24.8
45.2
39.1
36.4
4.4
100.0
100.0
100.0
43.0
42.2
42.7
42.6
0.2
36.5
39.1
30.5
35.4
1.9

[H2b] %[H2b]
o/ot=O

1.7
2.3
1.0

4.9
2.6
1.6
4.6
2.7
1.4

3.6
2.1
1.6

7.1
3.2
1.8
8.3
2.8
1.2

6.6
3.6
1.2

93.4
105.6
87.9
95.6
3.8
72.7
82.3
98.0
84.3
5.3
100.0
100.0
100.0
117.2
86.4
68.4
90.6
10.2
93.4
113.3
66.7
91.1
9.4
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Figure 9C

Cytoplasmic Decay Rates of p. mRNA in Hybridomas by the Use of
Actinomycin Cl or DRB Method (Continued).
The amount ofµ mRNA remaining in the cells after the addition of the
drug at each time point was determined by a betascope blot analyzer, and
normalized to the amount of GAPDH mRNA. Only the darkest band of
µ mRNA in each lane was quantified. The relative amount ofµ mRNA

([µ]) at 0 hr was defined as 100% and later time points were calculated

as a percentage thereof. The log of these relative µ mRNA levels after
addition of the drug was plotted as a function of time by SigmaPlot 5.0.
The values represent the means of three independent RNA isolations and
the error bars represent the standard errors of the mean. Solid circles,
triangles and squares denote the curves obtained from the experiments
depicted in Figure 9A and Table 5A; open circles, triangles and squares
denote the curves obtained from the experiments depicted in Figure 9B
and Table 5B.
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Histone genes are intronless multicopy genes which encode small basic
polypeptides that are essential elements of the eukaryotic nucleosome (Marzluff and
Hanson, 1993). Unlike other eukaryotic mRNAs, histone RNAs in most organisms do
not have poly A tails but instead contain a conserved stem-loop sequence at their 3' end
(Marzluff and Pandey, 1988). All histone mRNAs with this 3' end stem-loop structure
are regulated coordinately with DNA synthesis, mainly by changing the stability of
histone mRNA (Gallwitz, 1975). Histone mRNA levels increase rapidly at the onset of
DNA synthesis, and decline equally rapidly at the end of DNA synthesis. The levels
varies 30- to 50-fold during the cell cycle (Marzluff and Pandey, 1988). Thus, the
finding that the amount of H2b mRNA remained relatively stable during the 8 hourtreatment with DRB might result if: 1) the concentration of DRB used in the experiment
was not enough to block the transcription of abundant H2b mRNA or, 2) the regulation
of H2b mRNA decay is different from those ofµ and c-myc mRNAs in the case of DRB
treatment. To distinguish between these possibilities, I treated hybridoma FH with
increasing concentrations of DRB (0, 0.12 mM, 0.24 mM, 0.48 mM and 0.96

mM,

respectively), and quantified by Northern blot analysis the amount of H2B mRNA left
at 0 and 4 hr after addition of DRB (Figure 10). If the concentration of DRB I used
before (0.12 mM) was not enough to block all H2B mRNA transcription in FH, I would
expect to find the amount of H2B mRNA left in the cells would decrease as the
concentration of DRB increased. If the H2B mRNA is subjected to different regulation
pathway, I would expect to find that the increased concentration of DRB has no
significant effect on H2B mRNA level. As shown in panel a and summarized in panel
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d of Figure 10, the increased concentration of DRB did not alter the amount of H2b
mRNA (panel a in Figure 10). In contrast, the same amount of DRB reduced the amount
of c-myc mRNA. From these data, I conclude that the exceptionally stable amount of
H2b mRNA during the 8 hour-treatment with DRB is not due to DRB concentration too
low to block the transcription of abundant H2b mRNA. Instead it might result from the
metabolism of H2b mRNA being subjected to a different regulation pathway from that
ofµ or c-myc mRNA.
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Figure 10

Northern Blot Analysis to Determine the Effect of DRB Concentration
on the Level of H2b mRNA. After counting, 2 ml of FH cells (at a
density of 5 X 1<>5 cells/ml) were distributed into wells of 24-well Costar
plate and kept for 1 hr at 37°C before addition of DRB. The final
concentration of DRB is 0, 0.12 mM, 0.24 mM, 0.48 mM and 0.96 mM,
respectively. At 0 and 4 hr, 2 ml (about H>6) of cells were removed,
centrifuged, and subjected to cytoplasmic RNA isolation by the NP40/phenol method. 8 µg of RNA was loaded onto each lane and Northern
blot analysis was performed as described in the legend to Figure 9A. (a)
Autoradiogram of the nitrocellulose blot that was hybridized with an H2b
probe. (b) The same blot was rehybridized with a GAPDH probe to
control for the amount of RNA loaded onto each lane of the blot. To
quantify the effect ofDRB on transcription, the blot was rehybridized with
a c-myc probe. Lane 4: Ag, Ag8.653, total RNA isolated from Ag8.653
(that expressed no µ mRNA). (c) The amount of RNA loaded in each
lane, and the integrity and positions of pre-rRNA and rRNA markers were
visualized by staining with ethidium bromide. (d) A graph. The relative
amount of H2b or c-myc mRNA without DRB treatment at 0 hr was
defined as 100% and later H2b or c-myc mRNA amounts were calculated
as a percentage thereof. The relative H2b or c-myc mRNA levels after
addition of DRB was plotted as a function of concentration by SigmaPlot
5.0.
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3.5

Nonsense Codons Affect the Size ofµ mRNA
I showed previously thatµ mRNA in hybridomas VXH and CH2XH (lane 5' and

7', respectively in Figure 3A) had slower gel mobility than µ mRNA in hybridoma FH
(lane 6' in Figure 3A). The differences in gel mobility ofµ mRNA may be attributed to
the different amounts of RNA loaded on the agarose gel (0.4 µg for FH and 8 µg for
VXH and CH2XH). This possibility was further studied by a mixing experiment (Figure

11). I made five serial dilutions of 1:5 each of 5 µg RNA isolated from FH and
compensated for the amount of RNA in each lane to 5 µg by the addition of RNA
isolated from Ag8.653 (that does not expressµ mRNA). With equal amounts of RNA
loaded onto each lane, I still detected differences in the size ofµ mRNA in hybridomas
VXH and CH2XH from FH (panel a in Figure 11). Thus, I concluded that the differences

in gel mobility of µ mRNA in different subclones were not due to different amounts of
RNA loaded on the agarose gel.
Alternatively, the difference in gel mobility of µ mRNA may result from the
observation that µ mRNA in hybridomas VXH and CH2XH is larger in size than µ
mRNA in FH. There are several possibilities which may explain the larger size of µ
mRNA in hybridomas VXH and CH2XH (that contain nonsense codons in theirµ genes),
such as: 1) the µ transcripts in different hybridomas use different transcriptional start
sites, 2) the µ transcripts in different hybridomas use different polyadenylation sites or
the length of their poly A tail is different, or 3) the presence of a nonsense codon
prevents the splicing of small introns that are in the constant region ofµ RNA, which
results in the increase in the size ofµ mRNA by 300 to 500 hp. The last possibility was
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studied here by using 3 sets of primers that are specific for the coding region of µ
mRNA. If the presence of a nonsense codon prevents the splicing of small introns in the
constant region ofµ RNA, I should be able to detect the RT-PCR products from
hybridomas VXH and CH2XH as being bigger than that from hybridoma FH. As shown
in Figure 12, all RT-PCR products detected by 3 sets of primers were the same in all

hybridomas. Thus, I suggest that the presence of a nonsense codon does not prevent the
splicing of small introns in the constant region ofµ mRNA, which may contribute to the
size increase in µ mRNA with a nonsense codon in hybridomas VXH and CH2XH.
The possibility that the presence of a nonsense codon affects the use of different
polyadenylation sites in µ gene or the length of the poly A tail in µ mRNA was studied
by ribonuclease H digestion. Ribonuclease H is an enzyme that digests duplex RNAs.
Total cellular RNA isolated from different hybridomas was incubated with oligo d(T),
which hybridizes to the poly A tail. By treating the mixture with ribonuclease H, the
RNA-DNA duplex of poly A tail and oligo d(T) was digested away. If the larger size of
µ mRNA in hybridomas VXH and CH2XH (that contain nonsense codons in their µ

genes) results from it having a longer poly A tail than that ofµ mRNA in hybridomas
FH, they should have the same gel mobility after the ribonuclease H treatment. This was

exactly what we found (data not shown). Thus, I conclude that the presence of a
nonsense codon can influence the length of poly A tail in µ mRNA, which contributes,
at least in part, to the slower gel mobility ofµ mRNA in hybridomas VXH and CH2XH.
The remaining possibility is that the length of the 5'-untranslated regions may be
influenced by a nonsense codon. This hypothesis can be studied by RNase protection
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analysis using a probe that is specific for the 5'-untranslated region ofµ RNA.
All these mechanisms that account for the size differences in µ mRNA can also
apply to the size differences in precursorµ RNA. Since the precursorµ RNA contains
introns, the variations in the size of introns, such as different deletions in the large JHCµ intron on the V2 allele as discussed before, may be attributed to the size differences

in precursor µ RNA with or without a nonsense codon. As revealed by Southern blot
analysis, the µ gene in FH has a deletion of about 1.3 kb and VXH has a deletion of
about 1.85 kb when compared to that of CH2XH (Figure 2B). Based on these results, I
suggest that the various deletions in the large JH-Cµ intron on the V2 allele attribute, at
least partially, to the size differences between precursor µ RNAs with (in hybridomas
VXH and CH2XH) or without a nonsense codon (FH). However, the relationship between

the presence of a nonsense codon and deletion in the large JH-Cµ intron of µ gene is
unknown.
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Figure 11

Northern Blot Analysis to Test the Effect of RNA Loading on
Mobility. Total RNA isolated from hybridoma FH. 8 was serially diluted
at 1:5 five times (lane 2, 3, 4, 5, 6, and 7), and then the amount of RNA
was compensated by total RNA isolated from Ag8.653 (that does not
expressµ transcripts) for 5 µgin each sample. The same amount of total
RNA isolated from hybridomas VXH and CH2XH was also loaded on the
gel and Northern blot analysis was performed as described in the legend
to Figure 3A. (a) Autoradiogram (exposed for 72 hr) of the nitrocellulose
blot that was hybridized with a Cµ cDNA probe. (b) The same blot was
rehybridized with a GAPDH probe to control for the amount of RNA
loaded onto each lane of the blot. Film was exposed for 24 hr. With equal
amounts of RNA loaded onto each lane, there are still differences in the
size of µ mRNA in hybridomas VXH and CH2XH from FH (panel a).
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Figure 12

RT-PCR ~y to Compare the Length of Coding Region inµ mRNAs
with or without a Nonsense Codon. 5 µg total cellular RNA isolated by
the GIT/CsCl method from each hybridoma was used for cDNA synthesis.
1120 (0.2 µg) of cDNA product from FH and 1/10 (0.5 µg) of cDNA
product from VXH and CH2XH were amplified by RT-PCR as described
in section 2.8.2, and the resulting products were resolved by
electrophoresis in a 1 % TAB agarose gel and visualized by staining with
ethidium bromide in panel a. All RT-PCR products detected by 3 sets of
primers are the same as expected in three hybridomas. Panel b depicts a
schematic representation showing the positions of three sets of primers
that were used in RT-PCR and the expected sizes of RT-PCR product.
Asterisk(*) indicates nonspecific priming products of RT-PCR. Primer A
and Bare the same as described in the legend to Figure 2. Primer C is the
VH81X. Forward primer, while primer D is the Cµ2Bam. Backward
primer. All the sequences are listed in section 2.2.1.2.1.
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3.6

Discussion
Nonsense codons in mRNA are known to be recognized during translation in the

cytoplasm. Nonsense codons have been shown to decrease the cytoplasmic steady-state
level of µ mRNA by 60 to 100 fold (Jack et al., 1989). Since metabolism of µ mRNA
with a nonsense codon is regulated by post-transcriptional mechanisms (Jack et al. ,
1989), this lower cytoplasmic steady-state level ofµ mRNA with a nonsense codon can
result from either a nuclear or a cytoplasmic event, or both. The data presented in this
chapter demonstrate that µ mRNA with a nonsense codon is reduced in both the nucleus
and the cytoplasm of plasma cells. The involvement of a nuclear process in the nonsense
codon-mediated RNA degradation has been extensively discussed in Chapter I. Thus this
section of the dissertation focuses on the interpretation of the results obtained in this
chapter.

3.6.1

lg mRNA with a Nonsense Codon Starts to Decrease in the Nucleus of
Plasma Cells
To determine the level of nuclear RNA, one needs to exclude the cytoplasmic

components in the procedure of nuclear RNA isolation. Since the outer membrane of
nuclei is continuous with the membrane of the endoplasmic reticulum in the cytoplasm
(Amstein and Cox, 1992), the outer membrane of nuclei should be removed with the
cytoplasmic components. An ideal way to monitor the removal of cytoplasmic
components to use specific markers for inner and outer nuclear membranes to stain the
nuclei before and after preparation. If the outer membrane of nuclei has been exclusively
removed, we would expect to find no staining of outer nuclear membrane after the
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purification procedure. Although over 1,000 proteins have been reported in the nuclear
pore (Forbes, 1992; Rout and Wente, 1994), our laboratory does not have these specific
markers. In addition, our laboratory does not have a specific marker to detect
polyribosome contamination in the nuclei preparation. Thus, I used an alternative
approach to quantify the amount of cytoplasmic RNA contamination in the modified
nuclear RNA isolation protocol (section 2.12.3.2 in Chapter II; Nevins, 1980; Birnie,
1978; Penman, 1966). As shown in Figure 5B and summarized in Table 3A, I found that
the cytoplasmic contamination in nuclear RNA preparation was less than 0.01 %,
suggesting the effect of cytoplasmic RNA contamination on nuclear RNA isolation can
be ignored in our current protocol. The removal of cytoplasmic components was also
determined by several parameters, such as the absence of cytoplasmic tabs as revealed
by the phase contrast microscopy (Figure 6), the presence of enriched rRNA precursors,
the increased ratio of 28S to 18S rRNA (Figure 8a), and the decreased level of H2b
mRNA (Figure 8e) in the nuclear RNA samples.
As shown in Figure 8 and summarized in Table 4, I found that the nuclear µ
mRNA levels of µ mRNA with nonsense codons (in hybridomas VXH and CH2XH) are
decreased by about 7 fold when compared to that ofµ mRNA without a nonsense codon
(in hybridoma FH). This lower steady-state level ofµ mRNA in hybridomas VXH and
CH2XH does not result from the hybridomas having defects in the expression of mRNA

or protein, because hybridomas VXH and CH2XH express comparable amounts of -y2b,
H2b and c-myc mRNAs (Table 4 and Table 5) and -y2b protein (Beck-Engeser,
unpublished result). Thus, I conclude that the reduction in the level ofµ mRNA with a
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nonsense codon starts in the nucleus of plasma cells.
The lower nuclear level of µ mRNA with nonsense codons could result from 1)
µ mRNA with a nonsense codon being degraded faster in the nucleus; 2) the presence

of a nonsense codon preventing the processing of precursor µ transcripts to µ mRNA;
or, 3) both. Due to the low abundance of nuclear RNA, I did not measure the nuclear
decay rate ofµ mRNA by the use of a transcriptional inhibitor. However, the second
possibility is consistent with the finding that the steady-state level of nuclear precursor
µ RNA with a nonsense codon increases by at least 2 fold over that of precursor µ

transcript without a nonsense codon (Table 4). It has been reported that histone premRNA is rapidly degraded if it is not productively processed (Pandey et al., 1994),
therefore, the effect of a nonsense codon on µ RNA processing could be more severe
than what I found. In addition, I found that the length of precursor µ transcripts is
independent of the position of a nonsense codon in the µ gene: In both VH.stop- and
Cµ2.stop-containing hybridomas, precursorµ RNAs retain the large JH-Cµ intron (Figure
8c). This evidence suggests that a nonsense codon does not specifically prevent the
splicing of its downstream sequences. Instead, the accumulation of precursor µ transcripts
probably results from interaction between the nonsense codon recognition system with
the splicing system.
A similar phenomenon has also been reported by Cheng and Maquat (1993). They
found deletion of all splice sites that reside downstream of a nonsense codon does not
abrogate the nonsense codon-mediated reduction of TPI mRNA. I do not know, however,
whether there is a specific sequence in the large JH-Cµ intron that is subjected to the
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regulation of the nonsense codon recognition system. The inhibitory effect of a nonsense
codon on the splicing of precursor RNA transcripts has also been reported in the
literature (Naeger et al., 1992, Lozano et al., 1994). Accumulation of the precursor
RNAs has also been noticed by other groups studying the expression of T cell receptor
fi gene (personal communication with Dr. Miles F. Wilkinson) and AHFR gene (Kessler

et al., 1993) in mammalian systems.
The presence of precursor µ transcripts that are 300-500 bp smaller than the
largest precursor µ transcript in each hybridoma suggests that the splicing of primary µ
transcript does not occur in the 5' to 3' order. Instead, the splicing of this large intron
at proximal 5' end may occur after the splicing of small introns in the constant region
of the µ gene. This is consistent with studies which show that the size of the intron and
exon influence the efficiency of splicing: in eukaryotic genes that contain large exons
(i.e. 300 bp in Cµ exons ofµ gene), an increase in the size of an intron correlates with
decreased splicing efficiency (personal communication with Dr. Susan Berget). Out of
order splicing has also been reported in other systems (Beyer and Osheim, 1988;
Bingham, 1993).

3.6.2

µ mRNA with a Nonsense Codon is Degraded Faster Than µ mRNA
Without a Nonsense Codon in the Cytoplasm of Plasma Cells

The best method to measure the decay rate of a mRNA is to use metabolic
labeling. However, our previous experiments failed because uridine is toxic to B cells
(Jack, unpublished data). Alternatively, I used two well established inhibitors of RNA
synthesis to measure the cytoplasmic decay rates ofµ mRNA (Figure 9). Both DRB and
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higher concentrations of Actinomycin Cl (over 5 µg/ml) were found to inhibit the
phosphorylation of the C-terminal domain of the largest subunit of eukaryotic RNA
polymerase II in Hela cells exposed to heat shock, which results in inhibition of
transcription in Hela cells (Dubois et al., 1994). In contrast to the studies that show
nonsense codons do not influence the cytoplasmic decay rates of mRNA (see review in
Chapter I), I found that the levels ofµ mRNA with nonsense codons are decreased by
about 1.5 fold during the 8-hour drug treatment of Actinomycin Cl, while the level of
µ mRNA without a nonsense codon remains relatively stable during this period (Table

5). In the case of DRB treatment, the half-life of µ mRNA decreases from relatively
stable in FH (that contains functional µ mRNA) to 3 to 4 hr in VXH and CH2XH (that
contain nonsense codons in theirµ mRNAs) during the 8 hr-treatment. Based on these
data, I conclude that µ mRNA with nonsense codons is degraded faster than that without
a nonsense codon. This is consistent with the assumption that the only identified
translational machinery resides in the cytoplasm of an eukaryotic cell, thus mRNA with
a nonsense codon should be recognized and degraded in the cytoplasm.
In addition, I noticed the differences in the half lives ofµ mRNA when they were
measured by the two transcriptional inhibitors. I proposed that the differences are
probably due to the fact that Actinomycin Cl reduces the levels of cytoplasmic mRNAs
more dramatically than DRB (compareµ and GAPDH hybridizations in the Figures 9A
and 9B). Thus, the lower level of GAPDH mRNA at 8 hour after Actinomycin Cl
treatment is not accurate enough to serve as a loading control to normalize the level of
µ mRNA. This problem may be overcome by the use of a stable mRNA (such as 28S
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rRNA or /3-actin mRNA) as a loading control. The levels of 28S rRNA on the gel can
be visibly compared in panel e of Figure 9A and 9B, where rRNAs are revealed by
ethidium bromide staining.

3.6.3

DRB Does Not Influence the RNA Metabolism of H2b Gene
The fact that the amount of H2b mRNA left in FH cells did not decrease as the

concentration of DRB was increased (Figure 10) suggests that the metabolism of H2b
mRNA is subjected to a different regulation pathway in the presense of DRB. The DRBspecific stabilized effect of H2b mRNA would result if: a) DRB blocks the transcription
of a short-lived degradation factor that is specific for histone mRNA; or b) DRB, a
nucleotide analogue of adenosine, blocks the RNA binding site on H2b-specific RNA
degradation factor, and thus inhibits the nuclease activity of the enzyme (personal
communication with Dr. Jeff Ross). Dr. Ross' lab has recently purified a biochemically
activated nuclease that is specific for histone mRNA. He is going to test whether DRB
specifically blocks the histone-specific RNA degradation by using H2b mRNA +I- DRB
as substrates of the nuclease activity of the purified protein. If DRB blocks the histonespecific nuclease, they should find a high level of H2b mRNA when they include DRB
in the substrate, while a low level of H2b mRNA when there is no DRB in the substrate.
Alternatively, c) DRB may block the translation of the H2b mRNA. It has been shown
that the degradation of histone mRNA is mediated by a ribosome-associated nuclease.
Translation is needed to bring the nuclease to its specific substrate on the mRNA (Graves

et al., 1987). Thus DRB can also exert its effect by inhibiting the translation process of
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H2b mRNA. This hypothesis can be tested by an 35S methionine pulse-chase experiment.
If DRB blocks the translation of H2b mRNA, I would expect to see a decrease in the

level of 35S methionine-labeled H2b protein. d) DRB may not block the transcription of
H2b mRNA. This hypothesis may be tested by a nuclear run-on experiment. If DRB does
not block the transcription of DRB, I would expect to see the normal 3H-uridine
incorporation of H2b mRNA after addition of DRB.

I have summarized the findings of this Chapter in Figure 13. Briefly, I found that
the reduction of cytoplasmic level of µ mRNA with a nonsense codon in plasma cells
results from both a nuclear and a cytoplasmic event. In the nucleus, the presence of a
nonsense codon inhibits the splicing of the largest J 8 -Cµ intron in precursorµ RNA. In
the cytoplasm, degradation is attributed to the lower cytoplasmic level ofµ mRNA with
nonsense codons. This is the first report that has shown that both nuclear and cytoplasmic
events are involved in the nonsense codon-mediated mRNA degradation. This could be
a very unique phenomenon for lg mRNA. Thus, B cells have more than one mechanism
to eliminate nonproductive lg mRNAs, which may contribute to the potent efficiency of
humoral immune response.
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Figure 13

A Schematic Representation of µ RNA Metabolism in Plasma Cells.
Two different splicing pathways for functional µ RNA (left) orµ RNA
with a nonsense codon (right) in plasma cells. The genomic organization
of the murine µ gene is presented at the top. Exons are represented by
open boxes, and introns by solid lines. X designates the presence of a
nonsense codon. Forµ transcript with a nonsense codon (i.e., a functional
µ RNA), the presence of a nonsense codon prevents the splicing of the

largest JH-Cµ intron in primary transcript, which might contribute to the
lower nuclear level ofµ mRNA. Lower amounts ofµ mRNA escapes to
the cytoplasm, where it is subjected to rapid cytoplasmic degradation. The
effect of a nonsense codon on either nuclear degradation or nucleus-tocytoplasm export ofµ mRNA has not been determined.
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CHAPTER IV

TEST OF A MODEL TO EXPLAIN THE MECHANISM BY WHICH
JG µ mRNA WITH A NONSENSE CODON
IS DECREASED IN THE NUCLEUS OF PLASMA CELLS

4.1

Introduction
In Chapter III, I found that µ mRNA with a nonsense codon is decreased in both

the nucleus and the cytoplasm of plasma cells. The presence of a nonsense codon
prevents the splicing of the large J8 -Cµ intron. However, I have not elucidated how a
nonsense codon can signal the reduction ofµ mRNA in the nucleus. Several models have
been proposed to explain the mechanism of the nonsense codon-mediated mRNA
degradation (see Chapter I). The main objective of this chapter is to determine whether
the modified translational translocation model (Figure 14) is the mechanism by which a
nonsense codon triggers the reduction of µ mRNA in the nucleus.
Based on the assumption that cytoplasmic translational machinery is the only
identified factor that can recognize a nonsense codon, Urlaub et al. (1989) proposed a
translational translocation model. I have modified Urlaub's model to accommodate our
secretory µprotein. As a secretory protein, µprotein is first synthesized as a precursor
bearing an N-terminal signal peptide (also called leader peptide) (Kuby, 1994). Shortly
after its synthesis, the signal peptide binds to the signal recognition particle (SRP) in the
150
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cytoplasm. The SRP also interacts with the ribosome in which the nascent peptide
resides, thus pausing theµ. protein translation in the free polysome fraction. There are
many SRP-receptors and signal sequence receptors on the surface of endoplasmic
reticulum (ER). The binding of theµ. mRNA-ribosome-bound SRP to its receptor targets
the µ. mRNA-ribosome complex to the surface of ER. This targeting releases the
translational pausing effect of SRP, thus allowing µ. protein translation to continue
efficiently on the surface of ER (Amstein and Cox, 1992). Protein translation on the
surface of ER not only facilitates the splicing of the 3' part of the RNA molecule in the
nucleus, but also pulls the µ. mRNA into the cytoplasm. If translation is prematurely
terminated by a nonsense codon, the splicing of the 3' part of RNA in the nucleus is
inhibited. In addition, ribosomes fall off the RNA, thus the ribosomes cannot facilitate
the export of RNA to the cytoplasm. The 'trapped' unspliced RNA in the nucleus is
degraded, which leads to the reduction of nuclear µ. RNA and subsequently cytoplasmic
RNA.
Once the matureµ. mRNA is in the cytoplasm, its steady-state level is regulated
by a cytoplasmic mRNA degradation event. This is consistent with my finding that µ.
mRNA with nonsense codons have a shorter half-life than that of µ. mRNA without a
nonsense codon. Mason et al. (1988) have shown that the change of µ. mRNA
cytoplasmic location from the ER-membrane bound fraction to the free polysome fraction
decreases its stability by about 6 fold. Additionally, protein translation on the surface of
ER might increase the stability ofµ. mRNA, presumably by protecting the instability
sequences downstream of the nonsense codon from attack by cytoplasmic degradation
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factors.
There are several predictions from our model. If a nonsense codon decreases the
steady-state level of µ mRNA by inhibiting the nuclear splicing of downstream
sequences, then:
1) when a nonsense codon is present in different exons of a µ gene, the size of
partially spliced µ transcripts should correlate with the position of a nonsense
codon;
2) when I introduce a nonsense codon in the last exon, the steady-state level of
µ mRNA should not be affected since no downstream splicing is required for

RNA processing;
3) when I replace the genomic sequences downstream of the nonsense codon with
their corresponding cDNA sequences, the steady-state level ofµ mRNA should

be restored to its wild-type level since no downstream splicing is required for
RNA processing;
4) the presence of a nonsense codon should not influence the steady-state level of
µ mRNA when it is derived from a cDNA clone since no intron splicing is

required forµ mRNA expression.
The first prediction is challenged by my finding that precursor µ transcripts in
hybridoma CH2XH still contain the large JH-Cµ intron that resides upstream of the
nonsense codon (see Chapter III). In this chapter, I have tested the other predictions by
analyzing the RNA expression of functionally rearranged wild-type or in vitro modified
µgenes that have been stably introduced into terminally differentiated B lymphocytes.
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Figure 14

A Modified Translational Translocation Model.

I have modified

Urlaub's model to accommodate our secretoryµ protein. Ribosomes begin
to translate aµ RNA as it emerges from a nuclear pore and before the
completion of its 3' processing. Protein translation on the surface of ER
not only facilitates the splicing of the 3' part of the RNA molecule in the
nucleus, but also pulls theµ mRNA into the cytoplasm. If translation is
prematurely terminated by a nonsense codon, nuclear splicing of the 3'
part of the RNA is inhibited. Ribosomes then fall off the RNA, and the
ribosomes cannot facilitate the export of RNA to the cytoplasm. The
'trapped' unspliced RNA in the nucleus is degraded, which leads to the
reduction of nuclear µ RNA and subsequently cytoplasmic RNA.
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4.2

Results

4. 2 .1

Construction of Plasmids
All the constructs used in this study are generated in a pµ• based expression vector

(Figure 15). The functionally rearranged murine µ gene isolated from the hybridoma
17.2.25 contains the following sequences starting from the 5' end: a short leader exon,
an intron, a joined VDJ (ViJ exon, a large JH-Cµ intron, and a series of constant gene
exons of "a" allotype in genomic configuration (Loh et al., 1983; Grosschedl and
Baltimore, 1984; Grosschedl et al., 1985). The insertion of E. coli enzyme, guanosylphosphoribosyl transferase (gpt), into the expression vector allows the selection of stable
transfectants in the media containing xanthine and mycophenolic acid (MPA). The
expression of gpt mRNA was used as an internal control for the copy number of active
transcripts of the plasmid. Several restriction endonuclease sites have been engineered
into the pµ•gpt.dM vector for the purpose of convenient cloning.

4.2.1.1

Deletion of the Membrane Exons in the pµ•gpt Plasmid
The membrane exons in the µ gene were deleted to eliminate the effect of

alternative splicing on the stability ofµ mRNA (Peterson, 1994). The plasmid pµ•gpt was
linearized with EcoRV that cut between Cµ4 and membrane exons.

After

dephosphorylation treatment with CIP, the plasmid was re-ligated in the presence of a
Spe I linker. Thus, the membrane exons were within a Spel fragment of 0.92 kb, which
was subsequently deleted by Spel digestion and religation of the modified plasmid. The
resulting plasmid is designed as pµ•gptAM.
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Figure 15

A Schematic Representation of the Plasmid pµ•gptAM.
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4.2.1.2

cDNA Replacement and Deletion of Downstream Sequences of the
Nonsense Linker in the pµ•gptAM Plasmid

To study the effect of a nonsense codon on the splicing of downstream sequences,
I replaced genomic sequences downstream of a nonsense codon with their corresponding
cDNA sequences. A 3.316-kb Xbal-Spel fragment that includes sequences in Cµ exons
was isolated from the pµ•gptAM vector and subcloned into pGEM9zf(-). The subcloned
plasmid was then linearized with BamHI enzyme that cut in the middle of Cµ2 exon, and
the BamHI ends were blunted with Kienow enzyme (Pharmacia). A Nhel-containing
amber stop linker [5'-pd(CTAGCTAGCTAG)-3', Pharmacia, Lot # 2067220011] that
includes three amber nonsense codons in each open reading frame was cloned into the
Kienow blunted-BamHI site in the middle of Cµ2 exon. The plasmids were screened for
the presence of amber stop linker by Nhel digestion. Then the 3.4-kb EcoRI-Spel
fragments without or with a stop linker were cloned back to the pµ•gptAM vector,
resulting in the deletion of a 3.512-kb EcoRI-Xbal fragment in the large V8 -Cµ intron
(construct A and B in Figure 16a).
The 1.244-kb BamHI-Nhel fragment that includes genomic sequences from the
Cµ2 to Cµ4 exon was replaced by its corresponding 0. 862-kb cDNA sequence from
plasmid 5.1 (Reth and Alt, 1984) in the Xbal-Spel subclone. The introduction of the
Nhel-amber stop linker into the Cµ2 exon and the subsequent cloning procedure are the
same as described above (construct G and Hin Figure 16a). To make construct J and L
(in Figure 16a), a 0.86-kb Nhel fragment that contains the sequences downstream of the
stop linker was deleted or was cloned back in opposite orientation. The accuracy of
cloning was confirmed by several restriction enzyme digestions (Figure 16b).
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4.2.1.3

Introduction of a Nonsense Linker into Four Exons of Constant Region in
the pµ•gp~M Plasmid

To determine whether the position of a nonsense codon influences the steady-state
level ofµ mRNA in plasma cells, I generated DNA constructs containing wild-type and
modifiedµ genes with a nonsense linker at different exons of theµ gene (Figure 17). The
subclone plasmid that contains the 3.316-kb XbaI-SpeI fragment of Cµ exons in genomic
configuration (as described in section 4.2.1.2) was linearized with SmaI, BgllI, BstXI,
or ApaI, respectively. The 3'-overhangs of ApaI or BstXI were blunted with T4 DNA
polymerase, and the 5'-overhangs of BgllI was blunted with Kienow enzyme. After
dephosphorylation treatment with CIP, each plasmid was ligated in the presence of a
Nhel-containing amber stop linker. The 3.328-kb XbaI-SpeI fragments of Cµ exons that
contain nonsense codons in different Cµ exons were subsequently cloned back to the
pµ•gp~M

vector (Figure 17a). The presence of the Nhel-containing nonsense linker at

the proper positions was confirmed by NheI digestion (Figure l 7b).

4.2.1.4

Generation of a Pcmv-µ cDNA Clone With or Without a Nonsense Linker

To determine whether the presence of a nonsense codon influences the splicing
of precursor µ transcript, I generated aµ cDNA clone with or without a nonsense codon.
Since µ cDNA clone does not express efficiently under the authentic IgH promoter, l
replaced the IgH promoter with the human cytomegalovirus immediate early promoter
(pCMV). A µ 1 cDNA sequence, which was cloned from 991 hybridoma cells (Balb/c)
into the pCR™ II vector, was cut out as 1.9 kb of EcoRI-NheI fragment and cloned into
EcoRI/XbaI sites in pUHDl0-1.gpt expression vector by a two-step ligation as described
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in Chapter II (Construct Min Figure 22a). The parent pUHDl0-1 vector contains a 746bp fragment of pCMV (Deuschle et al., 1989). A BstEII site in Cµ2 exon of µs cDNA
was destroyed by Klenow treatment and cloned into a Nhel-containing amber stop linker
[5'-pd(CTAGCTAGCTAG)-3', Pharmacia, Lot# 2067220011] (construct Nin Figure
22a).

4.2.1.5

Generation of Stable Transfectants Containing Modified µ Genes
Plasmid DNAs containing modified functional rearranged µgenes were introduced

into a mouse plasmacytoma cell line J558L (µ->.. +) by electroporation. The cells were
maintained in MPA-containing growth media to select for the expression of gpt. The
expression ofµ gene was screened by cytoplasmic immunofluorescence (CIF) using goat
anti-IgM antibody:µ protein was detected in stable transfectants containing constructs A,
C, F, G and J (data not shown). Further experiments were carried out using pools that
were generated from 30-33 independent clones.
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Figure 16

Restriction Analysis of DNA Constructs Containing Wild-Type and
Modified p. Genes. (a) Schematic representations of wild-type and

modified µ. gene constructs, showing a nonsense linker (arrow) in the
middle of the Cµ.2 exon and the cDNA replacement of genomic sequences
downstream of the nonsense codon. Double lines depict the positions of
the restriction endonuclease sites. Photographs of ethidium bromidestained 1.0% agarose gels are shown in panels b to d. All plasmids were
diluted and quantitated to the same concentration for further experiments.
1 µ.g DNA of each construct was digested with 0.2-0.5 units of enzyme
and the digestion reaction was performed according to the manufacturer's
instructions. DNA standards used to determine the size of DNA
fragments: 1 kb DNA ladder (lane 1) and A!HindIII (lane 8). In panel b,
the integrity of the constant region ofµ. gene was confirmed by EcoRISpel digestion; In panel c, the accuracy of cDNA replacement in the

constant region ofµ. gene was confirmed by BstEII digestion; and, in
panel d, the presence of Nhel-containing nonsense linker at the proper
positions was confirmed by Nhel digestion. All the digests had the
predicted sizes as indicated on the right. The fragment (*) in lane 3 was
not digested in panel b, but yielded expected products in an independent
digestion.
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Figure 17

Restriction Analysis of DNA Constructs Containing Wild-Type and
Modified p. Genes Containing a Nonsense Codon at Different Positions
of the Constant Region of p. Gene. (a) Schematic representations ofwildtype and modifiedµ gene constructs, showing the nonsense linker (arrows)
in different exons of the µ gene. Double lines depict the positions of
restriction endonuclease sites. (b) A photograph of an ethidium bromidestained 1.0% agarose gel. All plasmids were diluted and quantified to the
same concentration for further experiments. 1 µg DNA of each construct
was digested with 0.2-0.5 units of Nhel and the digestion reaction was
performed according to the manufacturer's instructions. The presence of
the Nhel-containing nonsense linker at the proper positions was confirmed
by Nhel digestion. The resulting digests have the predicted sizes as
indicated at left. The integrity of the constant region of µ gene was
confirmed by the EcoRI-SpeI digestion (data not shown). DNA standards
used to determine the size of DNA fragments: 1 kb DNA ladder (lane 1)
and "A/HindIII (lane 8).
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4.2.2

Positional Effect of a Nonsense Codon on the Steady-State Level ofµ.
mRNA.
Total RNA in stable transfectants was isolated by the GIT/CsCl method and

analyzed by Northern blot analysis using a Cµ. probe. Results of two independent
experiments with similar findings are shown in Figures 18A and 18B. In Figure 18A, the
relative steady-state level ofµ. mRNA ([µ.])was calculated by dividing the hybridization
signal fromµ. mRNA by the signal of gpt mRNA (panel c). I found that the levels ofµ.
mRNA with nonsense codons in the middle of Cµ.l, Cµ.2, and Cµ.3 exons were decreased
by at least 5 fold (lane 3, 5, and 6, respectively, in Figure 18A) when compared to
control level (lane 2 in Figure 18A). In contrast, the level ofµ. mRNA with a nonsense
codon in the middle of Cµ.4 exon (lane 7 in Figure 18A) was comparable to controlµ.
mRNA (lane 2 in Figure 18A). These data are consistent with the translational
translocation model. However, the level of µ. mRNA with a nonsense codon at the end
of Cµ.l exon (construct C, lane 4 in Figure 18A) was about 80% of total[µ.] detected in
µ. mRNA without a nonsense codon (construct A, lane 2 in Figure 18A). The relatively

stable level ofµ. mRNA in stable transfectants containing construct C might result from:
a) a cloning or transfection error; b) the mRNA has skipped the exon that contains a
nonsense codon (i.e., Cµ.l exon in this case); or c) the translational translocation model
is not the mechanism by whichµ. mRNA with a nonsense codon is degraded. This is
because the translational machinery in the cytoplasm should recognize the nonsense codon
and send out a degradation signal no matter where it is in the open reading frame.
To distinguish among these possibilities, I performed immunoprecipitations using
goat anti-IgM antibody. As shown in Figure 19, the presence of the nonsense codon at

165
F ofµ gene decreases the coding region ofµ mRNA by 142 nt, which results in the
truncated protein being about 47 amino acids shorter (that correlates to 5.2 KD deletion
in molecular mass) than the completeµ chain (lane 9 in Figure 19). For C-containing
transfectants, the 1013 kb nucleotide sequence downstream of the nonsense codon
correlates with 338 amino acids shorter in the truncated protein of 32 KD (lane 6 in
Figure 19). Consistent with the lower levels ofµ mRNA expression (Figure 18A and
18B), there were no detectable µ proteins in lysates isolated from stable transfectants
containing constructs B, D and E (lane 5, 7 and 8, respectively, in Figure 19). Thus, I
conclude that the size of truncated proteins are consistent with the expected products
predicted from the positions of the nonsense codon. These data ruled out the possibility
of a cloning or transfection error, or exon skipping. However, these truncated proteins
were not secreted into the supernatant (lane 12 and 15, respectively).
The multiple bands of µ mRNA in lanes 2 and 7 in Figure 18A were not
reproducible, as shown in lanes 3 and 4 in Figure 18B. The different sizes ofµ mRNA
might result from the alternative use of either a membrane or a secreted poly A site. This
may result from the presence of two polyadenylation sites in the plasmid

pµ•gp~M

(Figure 15), although the membrane exons have been deleted. The distance between the
two poly A sites is about 350 bp, which may account for the difference in size of
multiple bands I found in Figure l 8A. Alternatively, the differences in the size of µ
mRNA might result from the presence of a nonsense codon. This is unlikely because the
multiple bands were also found in stable transfectants containing functional µ gene (lane2
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Figure 18A

Analysis of p. mRNA Expression in J558L Transfectants Containing a
Nonsense Codon at the Different Positions of the Constant Region in
the Gene. (a) Schematic representations of wild-type and modified µ
gene constructs, showing the nonsense linker (arrows) at different
positions of Cµ exons. (b) A representative autoradiogram of the
nitrocellulose blot hybridized with a Cµ cDNA probe (as shown in Figure
1). Total RNA (10 µg) from pooled J558L transfected cells was isolated
by the GIT/CsCl method and subjected to Northern blot analysis as
described in the legend to Figure 3A. The same blot was rehybridized
with a gpt probe to control for the loading of RNA. (c) The radioactivity
of the bands was determined by a betascope blot analyzer, and relative
amounts of µ mRNA (indicated sizes of µ mRNA were scanned in each
lane) were calculated by dividing the µ signal by the gpt signal. The
presence of a nonsense codon in the middle of Cµl (construct B, 17%),
Cµ2 (construct D, 15%), and Cµ3 (construct E, 20%) decreases the [µJ

by at least 5 fold when compared to the control [µ] (construct A, setting
to 100% ). The presence of a nonsense codon at the end of the Cµl exon
(construct C, 135%) and in the middle of the Cµ4 exon (construct F,
83 %) did not decrease the [µJ when compared to the control. Lane 1,
non-transfected J558L cells were used as a negative control. Arrows on
the left indicate the positions of ribosomal RNAs; on the right indicate the
positions of µ and gpt mRNAs.
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Figure 18B

Analysis of p. mRNA Expression in J558L Transfectants Containing a
Nonsense Codon at the Different Positions of the Constant Region in
the Gene.

(a) Schematic representations of wild-type and modified µ

gene constructs, showing the nonsense linker (arrows) at different
positions in Cµ exons. (b) A representative autoradiogram of the
nitrocellulose blot hybridized with a Cµ cDNA probe (as shown in Figure
1). Total RNA (10 µg) from pooled transfected J558L cells was isolated
by the GIT/CsCl method and subjected to Northern blot analysis as
described in the legend to Figure 3A. The same blot was rehybridized
with a gpt probe to control for the loading of RNA. Lanes 5 and 8,
nontransfected J558L cells were used as a negative control. Arrows on the
right indicate the positions of precursor µ RNA and µ mRNA. The
hybridization signals in this Figure were not quantitated.
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Figure 19

Analysis of Intracellular and Secreted p. Heavy Chain

Expr~ion

in

J558L Transfectants Containing a Nonsense Codon at the Different

Positions of the Constant Region in the Gene.

(a) Schematic

representations of wild-type and modified µ genes, showing the nonsense
linker (arrows) at different exons in µ gene. (b) A fluorograph of an
immunoprecipitation experiment. [35S]-methionine biometabolically labeled
cell extracts and supernatant of J558L transfectants were incubated with
goat antisera against mouse IgM, followed by S. aureus. Solubilized
proteins were analyzed by SDS-PAGE on a 10% acrylamide gel, and
labeled proteins were detected by fluorography.

Lane 1, J558L

plasmacytoma cells; lane 2, NYCH.µK cells that express µand K chains;
lanes 4 to 15, different pools of J558L cells transfected with wild-type and
modified µ genes as depicted in a. The protein with a molecular weight
(MW) of 32 KD (lane 6) was identified as ..::1Cµl-4, because it has the

predicted MW of a nonsense codon at C site in panel a. For the same
reason, a protein of 63.8 KD has been identified as ..::1Cµ4. All these
truncated proteins are not secreted outside the cell (lane 11 and 15,
respectively).
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in panel b of Figure 18A. Thus the presence of multiple bands that hybridized to aµ
cDNA probe is probably not due to the presence of a nonsense codon, and it may result
from use of an alternative poly A site.

4.2.3

cDNA Replacement of Sequences Downstream of a Nonsense Codon Does
Not Restore its Steady-State Level of lg µ mRNA to Its Wild-type
Another approach to test whether a nonsense codon decreases the steady-state

level ofµ mRNA by inhibiting the splicing of downstream sequences is to replace the
genomic sequences downstream of the nonsense codon with their corresponding cDNA
sequences, and analyze its effect on the steady-state level ofµ mRNA.
Total RNA in stable transfectants was isolated by the GIT/CsCl method and
analyzed by Northern blot analysis using a Cµ probe (panel bin Figure 20A and 20B).
The relative steady-state level ofµ mRNA was calculated by dividing the hybridization
signal from µ mRNA by the signal of gpt mRNA (panel b of Figure 20A and 20B), and
are summarized in panel c. G1 and G2 represent RNA isolated from stable transfectants
that were generated by two independent constructs from the same cloning process (i.e.,
the genomic sequences downstream of the nonsense codon had been replaced by their
corresponding cDNA sequences). G represents RNA isolated from the stable transfectant
that was generated by mixing equal amount of G1 and G2 • The undetectable level ofµ
mRNA in G2 (lane 6 in Figure 20A and lane 4 in Figure 20B) might result from an
unnoticed mutation in its DNA construct. The levels ofµ mRNA ([µ])in the transfectants
of construct G and G1 (lane4 and 5 in Figure 20A, respectively) were 2 to 4 times lower
than that of wild-type (lane 2). This might result from either another cloning or
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transfection error, or small introns between Cµ2-3 and/or Cµ3-4 are required for good
expression ofµ mRNA (See detailed discussion below).
The level ofµ mRNA in the transfectants of construct H (cDNA replacement with
a nonsense linker in the middle of Cµ2 exons) was at least 20 fold lower (lane 7 in
Figure 20A and lane 5 in Figure 20B) when compared to the control (lane 2 in Figure
20A and 20B). This result can be explained in two ways. One is that there is a cloning
error. This possibility was excluded by the result of the immunoprecipitation, in which
I found truncated µ protein in the lysate of H transfectants (lane 6 and 9, respectively,
Figure 21) was 40 KD. Their sizes were consistent with the expected products predicted
from the positions of the nonsense codon (that is, a deletion of 790 nucleotides
correlating with the loss of 263 amino acids). These data also ruled out the possibility
of a cloning or transfection error, or exon skipping. Since I have repeated these
experiments twice, it is unlikely that the same error has been repeated. The other
possibility is that this result also argues against the translational translocation model.
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Figure 20A

Analysis ofµ. mRNA Expression in J558L Transfectants Containing
Modified µ. Genes.

(a) Schematic representations of wild-type and

modified µ. genes, showing a nonsense linker (arrow) in the middle of the
Cµ.2 exon and the cDNA replacement of genomic sequences downstream
of the nonsense codon. (b) Northern blotting of µ. mRNAs. Total RNA
(10 µ.g) from J558L cells stably transfected with various µ. genes was
isolated by the GIT/CsCl method and subjected to Northern blot analysis
as described in the legend to Figure 3A. Nontransfected J558L cells were
used as a negative control (lane 1). G1 and G2 represent RNA isolated
from stable transfectants that were generated by two independent
constructs of the same cloning process. G represents RNA isolated from
a stable transfectant that was generated by mixing equal amounts of G1
and G2 • The presence of a nonsense codon in the middle of Cµ.2 exon
(lane 3) decreases the[µ] by about 30 fold when compared to the control
[µ] (lane 2). The levels ofµ. mRNA ([µ]) were 2 to 4 fold lower in the
transfectants containing construct G and G1 (lane 4 and 5, respectively);
4 fold lower in the transfectants containing construct J (lane 8); and 50
fold lower in transfectants containing construct L (lane 9), than that of
wild-type control (lane 2). The [µ] in transfectants containing constructs
G2 and H was below the detectable limit ( < 0.1 % of the [µ] in
transfectants containing construct A).
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Figure 20B

Analysis of p. mRNA Expression in J558L Transfectants Containing
Modified p. Genes.

(a) Schematic representations of wild-type and

modifiedµ genes, showing a nonsense linker (arrow) in the middle of the
Cµ2 exon and the cDNA replacement of genomic sequences downstream

of the nonsense codon. (b) Northern blotting of µ mRNAs. Total RNA
(10 µg) from transfected J558L cells was isolated by the GIT/CsCl method
and subjected to Northern blot analysis as described in the legend to
Figure 3A (upper panel). The same blot was rehybridized with a gpt probe
to control for the loading of RNA (lower panel). (c) The relative steadystate level ofµ mRNA was calculated by dividing the hybridization signal
from µ mRNA by the signal to gpt mRNA on the same lane. Lane 1,
non-transfected J558L cells were used as a negative control. Arrows on
the left indicate the positions of ribosomal RNAs; on the right indicate the
positions of precursorµ RNA,µ mRNA and gpt mRNA.
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Figure 21

Analysis of Intracellular p. Heavy Chain Expression in J558L
Transfectants Containing Modified p. Genes.

(a) Schematic

representations of the wild-type and modified µ genes, showing a nonsense
linker (arrow) in the middle of the Cµ2 exon and the cDNA replacement
of genomic sequences downstream of the nonsense codon.

(b) A

fluorograph of an immunoprecipitation. [35S]-methionine biometabolically
labeled cell extracts of J558L transfectants were first incubated with goat
antisera against mouse IgM, followed by S. aureus. Solubilized proteins
were analyzed by SDS-PAGE on a 10% acrylamide gel, and labeled
proteins were detected by fluorography. The protein with a MW of 40 KD
(lane 5, 10 and 11) was identified as

~Cµ2-4,

because it has the predicted

MW of a nonsense codon in the middle of Cµ2. Lane 1, J558L
plasmacytoma cells; lane 2, NYCH.µK cells that expressesµ and" chains;
lanes 4 to 15, different pools of J558L cells transfected with wild-type and
modifiedµ genes as depicted in a. Mand N are RNA isolated from cell
lines containing µ cDNA under the control of Pcmv (see panel a in Figure
22 for illustration and section 4.2.4 for discussion).
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4.2.4

Removal of Intron Sequences from lg µ. Gene Does Not Protect Its mRNA
from Nonsense Codon-Mediated RNA Degradation.
To determine whether a nonsense codon affects the steady-state level ofµ. mRNA

by interfering with its splicing process, I cloned a µ. cDNA clone with or without a
nonsense codon in the middle of the Cµ.2 exon into a cytomegalovirus promoter (pCMV)based expression vector and analyzed the steady-state level of µ. mRNA in stably
transfected cells.
While the level of µ. mRNA derived from a cDNA clone under the Pcmv (lane
4 in Figure 22) was only 5 % of the level of genomic µ. gene under the IgH promoter
(lane 2 in Figure 22), the level ofµ. mRNA derived from the µ. cDNA clone with a
nonsense codon was undetectable (lane 5 in Figure 22). If these results are reproducible,
they suggest that the removal of introns from the µ. gene cannot abrogate the effect of a
nonsense codon on theµ. mRNA level. Thus, these data argue against the effect of a
nonsense codon on splicing, at least as the only mechanism, inµ. mRNA metabolism.
However, the low level of total µ. mRNA with a nonsense codon derived from a Pcmv
may result from either the nuclear-cytoplasmic transport ofµ. mRNA being blocked, or
the mature µ. mRNA with a nonsense codon being subjected to the effect of other nuclear
or cytoplasmic degradation events. The effect of cytoplasmic RNA degradation is
supported by my previous finding that additional cytoplasmic degradation contributes to
the low steady-state level ofµ. mRNA with a nonsense codon (see Chapter III).
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Figure 22

Expr~ion

of p. mRNA Transcribed from Pcmv-µ cDNA with or

without a Nonsense Codon in J558L Transfectants.

(a) Schematic

representations ofµ. mRNA transcribed from Pcmv-cDNA with or without
a nonsense codon, showing a nonsense linker (arrow) in the middle of the
Cµ.2 exon. (b) Northern blotting ofµ. mRNAs. Total RNA (10 µ.g) from
J558L cells stably transfected with various µ. genes was isolated by the

GIT/CsCl method and subjected to Northern blot analysis as described in
Materials and Methods and in the legend to Figure 3A. Nontransfected
J558L cells were used as a negative control (lane 1). Lanes in this figure

are pasted together from the same RNA agarose gel in Figure 20A. The
autoradiogram of gpt hybridization is not shown here. The larger size of
µ. mRNA in lane 4 results from the size of Pcmv is about 0.5-kb bigger

than that of Pig (Deuschle et al. , 1989; Grosschedl and Baltimore, 1985).
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4.3

Discussion

4.3.1

A Nonsense Codon Does Not Affect the Steady-State Level ofµ mRNA
by Preventing the Splicing of Its Downstream Sequences
The level of µ mRNA with a nonsense codon at the end of the Cµ 1 exon

(construct C) when compared to its wild-type counterpart (construct A) strongly argues
against the translational translocation model (Figure 18A and 18B). This is strengthened
by the finding that neither a cDNA replacement of downstream sequences to the nonsense
codon (Figure 20A and 20B) nor cDNA clone with a nonsense codon expressed under
a Pcmv (Figure 22) restored the level ofµ mRNA to its wild-type counterpart. Together
with the data in Chapter III, in which I found long precursorµ transcripts in hybridomas
VXH and CH2XH that contain nonsense codons in their µ genes, I suggest that

degradation ofµ mRNA with a nonsense codon involves more complicated mechanisms
rather than simply the cytoplasmic translational machinery sending out signals to inhibit
the nuclear splicing process. An alternative explanation for the finding that a nonsense
codon affects splicing of µ RNA is via nuclear scanning rather than cytoplasmic
recognition: The nonsense codon is recognized by a nuclear degradation factor before,
or at the time of, RNA splicing. Since the spliceosome or other nuclear RNA binding
protein are bound to the RNA transcript in the nucleus (Green, 1991; Dreyfuss et al.,
1992), they might sequester the nonsense codon from recognition by a nuclear scanning
system. However, I could not rule out the possibility of recognition being independent
of RNA splicing and somehow interacting with the splicing process (see discussion in
Chapter III). This hypothesis needs to be further tested.
Consistent with my finding in Chapter III that the presence of a nonsense codon
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reduces µ mRNA level by increasing the cytoplasmic turnover rate, I found that the level
of µ mRNA derived from a µ cDNA with a nonsense codon in the middle of Cµ2 exon
under the control of Pcmv was undetectable when compared to that of its wild-type
counterpart. This suggests that an additional cytoplasmic event degrades µ mRNAs with
nonsense codons even if they can escape the nuclear degradation event. However, this
cytoplasmic degradation factor probably has a very short half-life or it only acts as a
secondary surveillance after the nuclear degradation event (see discussion in Chapter III).
Alternatively, the presence of a nonsense codon may also prevent the nucleus-cytoplasm
transport of µ mRNA. It might be important for B cells to have more than one
surveillance pathway to eliminate the lg mRNA with nonsense codons, and thus ensure
an effective humoral immune response.

4.3.2

Introns Are Required for Effective Expression ofµ Gene
The difference between the µ mRNA steady-state levels of construct G and A was

unexpected (Figure 20), and might argue that small introns between Cµ2-3 and Cµ3-4
are required for effective expression ofµ mRNA. This is consistent with a study which
showed that an intron is required for optimal expression of cytoplasmic µ mRNA
(Neuberger and Williams, 1988). This intron requirement is not specific for a particular
intron, but has a cumulative effect, i.e. as long as an intron is present in the expression
vector, the steady-state level of cytoplasmicµ mRNA is increased; and the more introns
that are present in the expression vector, the higher the steady-state level of cytoplasmic
µ mRNA. Cooperation between introns has been reported to increase both the specificity
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and the efficiency of splicing (Neel et al., 1993). On the other hand, this intron
requirement has also been shown to be promoter-dependent: An intron is required in the
case of lg or P-globin promoters, but not in the case of cytomegalovirus or heat-shock
promoters (Neuberger and Williams, 1988). Furthermore, this intron requirement is also
cell-type independent since it is also needed in fibroblast transfectants (Neuberger and
Williams, 1988).
lntron requirement has also been shown to be necessary for effective expression
of other eukaryotic genes (Reviewed by Liu, 1994), such as human, mouse and rabbit
P-globin (Hamer and Leder, 1979; Buchman et al., 1988; Collis et al., 1990), mouse
dihydrofolate reductase (Gasser et al., 1982; Buchman et al., 1988), human
triosephosphate isomerase (Nesic et al., 1993 and 1994), SV40 late transcripts (Ryu and
Mertz, 1989), human purine nucleoside phosphorylase (Jonsson et al., 1992), mouse
thymidylase synthase (Deng et al., 1989), and maize alcohol dehydrogenase-1 (Callis et

al., 1987; Ryu and Mertz, 1989). In contrast, many cellular and viral genes do not
contain introns, and introns are not needed for effective expression from most cDNA
clones. I do not know what features of a gene determine the intron requirement of
effective production of cytoplasmic mRNA. However, it is very interesting to find that
at least four of the genes (lg, P-globin, and dihydrofolate reductase, TPI) degrade their
nonsense codon-containing mRNAs via a unique nuclear mechanism, i.e. RNA
processing and/or transport. Thus, I speculate that the intron requirement for effective
gene expression might be a common feature for genes that are subjected to nonsense
codon-mediated mRNA degradation via a nuclear process.
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It has been shown that for most genes, the presence of introns does not

significantly influence their transcriptional rates (Hamer and Leder, 1979; Ryu and
Mertz, 1989; Ryu and Mertz, 1989; Collis et al., 1990); rather, their presence has very
dramatic post-transcriptional effects on mRNA metabolism, including stabilization of
primary transcripts within the nucleus, excision of introns, polyadenylation, and transport
of mature mRNA to the cytoplasm (Hamer and Leder, 1979; Buchman and Berg, 1988;
Ryu and Mertz, 1989; Collis et al., 1990; Huang and Gorman, 1990). When an intron
cannot provide the function required for efficient precursor RNA processing, its own
excision occurs inefficiently (Ryu et al., 1994).
The mechanism of intron requirement in gene expression is only speculative.
Introns might influence post-transcriptional processes via their sequences associating with
appropriate ribonucleoprotein (Dreyfuss et al., 1992; Jarmolowski et al., 1992). For
example, their promoter dependence might result from different promoters being
transcribed at different locations in the nucleus via specific transcriptional factors. I
propose that for certain promoters, such as CMV and heat shock, transcripts are
synthesized near the nuclear pore and can be readily exported. However, in the case of
lg and fj-globin promoters, they might transcribe their primary mRNAs far from the
nuclear pore, which makes their RNA export difficult. In these cases, factors that bind
to introns might not only help to stabilize or splice the RNA, but also help to locate the
RNAs on a track towards the nuclear pore and facilitate RNA export. If small introns
such as intron 4 and/or 5 ofµ gene in construct G are missing, even if there is no
nonsense codon, µ transcript is degraded in the nucleus because it could not be
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transported outside the nucleus. This also argues against the importance of the pulling
effect of translation proposed by the translational translocation model (Urlaub et al.,
1989). The similar results from construct H, J and K might result from a scanning
system that recognizing the nonsense linker as the authentic termination codon and the
downstream sequences as different lengths of 3' untranslated region. Since there are no
introns downstream to hold the RNA in the nucleus, µ transcripts might be easily
exported. This is supported by the finding that the use of different RNA polymerase II
promoters influences the cytoplasmic stability of fi-globin mRNA (Enssle et al., 1993).
This possibility argues against the use of other promoters with or without cDNA clones
in the study of nonsense codon-mediated mRNA degradation of the genes that require
intron for efficient expression.

4.4

Proposed Further Experiments

4.4.1

For the Result of Positional Effect of a Nonsense Codon
I showed that the presence of a nonsense codon at the end of Cµ 1 exon did not

decrease the µ mRNA level when compared to that of its wild-type counterpart. To test
whether this results from RNA binding protein sequestering (e.g. spliceosome) the
nonsense codon at the end of an exon, one can introduce a nonsense codon at the
beginning or the end of the Cµ2 exon, and repeat all the experiments. According to the
current central dogma of splicing, both the 5' end and 3' end of an exon participate in
the formation of a spliceosome (see reviews in Green, 1991; Lamond, 1993). If the
spliceosome sequesters the recognition of nonsense codons by nuclear degradation factor,
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one should find that the amount of µ mRNA is comparable to that of its wild-type
counterpart when the nonsense codon is present at either end of the Cµ2 exon. However,
the final proof might come from the characterized degradation factor or splicing factor
that is bound to the µ mRNA from the construct C-containing transfectant. The other
obstacle is that we also do not have a way to dissect the nuclear and cytoplasmic
compartments. Further plans depend on the results of these experiments.

4.4.2

For the Result of cDNA Replacement on µ mRNA Expression
To better control for the copy numbers between different transfectants, one might

perform a nuclear run-on experiment to measure the transcriptional rate of µ gene in
construct A, G and H.
To rule out the possibility of unnoticed mutations in the H DNA construct that
might affect our results, I have generated eight other independent clones. It would be
unlikely that independent clones have the same unnoticed phenotype as observed before.

4.4.3

For the Effect of a Nonsense Codon in µ mRNA Derived from Pcmv-µ
cDNA
Since µ gene expression in mammalian cells is promoter-dependent and intron-

dependent, the use of a Pcmv to express the µ gene from its corresponding cDNA clone
might not reflect the µ gene expression from its genomic sequence under the lg
promoter. Thus, one should be more cautious in interpreting data that are obtained from
the use of a cDNA clone.
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To better understand whether the use of a Pcmv to express µ gene represents in
vivo µ gene expression, one can quantify the levels of nuclear µ mRNA and cytoplasmic
µ mRNA by Northern blot analysis as described in Chapter III:
µ mRNA (WT):

cDNA

cDNA+a stop

Total RNA

lX

decreased

Nuclear RNA

lX

decreased

Cytoplasmic RNA

lX

decreased

Nuclear RNA

lX

lX

Cytoplasmic RNA

lX

decreased

Expected results:

Result A

Result B

Result A suggests that the nuclear degradation event is independent of the splicing
process. Result B might result from either the presence of additional cytoplasmic
degradation machinery that can degrade matureµ mRNA, or the blockage of nuclearcytoplasm transport ofµ mRNA derived from the Pcmv-cDNA clone.
To determine whetherµ cDNA clone with a nonsense codon is degraded faster
than its wild-type counterpart, one could use the Actinomycin C or DRB method as
described in Chapter II and III. But one obstacle is that the amount ofµ cDNA expressed
under the Pcmv is only 0.5% of the corresponding genomicµ gene expressed from lg
promoter. Thus, one would probably start with too littleµ mRNA.

SUMMARY

In summary, I have demonstrated that the presence of a nonsense codon reduces
µ mRNA levels in both the nucleus and the cytoplasm of plasma cells. In the nucleus,

the presence of a nonsense codon prevents the splicing of the largest JH-Cµ intron in
precursor RNA. In the cytoplasm, the presence of a nonsense codon reduces µ mRNA
level by increasing the rate ofµ mRNA turnover. Thus, there are distinct cytoplasmic
and nuclear mechanisms for the reduction of µ mRNA with nonsense codons. The
probability of producing nonproductive lg mRNAs in the process of generating
tremendous lg diversity is higher than most of other mRNAs; therefore, the existence of
at least two mechanisms to prevent the translation of nonproductive lg mRNAs might be
unique to B cells. However, the mechanism is much more complicated than one can
imagine! To date, no model has been proposed that accounts for all the results emerging
in the field. I think the main obstacle yet to be resolved is to determine whether the
recognition of a nonsense codon occurs only in the cytoplasm, or only in the nucleus, or
in both.

190

REFERENCES

Alt, F.W., Rosenberg, N., Casanova, R.J., Thomas, B. and Baltimore, D. (1982a)
Nature 296, 325-331.
Alt, F.W., Rosenberg, N., Bnea, V., Siden, B., Thomas, B. and Baltimore, D. (1982b)
J. Mol. Cell Biol. 2, 386-400.
Alt, F.W., Yancopoulos, G.D., Blackwell, T.K., Wood, C., Thomas, B., Boss, M.,
Coffman, R., Rosenberg, N., Tonegawa, S. and Baltimore, D. (1984)EMBOJ. 3, 12091219.
Altenburger, W., Steinmetz, M. and Zachau, H.G. (1980) Nature 281, 603-607.
Amstein, H.R.V. and Cox, R.A. (1992) In: Protein synthesis, Oxford University Press,
p89-91.
Atkinson, M.J., Michnick, D.A., Paige, C.J. and Wu, G.B. (1991) J. lmmunol. 146,
2805-2812.
Atwater, J.A., Wisdom, R. and Verma, l.M. (1990) Ann. Rev. Genet. 24, 519-541.
Aviv, H., Voloch, Z., Bastos, R. and Levy, S. (1976) Cell 8, 495-503.
Barker, G.F. and Beemon, K. (1991) Mol. Cell. Biol. 11, 2760-2768.
Baserga, S.J. and Benz Jr., B.J. (1992) Proc. Natl. Acad. Sci. USA 89, 2935-2939.
Baumann, B., Potash, M.J. and Kohler, G. (1985) EMBO J. 4, 351-359.
Belasco, J.G. and Brawerman, G. (1993) "Control of Messenger RNA Stability", eds:
Academic Press, San Diego, USA.
Belgrader, P., Cheng, J. and Maquat, L.B. (1993) Proc. Natl. Acad. Sci. USA 90, 482486.
Belgrader, P. and Maquat, L.B. (1994) Mol. Cell. Biol. 14, 6326-6336.

191

192
Belgrader, P., Cheng, J., Zhou, X., Stephenson, L.S. and Maquat, L.E. (1994) Mol.
Cell. Biol. 14, 8219-8228.
Birnie, G.D. (1978) Methods Cell Biol. 17, 13-26.
Bornemann, K.D., Brewer, J.W., Beck-Engesser, G.B., Corley, R.B., Haas, I.G. and
Jack, H.-M. (1995) Proc. Natl. Acad. Sci. USA, in press.
Bothwell, A.L.M., Paskind, M., Reth, M., Imanishi-Kari, T., Rajewsky, K. and
Baltimore, D. (1981) Cell 24, 625-637.
Buchman, A.R. and Berg, P. (1988) Mol. Cell. Biol. 8, 4395-4405.
Burrows, P.D., Beck-Engeser, G.B. and Wahl, M.R. (1983) Nature 306, 243-246.
Burrows, P.D., Beck, G.B. and Wahl, M.R. (1981) Proc. Natl. Acad. Sci. USA 78, 564568.
Beyer, A.L. and Osheim, Y.N. (1990) Genes and Dev. 2, 754-765.
Bingham, P.M. (1993) J. Cell. Biol. 121, 729-743.
Callis, J., Fromm, M. and Walbot, V. (1987) Genes and Dev. 1, 1183-1200.
Chasin, L.A., Urlaub, G., Mitchell, P., Ciudad, C., Barth, J., Carothers, A.M.,
Steigerwalt, R. and Grunberger, D. (1990) Prog. in Clin. & Biol. Res. 340A, 295-304.
Cheng, J., Fogel-Petrovic, M. and Maquat, L.E. (1990) Mol. Cell Biol. 10, 5215-5225.
Cheng, J. and Maquat L.E. (1993) Mol. Cell. Biol. 13, 1892-1902.
Cheng, J., Belgrader, P., Zhou, X., Stephenson, L.S. and Maquat, L.E. (1994) Mol.
Cell. Biol. 14, 6317-6325.
Chodosh, L.A., Fire, A., Sumuels, M., and Sharp, P.A. (1989) J. Biol. Chem. 264,
2250-2257.
Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156-159.
Cleveland, D.W. (1988) Trends. Biochem. Sci. 13, 339-343.
Collis, P., Antoniou, M. and Grosveld, F. (1990) EMBO J. 9, 233-240.
Connor, A., Wiersma, E. and Shulman, M.J. (1994) J. Biol. Chem. 269, 25178-25184.

193
Cox, A. and Emtage, J.S. (1989) Nucleic Acids Res. 17, 10439-10454.
Daar, I.Q. and Maquat, L.B. (1988) Mol. Cell. Biol. 8, 802-813.
Dani, C., Blanchard, J.M., Piechaczyk, M., El Sabroury, S., Marty, L. and Jeanteur,
P. (1984a) Proc. Natl. Acad. Sci. USA 81, 7046-7050.
Dani, C., Piechaczyk, M., Audigier, U., El Sabroury, S., Cathala, G., Marty, L., Fort,
P., Blanchard, J.M. and Jeanteur, P. (1984b) Eur. J. Biochem. 145, 299-304.
Decker, C.J. and Parker, R. (1994) TIBS 19, 336-340.
Deng, T., Li, Y., Jolliff, K., and Johnson, L.F. (1989) Mol. Cell. Biol. 9, 4079-4082.
Deuschle, U., Pepperkok, R., Wang, F., Giordano, T.J., McAllister, W.T., Ansorge,
W. and Bujard, H. (1989) Proc. Natl. Acad. Sci. USA 86, 5400-5404.
Diatz, H.C., Valle, D., Francomano, C.A., Kendzior, Jr., R.J., Pyeritz, R.E. and
Cutting, G.R. (1993) Science 259, 680-683.
Dubois, M.F., Bellier, S., Seo, S.J. and Bensaude, 0. (1994) J. Cell. Physiol. 158, 417426.
Dreyfuss, G., Matunis, M.J., Pinol-Roma, S. and Burd, C.G. (1992) Annu. Rev.
Biochem. 62, 289-321.
Eckner, R., Ellmeier, W. and Bimstiel, M.L. (1991) EMBO J. 10, 3513-3522.
Ehretsmann, C.P., Carpousis, A.J. and Krisch, H.M. (1992) FASEB J. 6, 3186-3192.
Enssle, J., Kugler, W., Hentze, M.W. and Kulozik, A.E. (1993) Proc. Natl. Acad. Sci.
USA 90, 10091-10095.
Favaloro, J., Treisman, R. and Kamen, R. (1980) Methods Enzymol. 65, 718-749.
Forbes, D.J. (1992) Annu. Rev. Cell Biol. 8, 495-527.
Fort, P., Marty, L., Piechaczyk, M., El Sabrouty, S., Dani, C., Jeanteur, P. and
Blanchard, J.M. (1985) Nucleic Acids Res. 13, 1431-1442.
Gallwitz, D. (1975) Nature 251, 247-248.
Gasser, C.S., Simonsen, C.C., Schilling, J.W. and Schimke, R.T. (1982) Proc. Natl.
Acad. Sci. USA 79, 6522-6566.

194
Genovese, C. and Milcarek, C. (1990) Mol. Immunol. 21, 733-743.
Genovese, C., Harrold, S. and Milcarek, C. (1991) Somatic Cell & Mol. Genet. 17, 6981.
Gerster, T., Picard D. and Schaffner, W. (1986) Cell 45, 45-52.
Grandy, D.K., Engel, J.D. and Dodgson, J.B. (1982) J. Biol. Chem. 251, 8577-8580.
'

Graves, R.A., Pandey, N.B., Chodchoy, N. and Marzloff, W.F. (1987) Cell 48, 615626.
Green, M.R. (1991) Annu. Rev. Cell Biol. 1, 559-599.
Greenberg, M.E. and Ziff, E.B. (1984) Nature 311, 433-438.
Grosschedl, R., Weaver, D., Baltimore, D. and Costantin, F. (1984) Cell 38, 647-658.
Grosschedl, R. and Baltimore, D. (1985a) Cell 41, 885-897.
Grosschedl, R., Costantini, F. and Baltimore, D. (1985b) Tissue-specific expression of
lg genes in transgenic mice and cultured cells. In: Banbury Report 20 (Cold Spring
Harbor, New York: Cold Spring Harbor Laboratory, 187-196.
Gruss, P., Lai, C. J., Dhar, R. and Khoury, G. (1979) Proc. Natl. Acad. Sci. USA 76,
4317-4321.
Hamer, D.H. and Leder, P. (1979) Cell 11, 737-747.
Herrick, D., Parker, R. and Jacobson, A. (1990) Mol. Cell. Biol. 10, 2269-2284.
Herrick, D.J. and Ross, J. (1994) Mol. Cell. Biol. 14, 2119-2128.
Holtzman, E., Smith, I., and Penman, S. (1966) J. Mol. Biol. 17, 131-135.
Honjo, T. (1983) Annu. Rev. Immunol. 1, 499-528.
Huang, M.T. and Gorman, C.M. (1990) Nucleic Acids Res. 18, 937-947.
Humphries, R.K., Ley, T.J., Anagnou, N.P., Baur, A.W. and Nienhuis, A.W. (1984)
Blood 64, 23-32.
Jack, H.-M. and Wabl, M. (1987) Proc. Natl. Acad. Sci. USA 84, 4934-4938.

195
Jack, H.-M. (1988) Expression der Gene fur die schweren Immunoglobulinketten in
verschiedenen B-Zell-Differenzierungsstadien. Ph.D. Dissertation, Eberhard-KarlsUniversitat Tiibingen, Tiibingen, Germany.
Jack, H.-M. and Wabl, M. (1988) EMBO J. 7, 1041-1046.
Jack, H.-M., Berg, J. and Wabl, M. (1989) Eur. J. Immunol. 19, 843-847.
Jack, H.-M., Beck-Engeser, G., Sloan, B., Wong, M.L. and Wabl, M. (1992) Proc.
Natl. Acad. Sci. USA 89, 11688-11691.
Jackson, R.J. (1993) Cell 14, 9-14.
Jarmolowski, A., Boelens, W.C., Izaurralde, E. and Mattaj, I.W. (1992) J. Cell. Biol.
124, 627-635.
Jonsson, J.J., Foresman, M.D., Wilson, N., and Mcivor, R.S. (1992) Nucleic Acids Res.
20, 3191-3198.
Kearney, J.P., Radbruch, A., Liesegang, B. and Rajewsky, K. (1979) J. Immunol. 123,
1548-1550.
Kedzierski, W. and Porter, J. (1991) BioTechniques 10, 210-214.
Kelly, K., Cochran, B.H., Stiles, C.D. and Leder, P. (1983) Cell 35, 603-610.
Kelly, D.E. and Perry, R.P. (1986) Nucleic Acids Res. 14, 5431-5447.
Kessler, S.W. (1975) J. Immunol. 115, 1617-1624.
Khalili, K. and Weinmann, R. (1984) J. Mol. Biol. 180, 1007-1021.
Krowczynska, A., Yenofsky, R. and Brawerman, G. (1985) J. Mol. Biol. 181, 231-239.
Kuby, J. (1994) Chapter 8. Organization and expression ofimmunoglobulin genes, p175208, in: Immunology, 2nd ed. W.H. Freeman and Company, New York, USA.
Kuehl, W.M. (1977) Curr. Topics Microbiol. Immunol. 76, 1-47.
Laemmli, U.K. (1970) Nature 227, 680-685.
Lamond, A.I. (1993) Curr. Biol. 3, 62-65.
Leeds, P., Peltz, S.W., Jacobson, A. and Culbertson, M.R. (1991) Genes Dev. 5, 2303-

196
2314.

Leeds, P., Wood, J.M., Lee, B.-S. and Culbertson, M.R. (1992) Mol. Cell. Biol. 12,
2165-2177.
Legrain, P. and Rosbash, M. (1989) Cell 51, 573-583.
Lim, S.K., Sigmung, C.D., Gross, K.W. and Maquat, L.E. (1992) Mol. Cell. Biol. 12,
1149-1161.
Liu, X. (1994) Effects of intron and exon sequence elements on intron-dependent and
intron-independent gene expression. Ph.D. Thesis, University of Wisconsin, Madison,
Wisconsin.
Loh, D.Y., Bothwell, A.L.M., White-Scharf, M.E., Imanishi-Kari, T. and Baltimore,
D. (1983) Cell 33, 85-93.
Losson, R. and Lacroute, F. (1979) Proc. Natl. Acad. Sci. USA 76, 5134-5137.
Lozano, F., Maertzdorf, B., Pannel, R. and Milstein, C. (1994) EMBO J. 13, 46174622.
Malim, M.H., Hauber, J., Le, S-Y., Maizel, J.V. and Cullen, B.R. (1989) Nature 338,
254-257.
Mason, J.O., Williams, G.T. and Neuberger, M.S. (1988) Genes Dev. 2, 1003-1011.
Maquat, L.E., Kinniburgh, A.J., Rachmilewitz, E.A. and Ross, J. (1981) Cell21, 543553.
Maquat, L.E. (1991) Curr. Opin. Cell Biol. 3, 1004-1012.
Marzluff, W.F. and Pandey, N.B. (1988) Trends Biochem. Sci. 13, 49-52.
Meo, T., Johnson, J.P., Beechey, C.V., Andrews, S.J., Peters, J. and Searle, A.G.
(1980) Proc. Natl. Acad. Sci. USA 77, 550-553.
Morrison, S.L. and Scharff, M.D. (1981) Rev. Immunol. 3, 1-22.
Muhlrad, D. and Parker, R. (1994) Nature 370, 578-581.
Mulligan, R.C. and Berg, P. (1981) Proc. Natl. Acad. Sci. USA 78, 2072-2076.
Naeger, L.K., Schoborg, R.V., Zhao, Q., Tullis, G.E. and Pintel, D.J. (1992) Genes

197
Dev., 6, 1107-1119.

Neel, H., Weil, D., Giansante, C. and Dautry, F. (1993) Genes Dev. 1, 2194-2205.
Nesic, D., Cheng, J. and Maquat, L.E. (1993) Mol. Cell. Biol. 13, 3359-3369.
Nesic, D. and Maquat, L.E. (1994) Genes Dev. 8, 363-375.
Nevins, J.R. (1980) Methods in Enz. 65, 768-774.
Neuberger, M.S. and Williams, G. T. (1988) Nucleic Acids Res. 16, 6713-6724.
Oi, V.T., Bryan, V.M., Herzenberg, L.A. and Herzenbery, L.A. (1980) J. Exp. Med.
151, 1260-1274.
Okada, A. and Alt, F.W. (1994) Seminar in Immunol. 6, 185-196.
Old, R.W. and Woodland, H.R. (1984) Cell 38, 624-626.
Pachter, J.S. (1992) Crit. Rev. Euk. Gene Exp. 2, 1-18.
Pandey, N.B., Williams, A.S., Sun, J.-H., Brown, V.D., Bond, U. and Marzluff, W.F.
(1994) Mol. Cell. Biol. 14, 1709-1720.
Parker, R. and Jacobson, A. (1990) Proc. Natl. Acad. Sci. USA 87, 2780-2784.
Peltz, S.W., Brown, A.H. and Jacobson A. (1993) Genes Dev. 1, 1737-1754.
Pelletier, J. and Sonenberg, N. (1988) Nature 334, 302-305.
Perry, R.P. and Kelly, D.E. (1970) J. Cell. Physiol. 16, 127-140.
Perry, R.P. and Kelly, D.E. (1979) Cell 18, 1333-1339.
Penman, S. (1966) J. Mol. Biol. 17, 117-130.
Peterson, M.L. (1994) A processing and the expression of immunoglobulin genes, p.
321-342. In: E.C. Snow (ed.), Handbook of Band T lymphocytes. Academic Press, San
Diego, California.
Pulak, R. and Anderson, P. (1993) Genes Dev. 7, 1885-1897.
Qian L., Theodor, L., Carter, M.S., Vu, M.N., Sasaki, A.W. and Wilkinson, M.F.
(1993) Mol. Cell. Biol. 13, 1686-1696.

198
Pulak, R. and Anderson, P. (1993) Genes Dev. 1, 1885-1897.
Reth, M.G. and Alt, F.W. (1984) Nature 312, 418-423.
Richter, J.D. (1991) Bioessays 13, 179-183.
Rogers, J., Choi, E., Souza, L., Carter, C., Word, C., Kuehl, M., Eisenberg, D. and
Wall, R. (1981) Cell, 26, 19-27.
Ross, J. (1989) Sci. Am. 260, 48-55.
Rout, M.P. and Wente, S.R. (1994) Trends Cell Biol. 4, 357-365.
Ryu, W.-S., Gelembiuk, G., Liu, X., and Mertz, J.E. (1994) (manuscript in
preparation).
Ryu, W.S. and Mertz, J.E. (1989) J. Virol. 63, 4386-4394.
Sachs, A.B. (1993) Cell 14, 413-421.
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: a laboratory
manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
Schibler, U., Marcu, K.B. and Perry, R.P. (1978) Cell 15, 1495-1509.
Shen-Ong, G.L.C., Keath, E.J., Piccoli, S.P. and Cole, M.D. (1982) Cell 31, 443-452.
Simpson, S.B. and Stoltzfus, C.M. (1994) Mol. Cell. Biol. 14, 1835-1844.
Sommerville, J. (1986) Trends Biochem. Sci. 11, 438-442.
Southern, P.J. and Berg, P. (1982) J. Mol. App. Genetics 1, 327-341.
Sun, J., Pilch, D.R. and Marzluff, W.F. (1992) Nucleic Acid. Res. 20, 6057-6066.
Takeshita, K., Forget, B.G., Scarpa, A. and Benz, E.J. (1984) Blood 64, 13-22.
Tokunaga, K., Taniguchi, H., Shimizu, M. and Sakiyama, S. (1986) Nucleic Acid. Res.
14, 2829.
Tonegawa, S. (1983) Nature 302, 575-581.
Tonegawa, S. (1985) Sci. Am 253, 122-142.

199
Tucker, P.W., Marcu, K.B., Newell, N., Richards, J. and Blattner, P.R. (1979)
Science 206, 1303-1306.
Urlaub, G., Mitchell, P.J., Ciudad, C.J. and Chasin, L.A. (1989) Mol. Cell. Biol. 9,
2868-2880.
Wahl, M.R., Beck-Engeser, G.B. and Burrows, P.D. (1984) Proc. Natl. Acad. Sci. USA
81, 867-870.
Wahl, M.R., Burrows, P.D., vonGabain, A. and Steinberg, C. (1985) Proc. Natl. Acad.
Sci. USA 82, 479-482.
Wall, R. and Kuehl, M. (1983) Ann. Rev. Immunol. 1, 394-422.
Wilhelm, J.E. and Vale, R.D. (1993) J. Cell Biol. 123, 269-274.
Wilkinson, M.F. (1988) Nucleic Acid. Res. 16, 10934.
Zandomeni, R., Bunick, D., Ackerman, S., Mittleman, B. and Weissmann, R. (1983)
J. Mol. Biol. 167, 561-574.

VITA
The author, Tianhong Li, was born in Beijing, People's Republic of China on
April 28, 1965 to Biqian Ye and Yichang Li.
Her secondary education was completed in July, 1983 at the Middle School
Attached to Qinghua University. In September, 1983, Ms. Li entered the School of
Medicine, Beijing Medical University, and received an M.D. in July, 1989. Ms. Li
began her graduate studies in the Department of Microbiology and Immunology, Loyola
University Chicago, in August, 1989. She joined the laboratory of Hans-Martin Jack,
Ph.D., in February, 1991. Ms. Li was the recipient of the Graduate School Assistantship
from August, 1989 to July, 1993. In the academic year of 1993-1994, Ms. Li was
awarded a University Dissertation Fellowship.
Ms. Li has accepted a position as a postdoctoral fellow in the laboratory of David
A. Dichek, M.D., at the Gladstone Institute of Cardiovascular Disease, University of
California at San Francisco, San Francisco, California. She will move on to study the
direct in vivo gene transfer into the blood vessel wall.

200

APPROVAL SHEET
The dissertation submitted by Tianhong Li has been read and approved by the following
committee:
Dr. Hans-Martin Jack, Ph.D., Director
Assistant Professor, Department of Microbiology and Immunology
Loyola University of Chicago
Dr. Sally A. Amero, Ph.D.
Assistant Professor, Department of Molecular and Cellular Biochemistry
Loyola University of Chicago
Dr. Thomas M. Gallagher, Ph.D.
Assistant Professor, Department of Microbiology and Immunology
Loyola University of Chicago
Dr. Phong T. Le, Ph.D.
Assistant Professor, Department of Cell Biology, Neurobiology and Anatomy
Loyola University of Chicago
Dr. Alan J. Wolfe, Ph.D.
Assistant Professor, Department of Microbiology and Immunology
Loyola University of Chicago
The final copies have been examined by the director of the dissertation and the signature
which appears below verifies the fact that any necessary changes have been incorporated
and that the dissertation is now given the final approval by the Committee with reference
to content and form.
This dissertation is, therefore, accepted in partial fulfillment of the requirements for the
degree of Doctor of Philosophy.

. ).,\ \q(

~(
Date

(

